data_2alb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2alb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HH ' ' C ' ' A' ' 99' ' ' GLY . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.407 ' C ' ' HH ' ' A' ' 91' ' ' TYR . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.403 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.005 0.431 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -125.47 -6.58 6.98 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.97 -12.15 21.57 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -69.04 153.83 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.05 1.34 . . . . 0.0 111.947 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -60.56 137.46 58.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.771 0.829 . . . . 0.0 112.134 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.11 -172.62 40.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.63 1.109 . . . . 0.0 113.208 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -57.7 -23.3 51.01 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.5 p -57.05 -38.25 72.96 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.6 -34.34 75.61 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.128 0.876 . . . . 0.0 112.579 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.32 -34.18 59.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.921 1.288 . . . . 0.0 111.878 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.36 -36.4 76.82 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.05 70.43 0.03 OUTLIER Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.192 -0.782 . . . . 0.0 114.412 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.73 -15.77 26.81 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.413 2.742 . . . . 0.0 113.763 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.15 147.73 50.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.568 1.147 . . . . 0.0 112.426 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 m 57.82 9.66 0.93 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.973 2.109 . . . . 0.0 116.619 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.679 1.592 . . . . 0.0 111.567 173.281 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.941 0.401 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.83 -17.03 2.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.706 1.202 . . . . 0.0 112.673 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.23 -29.13 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -68.68 -16.55 63.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.045 1.738 . . . . 0.0 114.905 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.6 p -70.18 -19.95 63.16 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.04 1.82 57.02 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -127.8 -19.68 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.651 1.18 . . . . 0.0 114.151 -171.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.2 p -57.93 -32.23 67.58 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.348 -1.47 . . . . 0.0 113.143 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.42 -5.81 16.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.74 1.616 . . . . 0.0 114.777 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -130.3 -22.81 2.75 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.854 1.661 . . . . 0.0 113.531 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.7 -35.63 75.25 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.38 79.62 0.03 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.298 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.71 -7.26 20.01 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.819 3.013 . . . . 0.0 115.299 -170.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.42 17.09 13.01 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.813 1.645 . . . . 0.0 112.482 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m -131.95 10.43 4.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.806 1.643 . . . . 0.0 113.687 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.854 2.061 . . . . 0.0 112.057 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.427 0.156 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -127.71 2.33 6.1 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.81 -5.9 16.36 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -51.25 124.66 12.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 113.955 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.1 t -62.89 132.56 52.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.21 1.004 . . . . 0.0 111.661 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.94 -36.96 1.28 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.244 1.402 . . . . 0.0 113.187 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -141.05 -14.22 0.91 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.229 1.012 . . . . 0.0 113.565 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -59.88 -34.39 73.1 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.063 -1.648 . . . . 0.0 112.592 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -65.54 -15.68 62.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.747 1.619 . . . . 0.0 114.363 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -104.62 -14.09 15.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.691 1.996 . . . . 0.0 113.747 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' HH ' ' C ' ' A' ' 99' ' ' GLY . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' C ' ' HH ' ' A' ' 91' ' ' TYR . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.38 -19.38 65.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.74 47.51 0.24 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.17 -15.75 28.64 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.329 2.686 . . . . 0.0 113.962 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.32 10.21 1.24 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.139 2.176 . . . . 0.0 116.605 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.1 m -149.79 139.31 21.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.769 2.028 . . . . 0.0 110.372 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.611 1.564 . . . . 0.0 113.62 172.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.354 0.121 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.49 -30.86 19.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.256 1.022 . . . . 0.0 110.377 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.86 -19.79 15.8 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.4 m95 41.2 43.8 2.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.415 1.886 . . . . 0.0 114.388 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m 55.9 30.02 15.2 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.995 2.118 . . . . 0.0 115.418 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.51 -18.52 0.02 OUTLIER Glycine 0 N--CA 1.481 1.688 0 N-CA-C 118.015 1.966 . . . . 0.0 118.015 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -94.79 -13.39 25.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.439 1.62 . . . . 0.0 113.881 -173.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.0 t -63.08 -45.12 93.64 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.552 -0.717 . . . . 0.0 111.566 173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -55.29 -28.98 57.23 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.894 1.678 . . . . 0.0 114.074 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -87.27 -12.48 46.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.787 1.635 . . . . 0.0 114.644 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.38 58.64 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.99 54.77 0.13 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.343 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.11 -17.29 54.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.664 2.909 . . . . 0.0 114.335 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.08 2.87 19.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.665 1.586 . . . . 0.0 113.269 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.3 m -82.32 4.12 25.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.563 1.545 . . . . 0.0 114.316 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.246 2.218 . . . . 0.0 113.196 -175.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.7 0.286 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.46 -17.46 64.2 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.633 1.173 . . . . 0.0 113.79 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.34 30.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -59.67 146.32 41.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 120.246 1.384 . . . . 0.0 112.408 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.15 -23.27 63.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -170.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.68 -14.61 77.88 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.937 0.78 . . . . 0.0 114.9 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -135.03 -31.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.32 -35.74 76.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.501 1.5 . . . . 0.0 113.709 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -58.87 -19.39 41.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.262 1.425 . . . . 0.0 113.854 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -98.6 -15.94 19.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.515 1.526 . . . . 0.0 114.242 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.55 -9.49 58.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.71 161.65 37.66 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.725 1.631 . . . . 0.0 113.609 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.18 -20.09 43.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.203 2.602 . . . . 0.0 113.796 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.09 61.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.8 p -75.13 -9.4 58.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.628 1.971 . . . . 0.0 113.607 -170.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.82 6.26 3.69 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.691 1.197 . . . . 0.0 113.668 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.55 -23.99 22.68 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -80.49 -2.28 45.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.94 1.296 . . . . 0.0 114.21 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.0 m -65.91 -21.36 66.44 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.49 -52.49 3.47 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.668 1.604 . . . . 0.0 113.545 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -70.32 -4.83 24.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.458 1.103 . . . . 0.0 113.767 171.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.92 -35.24 66.4 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.138 -0.976 . . . . 0.0 111.81 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -65.02 -16.93 63.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.363 . . . . 0.0 114.634 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.49 -22.19 30.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.091 1.356 . . . . 0.0 112.903 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.74 -32.45 73.58 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.01 -41.68 1.32 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -52.34 -33.14 54.67 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.967 3.111 . . . . 0.0 116.203 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.12 61.36 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -138.12 -14.83 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.588 172.1 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.014 0.435 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.27 7.36 4.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.94 1.296 . . . . 0.0 113.31 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.69 13.42 2.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -57.44 108.6 0.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.963 1.705 . . . . 0.0 112.874 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -58.07 -30.49 66.25 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.73 -16.79 59.56 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.462 1.506 . . . . 0.0 114.709 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -121.82 -28.97 4.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.809 1.244 . . . . 0.0 112.756 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.8 m -62.88 -35.8 81.19 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.325 -0.859 . . . . 0.0 112.611 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -50.94 -34.55 29.17 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -94.85 -16.78 22.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.675 2.39 . . . . 0.0 113.239 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.403 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.92 69.04 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.45 -179.25 21.43 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 124.875 1.226 . . . . 0.0 114.468 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.17 -21.59 23.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.72 2.947 . . . . 0.0 114.485 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.59 43.07 3.08 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.777 2.031 . . . . 0.0 115.674 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.1 m -124.36 11.16 8.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.844 1.258 . . . . 0.0 114.287 -170.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.575 1.95 . . . . 0.0 112.55 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.863 0.363 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.89 -26.94 2.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.578 1.551 . . . . 0.0 112.402 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.68 -22.78 18.15 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -61.91 -23.65 66.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.209 1.404 . . . . 0.0 113.731 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.19 145.83 55.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.225 1.01 . . . . 0.0 112.832 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.61 72.48 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.191 0.9 . . . . 0.0 115.02 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -107.2 0.86 23.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.1 t -58.34 -35.5 72.02 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.73 -1.231 . . . . 0.0 111.243 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -64.83 -24.65 67.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.589 1.556 . . . . 0.0 113.169 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -97.2 -29.3 13.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.775 1.63 . . . . 0.0 113.122 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.79 60.7 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.62 152.21 22.9 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 126.535 2.017 . . . . 0.0 111.826 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.37 -29.22 11.49 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.992 2.461 . . . . 0.0 113.49 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 46.79 24.86 0.38 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.335 2.254 . . . . 0.0 116.214 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -140.21 -15.31 0.99 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 127.116 2.166 . . . . 0.0 112.513 -172.627 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -76.77 -18.23 58.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.39 2.73 0.8 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 136.16 57.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.239 1.416 . . . . 0.0 114.585 -169.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.73 -18.67 60.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.755 1.622 . . . . 0.0 115.352 -172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.32 -30.81 71.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.401 1.0 . . . . 0.0 114.148 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -136.41 -20.64 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.2 p -63.16 -21.14 66.01 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.785 2.084 . . . . 0.0 114.319 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -93.1 -14.42 27.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.967 1.707 . . . . 0.0 113.831 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -107.3 -23.86 12.08 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.199 1.8 . . . . 0.0 113.466 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.19 -1.18 23.91 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.83 -179.03 52.75 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.674 1.131 . . . . 0.0 114.775 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.75 4.47 5.61 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.722 3.615 . . . . 0.0 114.732 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.89 -6.17 3.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.241 1.816 . . . . 0.0 115.857 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -62.62 -16.34 56.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.709 1.604 . . . . 0.0 114.924 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.216 1.806 . . . . 0.0 114.394 177.62 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -79.44 -23.29 43.25 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.542 -0.724 . . . . 0.0 112.7 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.18 -35.62 74.12 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -83.82 -8.65 59.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.17 21.64 3.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.122 1.769 . . . . 0.0 112.289 -173.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.85 -156.73 8.16 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.389 0.995 . . . . 0.0 114.521 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.39 31.71 4.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.093 1.757 . . . . 0.0 112.055 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.5 m -52.48 -39.61 61.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.741 1.216 . . . . 0.0 112.54 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.8 -22.23 61.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.245 2.218 . . . . 0.0 116.084 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -103.7 -23.71 13.42 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.873 2.069 . . . . 0.0 113.831 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.35 -25.98 59.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.89 66.55 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.281 -1.288 . . . . 0.0 113.576 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.21 -30.39 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 125.046 3.83 . . . . 0.0 115.586 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.06 -7.78 50.86 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 m -134.92 13.27 3.64 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.257 1.45 0 C-N-CA 126.676 1.99 . . . . 0.0 112.511 176.045 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -130.3 7.91 5.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.191 1.397 . . . . 0.0 113.172 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.64 -1.62 11.0 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.9 172.73 12.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.048 2.139 . . . . 0.0 112.153 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.7 m 51.81 31.74 8.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.868 1.667 . . . . 0.0 114.067 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.98 -176.14 43.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.664 1.602 . . . . 0.0 113.097 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -106.01 26.33 9.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.471 1.109 . . . . 0.0 113.434 -170.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 t -54.15 -39.77 66.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.927 0.891 . . . . 0.0 113.064 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -64.41 -17.31 63.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.425 1.49 . . . . 0.0 114.083 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.73 -29.49 8.31 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.491 1.517 . . . . 0.0 113.262 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.96 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.16 -177.79 40.1 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.947 1.26 . . . . 0.0 113.795 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.49 -23.28 76.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.637 3.558 . . . . 0.0 115.097 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.04 14.65 3.53 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.473 2.309 . . . . 0.0 115.593 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -137.99 14.9 2.86 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.245 1.818 . . . . 0.0 112.946 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 126.207 1.803 . . . . 0.0 114.408 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -130.99 13.61 5.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.401 1.48 . . . . 0.0 112.558 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.17 29.73 0.42 Allowed 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -78.13 5.39 10.2 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.644 1.578 . . . . 0.0 115.074 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.9 m 60.29 18.16 7.72 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.459 1.904 . . . . 0.0 114.884 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.34 -52.08 18.97 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.566 -0.709 . . . . 0.0 112.665 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -138.85 -9.58 1.36 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.6 p -69.37 -12.51 61.72 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -105.65 3.82 29.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.496 1.518 . . . . 0.0 113.314 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -123.14 -35.9 2.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.013 1.725 . . . . 0.0 112.425 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.16 -27.64 65.71 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.85 52.13 40.87 Favored Glycine 0 CA--C 1.546 1.983 0 C-N-CA 125.32 1.438 . . . . 0.0 115.868 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.49 -6.71 18.68 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.917 3.078 . . . . 0.0 115.105 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.83 158.62 10.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.906 1.283 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m 58.17 27.56 15.24 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.17 1.788 . . . . 0.0 114.734 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.476 1.911 . . . . 0.0 110.429 177.35 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 119.847 -0.12 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.2 -30.29 63.42 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.604 -0.685 . . . . 0.0 111.901 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.74 -12.6 22.1 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -67.88 168.96 10.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.032 1.733 . . . . 0.0 113.188 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 18.6 p -57.55 129.1 40.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.116 0.967 . . . . 0.0 112.959 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 164.34 179.04 38.26 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.088 0.852 . . . . 0.0 113.897 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -70.01 -4.4 20.67 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.6 m -61.58 -40.75 95.9 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.129 -0.982 . . . . 0.0 111.295 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -68.67 -26.01 65.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.891 1.676 . . . . 0.0 113.582 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -79.78 -25.47 40.94 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.917 1.287 . . . . 0.0 113.144 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -19.93 42.97 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.6 176.61 46.87 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.492 1.044 . . . . 0.0 113.689 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.46 -17.49 23.71 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.555 2.836 . . . . 0.0 113.377 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.87 164.45 35.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.915 1.686 . . . . 0.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.6 p -142.41 6.5 1.69 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 127.11 2.164 . . . . 0.0 112.76 -176.79 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.721 0.296 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.03 -23.66 2.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.318 1.447 . . . . 0.0 112.536 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.88 -7.23 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -69.11 -27.88 65.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.6 m -80.06 173.82 12.21 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.316 1.046 . . . . 0.0 113.42 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.23 19.58 5.48 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.608 1.575 . . . . 0.0 114.714 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -57.55 -24.32 55.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.261 1.824 . . . . 0.0 115.261 -170.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.6 m -60.92 -21.8 63.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.394 1.078 . . . . 0.0 112.851 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -118.21 -7.14 10.81 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.189 1.396 . . . . 0.0 114.355 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -121.13 -16.3 8.02 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.205 1.402 . . . . 0.0 114.5 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.5 73.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.81 -58.19 15.27 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.767 1.651 . . . . 0.0 114.849 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.21 -27.43 41.27 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.668 2.246 . . . . 0.0 113.242 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -14.57 61.93 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m 57.49 23.47 9.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.696 1.998 . . . . 0.0 115.007 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 126.041 1.736 . . . . 0.0 113.471 176.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.84 -33.06 74.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.625 0.77 . . . . 0.0 112.225 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -10.7 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -87.6 -2.12 58.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.381 . . . . 0.0 114.352 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -68.2 -14.46 63.0 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.62 -39.05 1.71 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.089 1.804 . . . . 0.0 114.692 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.1 0.63 11.01 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.873 1.669 . . . . 0.0 114.02 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.8 m -54.1 -39.49 66.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.954 1.701 . . . . 0.0 112.778 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -53.51 -31.96 48.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.77 2.028 . . . . 0.0 114.997 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -87.78 -21.23 25.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.494 1.518 . . . . 0.0 113.564 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.6 66.76 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.82 51.23 50.58 Favored Glycine 0 CA--C 1.544 1.874 0 C-N-CA 125.606 1.575 . . . . 0.0 116.066 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 -19.91 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.349 2.699 . . . . 0.0 114.558 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.76 13.09 1.7 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.173 1.389 . . . . 0.0 113.929 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -106.89 1.22 24.47 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.04 1.336 . . . . 0.0 114.389 -172.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.686 1.995 . . . . 0.0 110.595 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -139.8 9.28 2.38 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.43 -33.65 97.36 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -67.11 -14.28 62.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 p -126.26 3.51 7.08 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.24 -19.4 1.91 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -53.24 -39.04 63.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.016 1.908 . . . . 0.0 115.493 -168.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.9 p -66.28 -7.89 21.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -148.31 -34.64 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -82.56 -30.59 29.55 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -19.44 65.72 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.96 -169.48 33.21 Favored Glycine 0 CA--C 1.544 1.852 0 C-N-CA 125.842 1.687 . . . . 0.0 113.348 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.1 -27.46 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.75 2.967 . . . . 0.0 113.894 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.97 46.57 4.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.383 1.873 . . . . 0.0 115.044 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -65.38 -16.53 63.71 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.304 2.241 . . . . 0.0 110.471 -179.803 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.537 0.208 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.5 -20.27 54.58 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.85 -24.82 67.89 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -17.74 64.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.7 m -75.54 -8.71 57.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.25 -50.2 4.36 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.278 1.418 . . . . 0.0 114.831 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -60.06 -32.03 70.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.167 0.987 . . . . 0.0 112.093 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.69 -37.43 87.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.613 1.165 . . . . 0.0 112.214 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -69.65 -28.68 66.1 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.368 1.467 . . . . 0.0 113.081 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.6 -31.59 59.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.043 1.337 . . . . 0.0 112.478 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.44 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 66.93 0.11 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.158 -1.357 . . . . 0.0 114.52 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.69 -28.96 59.25 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 115.196 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.81 169.77 20.33 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.341 1.856 . . . . 0.0 111.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.735 1.614 . . . . 0.0 113.739 177.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.464 0.173 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.97 -23.42 52.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.66 -8.03 22.12 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -68.47 -23.39 64.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.4 m -72.66 143.07 48.25 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.138 0.975 . . . . 0.0 111.888 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -23.47 60.69 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.448 1.023 . . . . 0.0 114.825 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.87 -16.09 60.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.99 1.316 . . . . 0.0 114.145 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.38 -38.24 65.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -69.51 -19.52 63.73 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -103.15 -35.45 8.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.284 1.433 . . . . 0.0 112.627 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.25 -5.5 25.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.3 -162.31 30.54 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.835 1.683 . . . . 0.0 113.061 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -21.37 27.69 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.079 2.519 . . . . 0.0 113.722 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.46 167.02 19.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.771 1.228 . . . . 0.0 112.509 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -152.68 160.47 43.16 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.496 1.518 . . . . 0.0 111.369 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.168 2.187 . . . . 0.0 111.909 -177.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.393 0.616 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.48 -13.81 4.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.613 1.565 . . . . 0.0 112.417 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.01 4.45 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -66.01 -14.63 61.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.405 1.482 . . . . 0.0 114.264 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.5 p -141.83 167.68 21.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.672 1.589 . . . . 0.0 112.319 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.62 4.36 69.16 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.94 -16.81 53.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.356 1.578 . . . . 0.0 114.25 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.2 p -54.75 -32.17 59.52 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.222 1.009 . . . . 0.0 113.601 170.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -58.52 -21.62 52.73 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -108.83 -12.7 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.405 2.282 . . . . 0.0 112.966 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.85 -12.57 11.36 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.84 166.53 27.87 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.311 1.434 . . . . 0.0 113.368 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.16 -20.93 12.42 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.613 2.875 . . . . 0.0 114.395 -171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.27 18.72 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.559 1.543 . . . . 0.0 112.41 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -109.36 12.13 24.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.516 1.526 . . . . 0.0 112.911 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.393 2.277 . . . . 0.0 113.28 -176.21 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -81.57 -17.65 47.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.842 0.857 . . . . 0.0 113.27 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.73 -11.9 31.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.33 -20.57 62.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 113.636 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.2 m -72.88 150.1 42.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.538 1.135 . . . . 0.0 112.708 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.83 -24.3 64.4 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.467 1.032 . . . . 0.0 115.172 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -61.49 -19.07 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.916 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.8 t -57.18 -44.06 83.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.04 . . . . 0.0 111.74 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -63.08 -28.96 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.227 1.411 . . . . 0.0 113.344 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -91.02 -37.08 13.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.55 78.61 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.8 -57.49 12.21 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-O 118.693 -1.06 . . . . 0.0 114.204 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.0 2.85 7.16 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.959 3.106 . . . . 0.0 115.154 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.6 17.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -128.29 9.42 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.698 1.599 . . . . 0.0 113.781 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.642 1.577 . . . . 0.0 111.175 178.768 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 57' ' ' ALA . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 57' ' ' ALA . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 57' ' ' ALA . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 57' ' ' ALA . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.005 0.431 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -125.47 -6.58 6.98 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.97 -12.15 21.57 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -69.04 153.83 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.05 1.34 . . . . 0.0 111.947 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -60.56 137.46 58.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.771 0.829 . . . . 0.0 112.134 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.11 -172.62 40.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.63 1.109 . . . . 0.0 113.208 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -57.7 -23.3 51.01 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.5 p -57.05 -38.25 72.96 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.6 -34.34 75.61 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.128 0.876 . . . . 0.0 112.579 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.32 -34.18 59.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.921 1.288 . . . . 0.0 111.878 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.36 -36.4 76.82 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.05 70.43 0.03 OUTLIER Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.192 -0.782 . . . . 0.0 114.412 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.73 -15.77 26.81 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.413 2.742 . . . . 0.0 113.763 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.15 147.73 50.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.568 1.147 . . . . 0.0 112.426 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 m 57.82 9.66 0.93 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.973 2.109 . . . . 0.0 116.619 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.679 1.592 . . . . 0.0 111.567 173.281 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.941 0.401 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.83 -17.03 2.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.706 1.202 . . . . 0.0 112.673 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.23 -29.13 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -68.68 -16.55 63.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.045 1.738 . . . . 0.0 114.905 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.6 p -70.18 -19.95 63.16 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.04 1.82 57.02 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -127.8 -19.68 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.651 1.18 . . . . 0.0 114.151 -171.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.2 p -57.93 -32.23 67.58 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.348 -1.47 . . . . 0.0 113.143 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.42 -5.81 16.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.74 1.616 . . . . 0.0 114.777 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -130.3 -22.81 2.75 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.854 1.661 . . . . 0.0 113.531 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.7 -35.63 75.25 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.38 79.62 0.03 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.298 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.71 -7.26 20.01 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.819 3.013 . . . . 0.0 115.299 -170.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.42 17.09 13.01 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.813 1.645 . . . . 0.0 112.482 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m -131.95 10.43 4.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.806 1.643 . . . . 0.0 113.687 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.854 2.061 . . . . 0.0 112.057 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.427 0.156 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -127.71 2.33 6.1 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.81 -5.9 16.36 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -51.25 124.66 12.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 113.955 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.1 t -62.89 132.56 52.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.21 1.004 . . . . 0.0 111.661 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.94 -36.96 1.28 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.244 1.402 . . . . 0.0 113.187 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -141.05 -14.22 0.91 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.229 1.012 . . . . 0.0 113.565 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -59.88 -34.39 73.1 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.063 -1.648 . . . . 0.0 112.592 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -65.54 -15.68 62.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.747 1.619 . . . . 0.0 114.363 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -104.62 -14.09 15.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.691 1.996 . . . . 0.0 113.747 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.38 -19.38 65.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.74 47.51 0.24 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.17 -15.75 28.64 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.329 2.686 . . . . 0.0 113.962 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.32 10.21 1.24 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.139 2.176 . . . . 0.0 116.605 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.1 m -149.79 139.31 21.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.769 2.028 . . . . 0.0 110.372 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.611 1.564 . . . . 0.0 113.62 172.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.354 0.121 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.49 -30.86 19.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.256 1.022 . . . . 0.0 110.377 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.86 -19.79 15.8 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.4 m95 41.2 43.8 2.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.415 1.886 . . . . 0.0 114.388 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m 55.9 30.02 15.2 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.995 2.118 . . . . 0.0 115.418 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.51 -18.52 0.02 OUTLIER Glycine 0 N--CA 1.481 1.688 0 N-CA-C 118.015 1.966 . . . . 0.0 118.015 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -94.79 -13.39 25.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.439 1.62 . . . . 0.0 113.881 -173.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.0 t -63.08 -45.12 93.64 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.552 -0.717 . . . . 0.0 111.566 173.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -55.29 -28.98 57.23 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.894 1.678 . . . . 0.0 114.074 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -87.27 -12.48 46.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.787 1.635 . . . . 0.0 114.644 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.38 58.64 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.99 54.77 0.13 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.343 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.11 -17.29 54.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.664 2.909 . . . . 0.0 114.335 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.08 2.87 19.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.665 1.586 . . . . 0.0 113.269 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.3 m -82.32 4.12 25.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.563 1.545 . . . . 0.0 114.316 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.246 2.218 . . . . 0.0 113.196 -175.856 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.7 0.286 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.46 -17.46 64.2 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.633 1.173 . . . . 0.0 113.79 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.34 30.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -59.67 146.32 41.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 120.246 1.384 . . . . 0.0 112.408 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.15 -23.27 63.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -170.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.68 -14.61 77.88 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.937 0.78 . . . . 0.0 114.9 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -135.03 -31.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.32 -35.74 76.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.501 1.5 . . . . 0.0 113.709 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -58.87 -19.39 41.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.262 1.425 . . . . 0.0 113.854 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -98.6 -15.94 19.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.515 1.526 . . . . 0.0 114.242 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.55 -9.49 58.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.71 161.65 37.66 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.725 1.631 . . . . 0.0 113.609 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.18 -20.09 43.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.203 2.602 . . . . 0.0 113.796 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.09 61.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.8 p -75.13 -9.4 58.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.628 1.971 . . . . 0.0 113.607 -170.949 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.82 6.26 3.69 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.691 1.197 . . . . 0.0 113.668 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 57' ' ' ALA . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.55 -23.99 22.68 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -80.49 -2.28 45.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.94 1.296 . . . . 0.0 114.21 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.0 m -65.91 -21.36 66.44 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.49 -52.49 3.47 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.668 1.604 . . . . 0.0 113.545 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -70.32 -4.83 24.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.458 1.103 . . . . 0.0 113.767 171.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.92 -35.24 66.4 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.138 -0.976 . . . . 0.0 111.81 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -65.02 -16.93 63.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.363 . . . . 0.0 114.634 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.49 -22.19 30.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.091 1.356 . . . . 0.0 112.903 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.74 -32.45 73.58 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.01 -41.68 1.32 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -52.34 -33.14 54.67 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.967 3.111 . . . . 0.0 116.203 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.12 61.36 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -138.12 -14.83 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.588 172.1 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.014 0.435 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.27 7.36 4.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.94 1.296 . . . . 0.0 113.31 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.69 13.42 2.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -57.44 108.6 0.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.963 1.705 . . . . 0.0 112.874 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -58.07 -30.49 66.25 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.73 -16.79 59.56 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.462 1.506 . . . . 0.0 114.709 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -121.82 -28.97 4.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.809 1.244 . . . . 0.0 112.756 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.8 m -62.88 -35.8 81.19 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.325 -0.859 . . . . 0.0 112.611 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -50.94 -34.55 29.17 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -94.85 -16.78 22.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.675 2.39 . . . . 0.0 113.239 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.92 69.04 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.45 -179.25 21.43 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 124.875 1.226 . . . . 0.0 114.468 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.17 -21.59 23.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.72 2.947 . . . . 0.0 114.485 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.59 43.07 3.08 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.777 2.031 . . . . 0.0 115.674 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.1 m -124.36 11.16 8.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.844 1.258 . . . . 0.0 114.287 -170.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.575 1.95 . . . . 0.0 112.55 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.863 0.363 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.89 -26.94 2.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.578 1.551 . . . . 0.0 112.402 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 57' ' ' ALA . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.68 -22.78 18.15 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -61.91 -23.65 66.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.209 1.404 . . . . 0.0 113.731 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.19 145.83 55.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.225 1.01 . . . . 0.0 112.832 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.61 72.48 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.191 0.9 . . . . 0.0 115.02 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -107.2 0.86 23.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.1 t -58.34 -35.5 72.02 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.73 -1.231 . . . . 0.0 111.243 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -64.83 -24.65 67.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.589 1.556 . . . . 0.0 113.169 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -97.2 -29.3 13.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.775 1.63 . . . . 0.0 113.122 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.79 60.7 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.62 152.21 22.9 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 126.535 2.017 . . . . 0.0 111.826 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.37 -29.22 11.49 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.992 2.461 . . . . 0.0 113.49 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 46.79 24.86 0.38 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.335 2.254 . . . . 0.0 116.214 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -140.21 -15.31 0.99 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 127.116 2.166 . . . . 0.0 112.513 -172.627 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -76.77 -18.23 58.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.39 2.73 0.8 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 136.16 57.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.239 1.416 . . . . 0.0 114.585 -169.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.73 -18.67 60.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.755 1.622 . . . . 0.0 115.352 -172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.32 -30.81 71.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.401 1.0 . . . . 0.0 114.148 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -136.41 -20.64 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.2 p -63.16 -21.14 66.01 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.785 2.084 . . . . 0.0 114.319 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -93.1 -14.42 27.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.967 1.707 . . . . 0.0 113.831 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -107.3 -23.86 12.08 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.199 1.8 . . . . 0.0 113.466 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.19 -1.18 23.91 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.83 -179.03 52.75 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.674 1.131 . . . . 0.0 114.775 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.75 4.47 5.61 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.722 3.615 . . . . 0.0 114.732 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.89 -6.17 3.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.241 1.816 . . . . 0.0 115.857 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -62.62 -16.34 56.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.709 1.604 . . . . 0.0 114.924 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.216 1.806 . . . . 0.0 114.394 177.62 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -79.44 -23.29 43.25 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.542 -0.724 . . . . 0.0 112.7 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.18 -35.62 74.12 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -83.82 -8.65 59.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.17 21.64 3.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.122 1.769 . . . . 0.0 112.289 -173.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.85 -156.73 8.16 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.389 0.995 . . . . 0.0 114.521 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.39 31.71 4.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.093 1.757 . . . . 0.0 112.055 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.5 m -52.48 -39.61 61.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.741 1.216 . . . . 0.0 112.54 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.8 -22.23 61.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.245 2.218 . . . . 0.0 116.084 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -103.7 -23.71 13.42 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.873 2.069 . . . . 0.0 113.831 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.35 -25.98 59.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.89 66.55 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.281 -1.288 . . . . 0.0 113.576 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.21 -30.39 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 125.046 3.83 . . . . 0.0 115.586 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.06 -7.78 50.86 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 m -134.92 13.27 3.64 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.257 1.45 0 C-N-CA 126.676 1.99 . . . . 0.0 112.511 176.045 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -130.3 7.91 5.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.191 1.397 . . . . 0.0 113.172 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 57' ' ' ALA . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.64 -1.62 11.0 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.9 172.73 12.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.048 2.139 . . . . 0.0 112.153 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.7 m 51.81 31.74 8.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.868 1.667 . . . . 0.0 114.067 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.98 -176.14 43.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.664 1.602 . . . . 0.0 113.097 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -106.01 26.33 9.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.471 1.109 . . . . 0.0 113.434 -170.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 t -54.15 -39.77 66.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.927 0.891 . . . . 0.0 113.064 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -64.41 -17.31 63.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.425 1.49 . . . . 0.0 114.083 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.73 -29.49 8.31 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.491 1.517 . . . . 0.0 113.262 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.96 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.16 -177.79 40.1 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.947 1.26 . . . . 0.0 113.795 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.49 -23.28 76.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.637 3.558 . . . . 0.0 115.097 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.04 14.65 3.53 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.473 2.309 . . . . 0.0 115.593 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -137.99 14.9 2.86 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.245 1.818 . . . . 0.0 112.946 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 126.207 1.803 . . . . 0.0 114.408 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -130.99 13.61 5.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.401 1.48 . . . . 0.0 112.558 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 57' ' ' ALA . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.17 29.73 0.42 Allowed 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -78.13 5.39 10.2 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.644 1.578 . . . . 0.0 115.074 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.9 m 60.29 18.16 7.72 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.459 1.904 . . . . 0.0 114.884 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.34 -52.08 18.97 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.566 -0.709 . . . . 0.0 112.665 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -138.85 -9.58 1.36 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.6 p -69.37 -12.51 61.72 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -105.65 3.82 29.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.496 1.518 . . . . 0.0 113.314 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -123.14 -35.9 2.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.013 1.725 . . . . 0.0 112.425 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.16 -27.64 65.71 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.85 52.13 40.87 Favored Glycine 0 CA--C 1.546 1.983 0 C-N-CA 125.32 1.438 . . . . 0.0 115.868 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.49 -6.71 18.68 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.917 3.078 . . . . 0.0 115.105 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.83 158.62 10.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.906 1.283 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m 58.17 27.56 15.24 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.17 1.788 . . . . 0.0 114.734 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.476 1.911 . . . . 0.0 110.429 177.35 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 119.847 -0.12 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.2 -30.29 63.42 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.604 -0.685 . . . . 0.0 111.901 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.74 -12.6 22.1 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -67.88 168.96 10.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.032 1.733 . . . . 0.0 113.188 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 18.6 p -57.55 129.1 40.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.116 0.967 . . . . 0.0 112.959 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 164.34 179.04 38.26 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.088 0.852 . . . . 0.0 113.897 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -70.01 -4.4 20.67 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.6 m -61.58 -40.75 95.9 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.129 -0.982 . . . . 0.0 111.295 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -68.67 -26.01 65.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.891 1.676 . . . . 0.0 113.582 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -79.78 -25.47 40.94 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.917 1.287 . . . . 0.0 113.144 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -19.93 42.97 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.6 176.61 46.87 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.492 1.044 . . . . 0.0 113.689 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.46 -17.49 23.71 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.555 2.836 . . . . 0.0 113.377 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.87 164.45 35.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.915 1.686 . . . . 0.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.6 p -142.41 6.5 1.69 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 127.11 2.164 . . . . 0.0 112.76 -176.79 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.721 0.296 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.03 -23.66 2.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.318 1.447 . . . . 0.0 112.536 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.88 -7.23 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -69.11 -27.88 65.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.6 m -80.06 173.82 12.21 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.316 1.046 . . . . 0.0 113.42 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.23 19.58 5.48 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.608 1.575 . . . . 0.0 114.714 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -57.55 -24.32 55.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.261 1.824 . . . . 0.0 115.261 -170.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.6 m -60.92 -21.8 63.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.394 1.078 . . . . 0.0 112.851 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -118.21 -7.14 10.81 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.189 1.396 . . . . 0.0 114.355 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -121.13 -16.3 8.02 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.205 1.402 . . . . 0.0 114.5 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.5 73.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.81 -58.19 15.27 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.767 1.651 . . . . 0.0 114.849 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.21 -27.43 41.27 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.668 2.246 . . . . 0.0 113.242 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -14.57 61.93 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m 57.49 23.47 9.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.696 1.998 . . . . 0.0 115.007 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 126.041 1.736 . . . . 0.0 113.471 176.839 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.84 -33.06 74.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.625 0.77 . . . . 0.0 112.225 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -10.7 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -87.6 -2.12 58.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.381 . . . . 0.0 114.352 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -68.2 -14.46 63.0 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.62 -39.05 1.71 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.089 1.804 . . . . 0.0 114.692 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.1 0.63 11.01 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.873 1.669 . . . . 0.0 114.02 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.8 m -54.1 -39.49 66.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.954 1.701 . . . . 0.0 112.778 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -53.51 -31.96 48.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.77 2.028 . . . . 0.0 114.997 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -87.78 -21.23 25.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.494 1.518 . . . . 0.0 113.564 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.6 66.76 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.82 51.23 50.58 Favored Glycine 0 CA--C 1.544 1.874 0 C-N-CA 125.606 1.575 . . . . 0.0 116.066 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 -19.91 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.349 2.699 . . . . 0.0 114.558 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.76 13.09 1.7 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.173 1.389 . . . . 0.0 113.929 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -106.89 1.22 24.47 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.04 1.336 . . . . 0.0 114.389 -172.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.686 1.995 . . . . 0.0 110.595 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -139.8 9.28 2.38 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.43 -33.65 97.36 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -67.11 -14.28 62.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 p -126.26 3.51 7.08 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.24 -19.4 1.91 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -53.24 -39.04 63.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.016 1.908 . . . . 0.0 115.493 -168.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.9 p -66.28 -7.89 21.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -148.31 -34.64 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -82.56 -30.59 29.55 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -19.44 65.72 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.96 -169.48 33.21 Favored Glycine 0 CA--C 1.544 1.852 0 C-N-CA 125.842 1.687 . . . . 0.0 113.348 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.1 -27.46 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.75 2.967 . . . . 0.0 113.894 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.97 46.57 4.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.383 1.873 . . . . 0.0 115.044 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -65.38 -16.53 63.71 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.304 2.241 . . . . 0.0 110.471 -179.803 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.537 0.208 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.5 -20.27 54.58 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.85 -24.82 67.89 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -17.74 64.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.7 m -75.54 -8.71 57.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.25 -50.2 4.36 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.278 1.418 . . . . 0.0 114.831 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -60.06 -32.03 70.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.167 0.987 . . . . 0.0 112.093 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.69 -37.43 87.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.613 1.165 . . . . 0.0 112.214 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -69.65 -28.68 66.1 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.368 1.467 . . . . 0.0 113.081 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.6 -31.59 59.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.043 1.337 . . . . 0.0 112.478 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.44 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 66.93 0.11 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.158 -1.357 . . . . 0.0 114.52 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.69 -28.96 59.25 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 115.196 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.81 169.77 20.33 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.341 1.856 . . . . 0.0 111.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.735 1.614 . . . . 0.0 113.739 177.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.464 0.173 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.97 -23.42 52.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.66 -8.03 22.12 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -68.47 -23.39 64.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.4 m -72.66 143.07 48.25 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.138 0.975 . . . . 0.0 111.888 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -23.47 60.69 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.448 1.023 . . . . 0.0 114.825 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.87 -16.09 60.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.99 1.316 . . . . 0.0 114.145 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.38 -38.24 65.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -69.51 -19.52 63.73 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -103.15 -35.45 8.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.284 1.433 . . . . 0.0 112.627 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.25 -5.5 25.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.3 -162.31 30.54 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.835 1.683 . . . . 0.0 113.061 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -21.37 27.69 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.079 2.519 . . . . 0.0 113.722 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.46 167.02 19.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.771 1.228 . . . . 0.0 112.509 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -152.68 160.47 43.16 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.496 1.518 . . . . 0.0 111.369 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.168 2.187 . . . . 0.0 111.909 -177.875 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.393 0.616 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.48 -13.81 4.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.613 1.565 . . . . 0.0 112.417 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.01 4.45 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -66.01 -14.63 61.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.405 1.482 . . . . 0.0 114.264 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.5 p -141.83 167.68 21.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.672 1.589 . . . . 0.0 112.319 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.62 4.36 69.16 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.94 -16.81 53.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.356 1.578 . . . . 0.0 114.25 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.2 p -54.75 -32.17 59.52 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.222 1.009 . . . . 0.0 113.601 170.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -58.52 -21.62 52.73 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -108.83 -12.7 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.405 2.282 . . . . 0.0 112.966 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.85 -12.57 11.36 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.84 166.53 27.87 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.311 1.434 . . . . 0.0 113.368 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.16 -20.93 12.42 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.613 2.875 . . . . 0.0 114.395 -171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.27 18.72 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.559 1.543 . . . . 0.0 112.41 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -109.36 12.13 24.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.516 1.526 . . . . 0.0 112.911 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.393 2.277 . . . . 0.0 113.28 -176.21 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -81.57 -17.65 47.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.842 0.857 . . . . 0.0 113.27 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.73 -11.9 31.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.33 -20.57 62.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 113.636 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.2 m -72.88 150.1 42.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.538 1.135 . . . . 0.0 112.708 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.83 -24.3 64.4 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.467 1.032 . . . . 0.0 115.172 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -61.49 -19.07 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.916 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.8 t -57.18 -44.06 83.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.04 . . . . 0.0 111.74 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -63.08 -28.96 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.227 1.411 . . . . 0.0 113.344 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -91.02 -37.08 13.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.55 78.61 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.8 -57.49 12.21 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-O 118.693 -1.06 . . . . 0.0 114.204 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.0 2.85 7.16 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.959 3.106 . . . . 0.0 115.154 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.6 17.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -128.29 9.42 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.698 1.599 . . . . 0.0 113.781 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.642 1.577 . . . . 0.0 111.175 178.768 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo . . . . . 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo . . . . . 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 57' ' ' ALA . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 57' ' ' ALA . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 57' ' ' ALA . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 57' ' ' ALA . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.545 0.767 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.005 0.431 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -125.47 -6.58 6.98 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.62 132.14 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.183 1.393 . . . . 0.0 110.218 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.76 133.16 47.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.095 0.958 . . . . 0.0 111.156 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.85 63.77 0.64 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.378 -1.451 . . . . 0.0 110.68 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.2 158.18 33.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.779 1.631 . . . . 0.0 113.856 -170.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -147.56 161.11 41.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.783 1.633 . . . . 0.0 110.752 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -53.93 -23.45 12.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.639 1.176 . . . . 0.0 114.091 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.91 -28.19 66.45 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.54 1.136 . . . . 0.0 113.94 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.13 -12.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -47.26 -44.65 23.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.291 1.436 . . . . 0.0 112.555 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.49 -8.18 3.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.176 1.79 . . . . 0.0 115.311 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 p -106.69 -23.06 12.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.193 1.397 . . . . 0.0 114.161 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -91.24 -29.33 17.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 112.897 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -22.28 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.543 0.737 . . . . 0.0 112.694 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -78.27 -8.38 58.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.216 1.807 . . . . 0.0 113.423 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.85 -7.95 55.72 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.677 0.791 . . . . 0.0 113.093 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 p -61.96 150.86 36.58 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.762 1.625 . . . . 0.0 112.062 172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.47 -68.58 0.1 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.872 0.748 . . . . 0.0 112.953 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -66.97 -35.22 79.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.212 1.005 . . . . 0.0 112.979 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.66 -16.18 56.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.619 1.168 . . . . 0.0 113.835 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -24.1 2.78 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.193 1.854 . . . . 0.0 114.786 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -155.47 173.06 17.22 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.157 1.479 . . . . 0.0 113.399 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.3 ttm -126.2 140.59 52.43 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 109.257 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -105.75 145.11 31.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 108.377 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.41 146.43 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.664 0.786 . . . . 0.0 111.114 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -115.0 116.55 28.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.838 1.655 . . . . 0.0 109.938 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -87.42 131.67 34.24 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.208 0.603 . . . . 0.0 109.711 170.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.24 -176.14 5.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.853 1.261 . . . . 0.0 112.668 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.0 159.75 60.77 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.573 1.149 . . . . 0.0 110.477 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.97 -12.15 21.57 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.928 3.086 . . . . 0.0 114.543 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -69.04 153.83 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.05 1.34 . . . . 0.0 111.947 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -60.56 137.46 58.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.771 0.829 . . . . 0.0 112.134 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 165.11 -172.62 40.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.63 1.109 . . . . 0.0 113.208 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -57.7 -23.3 51.01 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.5 p -57.05 -38.25 72.96 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.6 -34.34 75.61 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.128 0.876 . . . . 0.0 112.579 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.32 -34.18 59.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.921 1.288 . . . . 0.0 111.878 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -84.52 -27.07 27.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.366 1.466 . . . . 0.0 114.07 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.52 -50.59 71.14 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.66 -21.47 39.1 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.295 1.996 . . . . 0.0 113.337 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -78.4 -41.39 33.23 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.819 -0.551 . . . . 0.0 111.563 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -69.08 -34.19 74.73 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.882 -1.136 . . . . 0.0 112.227 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.72 -48.02 80.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.767 1.227 . . . . 0.0 111.378 169.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.89 92.79 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 112.507 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.89 92.17 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.532 -0.73 . . . . 0.0 112.278 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.03 76.96 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.663 -0.648 . . . . 0.0 112.274 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 m -65.44 -45.21 84.69 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.489 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -68.39 -22.72 64.62 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.851 1.26 . . . . 0.0 114.256 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -121.23 17.65 11.52 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.915 1.686 . . . . 0.0 112.581 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -56.22 -30.34 62.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.5 20.92 20.14 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.519 1.533 . . . . 0.0 113.45 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 mt -132.99 -45.97 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.253 1.421 . . . . 0.0 111.889 -170.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 t -148.56 105.68 3.5 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 126.362 1.865 . . . . 0.0 110.073 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.57 132.29 51.28 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.279 2.653 . . . . 0.0 112.107 169.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.71 147.11 46.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.144 1.778 . . . . 0.0 109.744 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.29 160.69 41.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 0.0 113.366 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -130.53 144.2 51.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.716 1.206 . . . . 0.0 111.21 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.19 123.69 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.919 1.288 . . . . 0.0 110.758 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.33 109.7 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.232 1.013 . . . . 0.0 111.858 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.08 -29.79 67.59 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.519 1.528 . . . . 0.0 114.378 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.1 p -71.41 -23.71 61.92 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.085 -1.009 . . . . 0.0 113.699 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.0 15.6 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -137.5 41.51 2.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 124.499 2.095 . . . . 0.0 112.005 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -59.95 -35.87 75.86 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 127.664 2.386 . . . . 0.0 111.192 -169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -61.28 -39.28 89.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.296 1.838 . . . . 0.0 114.202 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.4 m -71.98 -45.83 59.54 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.966 0.906 . . . . 0.0 109.726 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.2 m -72.31 -29.54 63.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -79.42 -34.47 41.68 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.03 0.832 . . . . 0.0 111.656 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.66 -30.05 71.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 111.649 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.18 -7.0 52.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.37 31.51 71.42 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.322 1.439 . . . . 0.0 114.307 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.47 -53.1 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.898 1.279 . . . . 0.0 111.407 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.9 m 52.64 11.02 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.703 2.483 . . . . 0.0 117.703 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.58 169.18 26.69 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.694 2.568 . . . . 0.0 108.969 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.37 159.28 32.1 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.19 140.53 65.14 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 118.515 0.505 . . . . 0.0 112.383 -4.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.0 m -132.36 108.64 9.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.191 1.396 . . . . 0.0 110.084 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.78 134.35 41.07 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.791 0.836 . . . . 0.0 112.554 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -136.93 163.13 31.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.23 135.34 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.473 1.909 . . . . 0.0 110.561 -169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.55 91.48 2.85 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.322 1.449 . . . . 0.0 111.435 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -64.86 125.81 25.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.235 1.414 . . . . 0.0 110.661 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.7 t70 48.77 28.39 1.87 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.501 1.52 . . . . 0.0 114.076 -173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.07 20.78 60.23 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 124.674 1.131 . . . . 0.0 115.295 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.67 143.57 39.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.862 1.665 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -52.16 123.76 11.4 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.57 -37.1 10.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.836 0.854 . . . . 0.0 110.708 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.79 -93.34 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.781 0.705 . . . . 0.0 112.146 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.7 156.81 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.869 1.268 . . . . 0.0 112.127 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.78 150.09 49.1 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.353 0.661 . . . . 0.0 111.925 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -145.22 74.32 1.4 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.705 1.202 . . . . 0.0 111.662 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.8 -177.22 41.28 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.702 1.144 . . . . 0.0 113.558 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.43 146.32 63.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.774 2.983 . . . . 0.0 113.715 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.1 69.94 5.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.296 1.038 . . . . 0.0 110.616 169.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.5 p -152.74 158.43 42.28 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.35 2.26 . . . . 0.0 110.194 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.22 -42.88 70.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.715 0.806 . . . . 0.0 112.635 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 112.374 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.96 93.45 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.737 1.161 . . . . 0.0 112.095 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.4 mm -63.14 -47.77 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 117.868 0.834 . . . . 0.0 111.187 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.79 -44.52 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.893 0.877 . . . . 0.0 110.85 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 m -60.88 -42.94 98.92 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.549 -0.719 . . . . 0.0 112.78 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -60.38 -31.3 70.22 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.38 1.072 . . . . 0.0 112.151 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.24 -53.37 9.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.044 0.938 . . . . 0.0 111.799 169.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -55.46 -38.32 68.92 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.936 -1.103 . . . . 0.0 113.387 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -58.02 -18.52 24.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.592 1.957 . . . . 0.0 115.235 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -121.78 -32.66 3.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 113.285 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.36 -36.4 76.82 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.05 70.43 0.03 OUTLIER Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.192 -0.782 . . . . 0.0 114.412 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.73 -15.77 26.81 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.413 2.742 . . . . 0.0 113.763 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.15 147.73 50.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.568 1.147 . . . . 0.0 112.426 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 m 57.82 9.66 0.93 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.973 2.109 . . . . 0.0 116.619 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.6 t . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.679 1.592 . . . . 0.0 111.567 173.281 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.941 0.401 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -132.83 -17.03 2.51 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.706 1.202 . . . . 0.0 112.673 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.69 134.4 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.207 1.003 . . . . 0.0 110.194 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.26 147.1 51.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.156 0.982 . . . . 0.0 112.422 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.84 95.74 5.26 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.295 1.038 . . . . 0.0 109.562 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.5 mt -106.4 153.51 22.15 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 112.986 -169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.0 p -143.81 174.65 10.63 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.917 1.687 . . . . 0.0 111.444 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -51.81 -26.58 10.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.31 -23.13 38.06 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -138.5 -14.54 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -169.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -54.03 -39.37 66.1 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.686 1.584 . . . . 0.0 112.448 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.89 -8.29 14.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 114.944 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.7 p -91.71 -21.16 20.89 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -95.86 -25.42 16.02 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -23.42 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.317 0.647 . . . . 0.0 112.101 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 m -81.13 -16.94 51.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.554 1.542 . . . . 0.0 113.301 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.22 -8.46 56.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.264 1.026 . . . . 0.0 113.153 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.5 p -59.4 -23.69 62.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.893 1.677 . . . . 0.0 115.179 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.97 -31.65 25.47 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.582 1.087 . . . . 0.0 114.954 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.0 m -81.86 -12.57 58.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.45 -10.98 4.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.535 1.534 . . . . 0.0 114.399 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.7 -28.05 2.84 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.866 1.698 . . . . 0.0 114.642 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.2 172.41 17.64 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.521 1.528 . . . . 0.0 112.284 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.7 ttp -123.21 147.27 47.06 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.409 1.484 . . . . 0.0 109.352 169.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.0 tp -113.33 135.16 54.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.621 1.169 . . . . 0.0 108.836 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.15 143.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.647 0.779 . . . . 0.0 110.589 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -114.31 101.08 8.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.513 1.525 . . . . 0.0 109.266 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.71 128.35 33.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.822 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.75 174.05 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.44 0.696 . . . . 0.0 111.864 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.72 68.95 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.232 . . . . 0.0 108.643 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.23 -29.13 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.05 2.5 . . . . 0.0 114.316 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -68.68 -16.55 63.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.045 1.738 . . . . 0.0 114.905 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.6 p -70.18 -19.95 63.16 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.04 1.82 57.02 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -127.8 -19.68 4.03 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.651 1.18 . . . . 0.0 114.151 -171.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.2 p -57.93 -32.23 67.58 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.348 -1.47 . . . . 0.0 113.143 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.42 -5.81 16.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.74 1.616 . . . . 0.0 114.777 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -130.3 -22.81 2.75 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.854 1.661 . . . . 0.0 113.531 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.2 tp -83.79 -29.85 27.06 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.894 1.278 . . . . 0.0 113.582 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.93 -47.85 85.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.14 -20.67 32.73 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.856 1.704 . . . . 0.0 113.085 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -74.92 -40.96 60.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.102 0.865 . . . . 0.0 111.064 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -73.85 -31.57 63.25 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.315 -0.865 . . . . 0.0 112.601 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.02 -41.2 97.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.791 1.236 . . . . 0.0 111.847 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.4 98.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.02 0.528 . . . . 0.0 111.452 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.11 92.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.24 0.927 . . . . 0.0 112.473 172.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -43.53 98.68 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.033 0.533 . . . . 0.0 111.564 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.5 m -59.74 -43.79 94.08 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.513 1.125 . . . . 0.0 112.352 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -71.41 -24.95 62.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.8 mt -113.47 18.58 17.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.608 1.563 . . . . 0.0 112.346 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.1 113.1 1.95 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.5 1.52 . . . . 0.0 111.65 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.25 1.09 89.87 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.54 1.066 . . . . 0.0 115.055 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.29 -39.78 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.121 1.768 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -144.5 125.48 7.72 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.478 1.511 . . . . 0.0 109.78 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.75 126.82 13.77 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.137 1.891 . . . . 0.0 110.405 170.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.5 136.56 52.88 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.396 1.478 . . . . 0.0 110.476 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.17 163.12 33.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.006 1.322 . . . . 0.0 112.266 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.1 160.86 38.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.47 1.108 . . . . 0.0 112.718 169.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.8 t -144.17 127.49 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.995 1.718 . . . . 0.0 109.146 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.26 100.4 12.67 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.826 1.25 . . . . 0.0 111.33 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -67.02 -21.77 65.92 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -66.1 -21.81 66.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.74 1.154 . . . . 0.0 112.198 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.47 -5.65 11.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.458 1.903 . . . . 0.0 113.048 -174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -146.91 47.8 1.16 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.216 2.206 . . . . 0.0 111.663 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.6 m -62.98 -38.29 90.53 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.452 1.501 . . . . 0.0 111.846 -169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -68.05 -38.2 82.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 112.142 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -61.34 -43.56 98.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.527 0.731 . . . . 0.0 110.597 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 98.4 m -75.25 -34.91 61.44 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -71.02 -18.87 62.57 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.08 -1.013 . . . . 0.0 113.005 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -61.85 -22.33 65.42 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 112.41 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.85 -25.63 4.98 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.97 34.79 3.63 Favored Glycine 0 N--CA 1.471 1.001 0 C-N-CA 123.643 0.639 . . . . 0.0 113.853 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.29 51.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 126.423 1.889 . . . . 0.0 112.079 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.5 m -72.71 -2.28 19.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.957 1.703 . . . . 0.0 114.925 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.95 56.67 0.31 Allowed Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.106 1.336 . . . . 0.0 112.931 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 158.68 3.41 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.83 148.79 91.45 Favored 'Cis proline' 0 C--N 1.355 0.89 0 CA-C-N 118.664 0.558 . . . . 0.0 112.498 -5.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -138.66 111.76 7.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.761 1.224 . . . . 0.0 110.164 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.25 136.01 33.09 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.888 0.475 . . . . 0.0 110.644 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -136.25 155.03 50.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.539 1.536 . . . . 0.0 112.368 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.17 136.96 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 126.117 1.767 . . . . 0.0 109.364 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -130.63 88.72 2.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.398 1.079 . . . . 0.0 110.763 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -65.94 123.35 19.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.468 1.107 . . . . 0.0 110.55 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.32 28.8 1.73 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.207 1.403 . . . . 0.0 114.364 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.62 18.88 46.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.603 1.097 . . . . 0.0 115.436 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.89 139.61 34.41 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.256 1.423 . . . . 0.0 109.945 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.37 112.25 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.131 0.972 . . . . 0.0 112.684 -170.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.78 -38.25 54.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.524 0.73 . . . . 0.0 110.228 170.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.71 -81.64 0.13 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 123.358 0.504 . . . . 0.0 114.068 168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.62 152.18 13.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 0.0 111.803 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.48 151.69 34.53 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.65 0.78 . . . . 0.0 110.544 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -147.52 126.79 13.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.702 1.201 . . . . 0.0 110.504 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.59 -168.0 39.3 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 123.703 0.668 . . . . 0.0 113.626 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.43 -17.96 17.95 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.813 3.675 . . . . 0.0 117.356 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 51.72 51.13 17.26 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.721 1.608 . . . . 0.0 112.268 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.9 p -147.74 164.32 33.96 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.546 2.739 . . . . 0.0 108.9 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.86 -48.09 42.28 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.53 -35.31 80.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.182 1.393 . . . . 0.0 111.868 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.36 -28.03 73.6 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 125.287 1.422 . . . . 0.0 113.78 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.0 mm -79.68 -46.94 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.865 1.332 . . . . 0.0 110.609 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.92 -41.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.668 0.787 . . . . 0.0 111.481 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 m -60.51 -45.23 94.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.82 0.848 . . . . 0.0 113.055 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -63.42 -36.3 83.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.672 -0.642 . . . . 0.0 112.457 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.91 -52.39 20.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.687 0.795 . . . . 0.0 111.877 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -62.69 -32.29 73.35 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.906 -1.121 . . . . 0.0 113.125 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -64.5 -14.71 58.65 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -117.6 -35.26 4.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.026 1.33 . . . . 0.0 112.954 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.7 -35.63 75.25 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.38 79.62 0.03 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.298 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.71 -7.26 20.01 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.819 3.013 . . . . 0.0 115.299 -170.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.42 17.09 13.01 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.813 1.645 . . . . 0.0 112.482 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m -131.95 10.43 4.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.806 1.643 . . . . 0.0 113.687 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.854 2.061 . . . . 0.0 112.057 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.427 0.156 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -127.71 2.33 6.1 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.64 139.59 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.871 1.668 . . . . 0.0 110.259 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.15 148.61 48.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.309 1.043 . . . . 0.0 111.279 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -142.01 89.74 2.21 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.595 1.158 . . . . 0.0 110.171 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.81 167.12 10.73 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.635 1.174 . . . . 0.0 113.299 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -148.63 161.04 42.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.58 1.952 . . . . 0.0 109.427 169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.51 -26.03 19.19 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.62 -26.14 63.4 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.695 1.198 . . . . 0.0 114.151 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.68 -12.89 0.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.67 -41.72 55.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.308 1.443 . . . . 0.0 113.069 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.58 -2.53 1.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.966 2.107 . . . . 0.0 115.139 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 m -136.5 28.67 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.2 1.4 . . . . 0.0 112.597 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -129.01 -13.68 4.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.238 1.815 . . . . 0.0 113.695 170.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.68 -25.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.396 1.079 . . . . 0.0 113.461 171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -72.89 -9.31 58.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.864 1.666 . . . . 0.0 113.504 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -79.49 55.13 1.88 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.605 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -66.6 165.43 14.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.443 1.497 . . . . 0.0 113.564 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.54 -174.09 18.76 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.458 . . . . 0.0 113.51 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 m -54.81 -26.34 34.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.278 1.831 . . . . 0.0 114.164 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 -15.52 60.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.494 1.518 . . . . 0.0 114.62 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 10.62 66.94 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.523 1.058 . . . . 0.0 113.762 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.96 175.24 11.14 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.006 1.322 . . . . 0.0 113.394 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ttt -128.4 147.17 50.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.59 1.956 . . . . 0.0 109.354 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -119.28 133.15 55.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.669 1.187 . . . . 0.0 109.322 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.49 150.45 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.855 0.862 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.65 117.99 28.96 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.312 1.445 . . . . 0.0 109.969 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.17 123.3 34.51 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -151.52 -163.91 1.87 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.966 1.306 . . . . 0.0 111.238 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 156.24 37.6 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.581 1.152 . . . . 0.0 110.711 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.81 -5.9 16.36 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.783 2.989 . . . . 0.0 114.808 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -51.25 124.66 12.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 113.955 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.1 t -62.89 132.56 52.51 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.21 1.004 . . . . 0.0 111.661 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.94 -36.96 1.28 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.244 1.402 . . . . 0.0 113.187 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -141.05 -14.22 0.91 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.229 1.012 . . . . 0.0 113.565 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -59.88 -34.39 73.1 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.063 -1.648 . . . . 0.0 112.592 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -65.54 -15.68 62.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.747 1.619 . . . . 0.0 114.363 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -104.62 -14.09 15.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.691 1.996 . . . . 0.0 113.747 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.9 tp -119.35 -30.83 4.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.558 1.543 . . . . 0.0 113.546 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.42 -45.04 90.26 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-O 117.416 -1.278 . . . . 0.0 114.35 174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.97 -17.19 19.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.976 1.784 . . . . 0.0 113.432 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -76.8 -45.9 27.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.12 -0.988 . . . . 0.0 111.624 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.48 -34.04 65.14 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.591 -0.693 . . . . 0.0 112.825 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.3 -33.8 75.0 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.051 -1.03 . . . . 0.0 113.587 171.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.72 96.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.821 0.448 . . . . 0.0 111.268 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.43 99.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.955 0.798 . . . . 0.0 111.79 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.77 79.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.98 0.912 . . . . 0.0 112.404 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.3 m -69.71 -47.02 64.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.057 1.343 . . . . 0.0 111.457 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -70.69 -26.15 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.0 mt -107.49 5.32 27.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.134 1.374 . . . . 0.0 114.081 -176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.89 -35.31 32.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.29 -10.23 85.65 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.75 1.167 . . . . 0.0 115.49 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.45 -44.01 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 0.0 112.292 -170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.61 118.87 3.53 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.334 1.054 . . . . 0.0 110.96 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.42 154.76 45.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 111.257 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -123.83 149.42 45.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.477 1.511 . . . . 0.0 110.149 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.57 165.84 26.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.704 1.202 . . . . 0.0 113.596 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -135.14 151.21 50.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.591 1.556 . . . . 0.0 112.227 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -143.53 146.41 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.732 2.013 . . . . 0.0 108.783 170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -109.12 122.15 46.68 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.282 -0.886 . . . . 0.0 112.169 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.5 t -62.91 -34.12 76.76 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.118 1.367 . . . . 0.0 113.379 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 t -69.38 -32.11 70.93 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.494 -0.754 . . . . 0.0 112.323 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.97 -37.27 58.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.496 0.719 . . . . 0.0 112.399 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -140.06 79.95 1.74 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.275 1.43 . . . . 0.0 112.077 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -76.13 -33.64 59.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.054 0.941 . . . . 0.0 111.064 -171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -59.03 -45.17 91.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.329 1.052 . . . . 0.0 112.963 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -67.26 -42.87 83.17 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.625 1.17 . . . . 0.0 110.081 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.73 -45.21 86.1 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.321 1.048 . . . . 0.0 111.756 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -77.85 -34.96 51.57 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.56 -0.712 . . . . 0.0 112.373 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.0 -28.71 69.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.826 0.85 . . . . 0.0 112.893 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.54 -6.18 41.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.528 0.731 . . . . 0.0 112.894 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.64 12.99 56.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.065 1.317 . . . . 0.0 114.006 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 t -80.21 58.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.588 1.955 . . . . 0.0 110.486 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.8 m -74.05 -3.11 27.37 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.921 1.289 . . . . 0.0 114.17 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.73 58.41 0.25 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.593 1.092 . . . . 0.0 114.068 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -56.55 155.32 14.34 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.828 1.251 . . . . 0.0 114.304 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 136.15 35.96 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 119.616 0.898 . . . . 0.0 113.46 3.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.2 m -132.11 112.74 12.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.82 1.248 . . . . 0.0 109.672 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 134.52 39.88 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.217 0.607 . . . . 0.0 110.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -130.24 153.41 48.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 112.428 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.7 134.13 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 -168.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -132.12 93.9 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.893 1.277 . . . . 0.0 111.554 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -68.39 127.33 32.59 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.339 1.056 . . . . 0.0 110.427 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t0 49.29 31.64 3.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.741 1.216 . . . . 0.0 113.773 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.65 72.75 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -136.46 138.43 41.43 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.71 1.604 . . . . 0.0 109.83 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.05 128.02 31.71 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.494 -0.754 . . . . 0.0 112.153 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.62 -16.67 10.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.208 1.003 . . . . 0.0 111.371 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.88 -120.13 0.93 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.09 0.852 . . . . 0.0 111.406 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.28 27.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.776 1.63 . . . . 0.0 112.375 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -67.43 153.43 43.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.412 1.085 . . . . 0.0 112.067 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -150.87 95.88 2.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.887 1.275 . . . . 0.0 110.227 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.45 -168.93 39.8 Favored Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.083 0.849 . . . . 0.0 114.084 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -54.34 -19.87 18.34 Favored 'Trans proline' 0 CA--C 1.546 1.122 1 C-N-CA 125.458 4.105 . . . . 0.0 118.937 -175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 53.6 45.2 28.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.344 1.458 . . . . 0.0 112.795 -169.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.1 p -139.14 162.4 35.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.086 2.155 . . . . 0.0 109.712 175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.64 -46.59 49.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -67.12 -30.7 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.433 1.093 . . . . 0.0 112.251 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.22 -27.39 70.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.343 0.973 . . . . 0.0 113.388 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.54 -46.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.132 1.466 . . . . 0.0 110.351 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.92 -46.0 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.036 0.934 . . . . 0.0 111.275 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -59.89 -43.09 94.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.439 0.695 . . . . 0.0 112.806 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -61.87 -35.64 78.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.401 1.08 . . . . 0.0 112.47 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.48 -44.98 49.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.294 1.038 . . . . 0.0 113.084 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -56.26 -33.74 65.75 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.867 -1.145 . . . . 0.0 113.548 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.57 -11.99 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.434 1.893 . . . . 0.0 115.101 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -130.16 -29.84 2.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.12 1.368 . . . . 0.0 114.368 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.38 -19.38 65.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.74 47.51 0.24 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.17 -15.75 28.64 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.329 2.686 . . . . 0.0 113.962 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.32 10.21 1.24 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.139 2.176 . . . . 0.0 116.605 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.1 m -149.79 139.31 21.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.769 2.028 . . . . 0.0 110.372 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.611 1.564 . . . . 0.0 113.62 172.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.354 0.121 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.49 -30.86 19.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.256 1.022 . . . . 0.0 110.377 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.63 139.05 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.445 1.898 . . . . 0.0 110.501 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.28 143.33 43.05 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.262 1.425 . . . . 0.0 111.517 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.56 70.93 0.86 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.554 1.168 . . . . 0.0 110.513 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.09 159.59 33.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.077 1.351 . . . . 0.0 112.191 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -145.09 170.85 15.4 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.489 1.516 . . . . 0.0 111.676 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.92 -21.77 22.36 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.495 1.118 . . . . 0.0 113.989 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.76 -23.79 49.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.828 1.251 . . . . 0.0 113.919 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -137.0 -20.51 1.26 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -169.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -53.01 -44.76 67.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.122 1.328 . . . . 0.0 113.24 -170.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.3 -2.24 4.22 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.175 1.79 . . . . 0.0 115.482 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -139.44 18.23 2.56 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.632 -1.292 . . . . 0.0 113.959 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -110.76 -11.67 14.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.117 1.767 . . . . 0.0 113.558 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -24.08 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.018 0.826 . . . . 0.0 112.913 169.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.8 m -77.25 -6.12 51.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.053 2.141 . . . . 0.0 114.119 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -80.11 48.08 0.96 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.019 1.728 . . . . 0.0 112.122 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -62.69 155.92 25.03 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.838 2.055 . . . . 0.0 112.968 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.74 -177.11 41.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.706 1.146 . . . . 0.0 113.333 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.2 m -59.52 -24.45 63.67 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -15.14 62.41 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 16.22 55.28 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.379 0.99 . . . . 0.0 113.715 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -148.8 173.39 13.32 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.773 1.286 . . . . 0.0 113.335 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttp -127.49 151.43 48.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.257 1.823 . . . . 0.0 109.241 169.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.97 137.34 54.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.424 1.49 . . . . 0.0 109.206 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.45 146.52 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.372 1.069 . . . . 0.0 111.154 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -120.31 98.6 6.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.516 1.926 . . . . 0.0 108.488 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -75.16 135.99 41.07 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -153.34 169.4 23.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.54 104.16 12.18 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 121.163 -0.961 . . . . 0.0 109.049 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.86 -19.79 15.8 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.463 2.109 . . . . 0.0 114.31 -170.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.4 m95 41.2 43.8 2.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.415 1.886 . . . . 0.0 114.388 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m 55.9 30.02 15.2 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.995 2.118 . . . . 0.0 115.418 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.51 -18.52 0.02 OUTLIER Glycine 0 N--CA 1.481 1.688 0 N-CA-C 118.015 1.966 . . . . 0.0 118.015 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -94.79 -13.39 25.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.439 1.62 . . . . 0.0 113.881 -173.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.0 t -63.08 -45.12 93.64 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.552 -0.717 . . . . 0.0 111.566 173.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -55.29 -28.98 57.23 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.894 1.678 . . . . 0.0 114.074 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -87.27 -12.48 46.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.787 1.635 . . . . 0.0 114.644 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.9 tp -132.92 -26.77 1.72 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.66 -43.36 92.57 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.39 -22.11 34.23 Favored 'Trans proline' 0 C--N 1.357 0.986 0 CA-C-N 121.969 1.739 . . . . 0.0 112.595 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.43 -38.26 41.8 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.324 0.965 . . . . 0.0 112.072 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.3 -34.88 68.45 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.27 -0.893 . . . . 0.0 111.756 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -64.67 -42.99 94.98 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.079 1.352 . . . . 0.0 111.838 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.068 0.547 . . . . 0.0 111.011 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.92 89.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.888 0.767 . . . . 0.0 112.95 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.51 75.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.706 0.802 . . . . 0.0 112.539 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.8 m -73.01 -43.54 62.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.113 1.365 . . . . 0.0 111.446 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -71.69 -21.08 61.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -118.2 11.84 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.497 1.919 . . . . 0.0 112.896 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -51.05 116.68 2.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.19 1.796 . . . . 0.0 112.617 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.73 -22.12 19.11 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.54 1.543 . . . . 0.0 114.711 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mt -82.23 -49.01 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.424 1.112 . . . . 0.0 109.627 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.47 112.64 3.23 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.035 1.334 . . . . 0.0 109.951 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.88 151.66 51.19 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.762 1.641 . . . . 0.0 111.029 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.31 147.62 41.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.777 1.631 . . . . 0.0 109.521 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.47 166.16 24.98 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.404 1.082 . . . . 0.0 112.935 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.05 159.34 41.08 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.799 1.24 . . . . 0.0 112.076 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -143.5 125.07 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.318 1.847 . . . . 0.0 108.709 169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -89.12 101.31 13.96 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.533 -0.73 . . . . 0.0 111.324 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.1 t -53.63 -41.47 66.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.032 1.733 . . . . 0.0 114.092 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.2 t -63.15 -23.62 67.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.067 0.947 . . . . 0.0 113.092 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.69 -8.5 15.4 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.274 1.43 . . . . 0.0 113.959 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -143.18 49.88 1.43 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 124.469 2.081 . . . . 0.0 111.946 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -65.81 -30.51 71.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.318 1.847 . . . . 0.0 112.847 -169.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -61.75 -43.18 99.36 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.881 0.873 . . . . 0.0 112.338 172.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -73.66 -34.21 64.84 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.437 0.695 . . . . 0.0 111.807 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.78 -51.58 47.22 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.873 -1.142 . . . . 0.0 113.123 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -71.09 -32.23 68.81 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.395 -0.815 . . . . 0.0 112.917 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.7 -27.09 37.96 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.413 1.485 . . . . 0.0 113.9 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -114.56 -3.53 12.93 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.909 1.283 . . . . 0.0 113.45 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.9 31.56 69.92 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.75 1.167 . . . . 0.0 113.926 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.29 -18.25 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.495 1.918 . . . . 0.0 115.438 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -51.24 9.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 129.789 3.236 . . . . 0.0 119.363 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.21 32.61 6.88 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 127.255 2.36 . . . . 0.0 112.429 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.25 156.49 5.63 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.68 1.992 . . . . 0.0 115.613 -173.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.16 142.81 59.34 Favored 'Cis proline' 0 C--N 1.358 1.039 0 CA-C-N 118.835 0.62 . . . . 0.0 113.133 -2.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.4 m -127.63 93.22 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.835 1.254 . . . . 0.0 109.757 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.82 129.71 37.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.458 0.703 . . . . 0.0 111.202 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.82 158.41 44.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 111.65 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 90.3 mt -124.27 140.0 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.031 1.732 . . . . 0.0 109.174 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.03 90.38 3.02 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.664 1.186 . . . . 0.0 110.697 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -69.09 124.11 22.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.545 1.538 . . . . 0.0 110.533 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.5 t70 48.77 35.1 5.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.066 1.746 . . . . 0.0 113.594 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.51 27.51 59.17 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.02 143.72 30.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.985 1.314 . . . . 0.0 109.544 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.28 113.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.57 -0.706 . . . . 0.0 112.595 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 -44.56 23.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.129 0.572 . . . . 0.0 109.466 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.79 -78.44 0.17 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 123.978 0.799 . . . . 0.0 113.403 168.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.68 155.0 36.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.686 1.594 . . . . 0.0 111.204 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.0 156.7 32.89 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.304 1.042 . . . . 0.0 112.41 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -144.06 66.88 1.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.989 1.316 . . . . 0.0 112.074 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.66 -178.72 44.76 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 124.902 1.239 . . . . 0.0 112.811 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.3 140.88 96.62 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.196 2.598 . . . . 0.0 111.496 170.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -81.37 45.63 0.88 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.947 1.299 . . . . 0.0 113.514 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -135.91 155.44 50.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.565 1.946 . . . . 0.0 110.705 -173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.77 -48.49 30.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -70.46 -28.42 65.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.76 -45.73 81.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.009 1.29 . . . . 0.0 112.164 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mm -60.48 -47.69 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.464 1.132 . . . . 0.0 110.567 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.29 -46.91 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.721 0.808 . . . . 0.0 111.022 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.2 m -58.53 -43.75 89.33 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -62.32 -36.61 82.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.415 1.086 . . . . 0.0 112.454 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.46 -48.62 32.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.86 -34.99 72.24 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.731 -1.231 . . . . 0.0 113.059 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -62.19 -10.98 12.13 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.478 1.911 . . . . 0.0 114.89 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -128.9 -35.23 1.88 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.306 1.442 . . . . 0.0 113.221 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.38 58.64 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.99 54.77 0.13 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.78 -1.011 . . . . 0.0 115.343 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.11 -17.29 54.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.664 2.909 . . . . 0.0 114.335 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.08 2.87 19.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.665 1.586 . . . . 0.0 113.269 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.3 m -82.32 4.12 25.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.563 1.545 . . . . 0.0 114.316 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.246 2.218 . . . . 0.0 113.196 -175.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.7 0.286 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.46 -17.46 64.2 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.633 1.173 . . . . 0.0 113.79 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.62 133.96 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.3 1.44 . . . . 0.0 110.326 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.49 135.26 48.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.392 0.677 . . . . 0.0 111.384 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.37 95.1 5.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.024 0.929 . . . . 0.0 109.731 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.67 169.5 9.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.546 1.138 . . . . 0.0 113.953 -168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -162.35 175.09 11.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.15 1.78 . . . . 0.0 110.417 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -51.22 -29.11 13.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.403 1.481 . . . . 0.0 114.693 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.65 -25.11 68.07 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.627 1.571 . . . . 0.0 114.659 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -138.19 -18.9 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.82 -37.31 73.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.8 1.24 . . . . 0.0 113.068 -176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.43 -1.89 1.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.197 2.199 . . . . 0.0 115.085 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -129.38 26.15 5.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 112.248 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -128.1 -18.27 4.18 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -21.64 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.741 1.616 . . . . 0.0 113.942 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -72.21 -15.86 61.94 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.297 1.839 . . . . 0.0 113.232 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.74 -7.03 45.63 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -66.47 -20.49 66.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -43.56 -45.0 6.85 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.604 1.573 . . . . 0.0 116.591 -169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 m -86.72 -20.49 27.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.95 -27.38 15.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.232 1.413 . . . . 0.0 113.599 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.03 7.6 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.275 1.417 . . . . 0.0 114.235 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -152.07 170.96 18.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.035 1.417 . . . . 0.0 112.682 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.2 ttt -120.98 147.53 45.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.244 1.817 . . . . 0.0 110.099 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.26 133.57 55.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.848 1.259 . . . . 0.0 108.502 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.35 138.49 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.707 -0.621 . . . . 0.0 111.036 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -111.93 110.75 21.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.55 1.54 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.67 118.82 30.41 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -149.69 164.94 33.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.762 0.825 . . . . 0.0 113.121 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.28 97.85 48.93 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.239 1.416 . . . . 0.0 110.227 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.34 30.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.499 1 C-N-CA 127.01 5.14 . . . . 0.0 119.706 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -59.67 146.32 41.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 120.246 1.384 . . . . 0.0 112.408 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.8 m -60.15 -23.27 63.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -170.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.68 -14.61 77.88 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.937 0.78 . . . . 0.0 114.9 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -135.03 -31.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.32 -35.74 76.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.501 1.5 . . . . 0.0 113.709 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -58.87 -19.39 41.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.262 1.425 . . . . 0.0 113.854 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -98.6 -15.94 19.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.515 1.526 . . . . 0.0 114.242 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.6 tp -131.42 -27.87 1.93 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.546 1.138 . . . . 0.0 113.566 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -44.56 99.78 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 117.848 -1.073 . . . . 0.0 113.585 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.38 -16.1 17.43 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.863 1.708 . . . . 0.0 113.349 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -79.44 -49.15 12.76 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.036 -1.04 . . . . 0.0 111.607 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -73.91 -30.5 62.62 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.366 -0.834 . . . . 0.0 113.226 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.7 -32.44 69.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.016 -1.052 . . . . 0.0 113.235 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.989 -0.445 . . . . 0.0 111.233 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.0 95.65 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.293 0.951 . . . . 0.0 111.661 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -30.73 71.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.752 0.821 . . . . 0.0 112.84 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 m -71.53 -42.6 67.71 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.711 1.204 . . . . 0.0 111.862 171.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -76.19 -27.28 56.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.527 1.131 . . . . 0.0 113.499 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.87 12.19 32.81 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.685 1.994 . . . . 0.0 112.79 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -52.37 -32.91 40.77 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.79 7.75 55.64 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.621 -1.1 . . . . 0.0 114.042 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.42 -41.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.994 1.318 . . . . 0.0 112.997 -169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 t -145.22 127.45 8.01 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.679 1.192 . . . . 0.0 111.373 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.41 129.02 14.27 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.249 2.633 . . . . 0.0 111.354 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.97 137.43 52.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.172 1.389 . . . . 0.0 110.455 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.26 167.83 20.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.509 0.724 . . . . 0.0 111.833 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -137.91 161.94 35.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.482 0.713 . . . . 0.0 112.775 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.47 128.05 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.487 1.915 . . . . 0.0 108.036 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -98.0 88.53 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.591 0.757 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.1 m -59.18 -22.84 61.62 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 t -66.9 -18.81 65.56 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.1 -9.26 9.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.132 2.173 . . . . 0.0 113.163 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.6 44.8 1.61 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 124.028 1.871 . . . . 0.0 112.838 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 m -61.13 -35.43 77.05 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.46 -174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.93 -39.0 93.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.8 1.24 . . . . 0.0 112.36 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -69.93 -38.45 76.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.177 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.0 m -83.29 -44.02 15.39 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -69.74 -32.61 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.906 -1.121 . . . . 0.0 112.878 -175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -52.97 -26.38 15.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.166 1.786 . . . . 0.0 113.878 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -111.68 -2.48 15.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.117 1.367 . . . . 0.0 113.362 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.68 17.98 29.16 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 124.602 1.096 . . . . 0.0 114.187 170.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.49 58.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.484 1.513 . . . . 0.0 110.824 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -83.77 -0.32 50.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.394 1.478 . . . . 0.0 113.319 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.23 51.19 0.5 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.93 1.252 . . . . 0.0 112.93 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.13 153.15 5.05 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.337 1.455 . . . . 0.0 114.308 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.53 146.39 81.56 Favored 'Cis proline' 0 C--N 1.356 0.936 0 CA-C-N 118.991 0.676 . . . . 0.0 113.007 -2.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.1 m -141.8 116.71 9.88 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.762 1.225 . . . . 0.0 109.105 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.53 148.15 23.54 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.764 -0.585 . . . . 0.0 110.771 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -136.37 146.8 46.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.217 1.007 . . . . 0.0 112.081 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.1 mt -113.58 136.02 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.856 1.662 . . . . 0.0 109.784 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -135.65 95.38 3.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.166 0.986 . . . . 0.0 111.827 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -66.61 126.74 29.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.302 1.041 . . . . 0.0 110.187 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.4 t70 48.29 25.2 0.82 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.762 1.625 . . . . 0.0 114.65 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.84 10.73 54.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.89 1.233 . . . . 0.0 115.885 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.57 151.37 47.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.645 1.722 . . . . 0.0 110.081 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -51.94 131.22 31.08 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.788 1.235 . . . . 0.0 113.202 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.82 -16.0 6.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.194 0.997 . . . . 0.0 112.55 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.7 -123.23 1.08 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.097 0.855 . . . . 0.0 112.71 169.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.25 27.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.948 2.099 . . . . 0.0 111.437 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -134.42 134.21 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.581 1.153 . . . . 0.0 111.786 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -139.85 20.72 2.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.168 1.787 . . . . 0.0 112.472 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.99 -160.38 4.61 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.765 1.65 . . . . 0.0 114.787 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -53.63 -4.2 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.124 1 C-N-CA 125.719 4.279 . . . . 0.0 119.176 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 42.29 46.25 3.86 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 126.48 1.912 . . . . 0.0 114.583 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -146.48 154.27 41.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.343 2.657 . . . . 0.0 109.021 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.97 -49.05 42.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.358 1.063 . . . . 0.0 113.542 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.42 -27.11 64.99 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.649 1.18 . . . . 0.0 112.66 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.0 96.6 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.785 0.721 . . . . 0.0 111.642 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.8 mm -64.86 -45.56 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 117.74 0.77 . . . . 0.0 111.19 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.33 -43.17 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.575 1.15 . . . . 0.0 111.489 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -61.2 -46.54 90.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.308 1.043 . . . . 0.0 112.347 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.57 -39.06 75.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.901 0.88 . . . . 0.0 112.598 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -50.34 21.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.164 0.986 . . . . 0.0 112.758 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -64.0 -22.93 67.14 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.489 -1.382 . . . . 0.0 113.663 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.88 -12.89 61.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.316 1.447 . . . . 0.0 114.732 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.3 -36.34 2.5 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.73 1.212 . . . . 0.0 113.541 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.55 -9.49 58.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.137 0.975 . . . . 0.0 113.388 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.71 161.65 37.66 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.725 1.631 . . . . 0.0 113.609 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.18 -20.09 43.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.203 2.602 . . . . 0.0 113.796 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.09 61.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.8 p -75.13 -9.4 58.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.628 1.971 . . . . 0.0 113.607 -170.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.081 0.467 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.82 6.26 3.69 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.691 1.197 . . . . 0.0 113.668 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.99 131.81 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.634 1.174 . . . . 0.0 110.363 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.73 113.71 8.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.599 1.16 . . . . 0.0 111.381 172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.46 59.71 5.23 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.667 1.187 . . . . 0.0 112.138 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.5 mt -64.57 148.75 50.15 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -157.4 170.4 22.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.904 1.682 . . . . 0.0 110.002 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.99 -25.87 5.28 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -23.43 65.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.111 1.364 . . . . 0.0 114.006 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -139.01 -21.53 0.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -172.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -50.16 -45.17 53.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.272 1.029 . . . . 0.0 112.738 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.02 -5.48 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.2 p -109.85 -17.87 13.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.368 1.467 . . . . 0.0 114.511 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -100.87 -20.01 15.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.714 1.206 . . . . 0.0 113.943 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -19.6 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.15 0.98 . . . . 0.0 113.524 172.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.9 m -71.99 -18.64 61.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.162 1.785 . . . . 0.0 112.833 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.42 -5.45 28.48 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -63.62 -21.74 66.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.556 1.542 . . . . 0.0 115.132 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.05 -33.33 36.9 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.35 1.452 . . . . 0.0 116.687 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 p -85.61 -38.92 17.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.894 1.347 . . . . 0.0 113.758 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.59 -23.98 27.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.674 1.59 . . . . 0.0 114.405 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.6 -29.46 8.41 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.274 1.892 . . . . 0.0 113.922 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 pp -152.17 173.04 15.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.259 1.424 . . . . 0.0 112.488 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 56.3 ttm -128.91 143.79 50.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.649 1.58 . . . . 0.0 110.059 170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.7 134.78 42.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 170.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 57' ' ' ALA . 37.7 t -138.17 138.82 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.276 -0.89 . . . . 0.0 110.713 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.16 124.43 52.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.086 1.354 . . . . 0.0 110.568 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -106.45 123.84 48.69 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.974 1.31 . . . . 0.0 108.532 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.78 -162.82 1.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.64 1.176 . . . . 0.0 112.197 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.74 144.96 17.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.806 1.642 . . . . 0.0 109.433 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.55 -23.99 22.68 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.079 2.519 . . . . 0.0 113.881 -172.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -80.49 -2.28 45.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.94 1.296 . . . . 0.0 114.21 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.0 m -65.91 -21.36 66.44 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.49 -52.49 3.47 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.668 1.604 . . . . 0.0 113.545 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -70.32 -4.83 24.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.458 1.103 . . . . 0.0 113.767 171.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.92 -35.24 66.4 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.138 -0.976 . . . . 0.0 111.81 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -65.02 -16.93 63.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.106 1.363 . . . . 0.0 114.634 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.49 -22.19 30.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.091 1.356 . . . . 0.0 112.903 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.09 -29.79 8.77 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.93 1.292 . . . . 0.0 113.456 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.13 -46.23 82.45 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 170.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.59 -20.6 23.19 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.622 2.215 . . . . 0.0 113.236 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -78.45 -44.77 23.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.576 -0.703 . . . . 0.0 111.022 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -70.18 -33.27 71.53 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.254 -0.904 . . . . 0.0 112.281 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.11 -32.62 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.652 -1.28 . . . . 0.0 114.069 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.64 97.74 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 122.121 -0.362 . . . . 0.0 110.708 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.54 98.68 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.081 -1.012 . . . . 0.0 112.798 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.95 -32.78 74.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.656 0.782 . . . . 0.0 112.106 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.8 m -72.12 -43.13 65.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.873 1.269 . . . . 0.0 111.529 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -73.86 -25.11 59.88 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.771 1.228 . . . . 0.0 114.01 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.5 mt -111.01 16.74 21.01 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.104 1.762 . . . . 0.0 112.496 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.96 116.79 3.72 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.243 1.417 . . . . 0.0 111.832 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.34 -0.09 89.37 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.497 1.046 . . . . 0.0 114.911 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.99 -42.77 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.908 1.683 . . . . 0.0 110.618 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 t -144.62 112.6 5.01 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.783 1.633 . . . . 0.0 109.077 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.26 140.56 44.88 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.091 1.861 . . . . 0.0 110.17 170.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.4 142.78 48.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.7 1.6 . . . . 0.0 109.953 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -137.51 162.4 33.81 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.111 0.565 . . . . 0.0 112.016 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -134.98 145.86 48.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.589 1.156 . . . . 0.0 111.827 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.62 145.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.955 2.102 . . . . 0.0 108.214 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -114.69 121.37 43.17 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.543 -0.723 . . . . 0.0 110.642 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -63.84 -18.99 64.7 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.7 p -70.41 -30.24 67.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.465 -0.772 . . . . 0.0 112.402 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.61 -26.03 16.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.311 1.444 . . . . 0.0 113.414 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -137.64 61.98 1.59 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.888 1.804 . . . . 0.0 112.619 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -66.53 -41.01 89.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.735 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -64.64 -41.73 95.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 0.0 111.671 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -61.9 -45.88 91.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.115 0.566 . . . . 0.0 110.691 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.4 m -65.88 -39.27 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -72.87 -34.15 66.55 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.498 -0.751 . . . . 0.0 112.612 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.19 -30.29 70.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.188 0.995 . . . . 0.0 112.064 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -93.64 -9.96 36.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.935 0.894 . . . . 0.0 112.941 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.96 21.1 59.82 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.812 1.196 . . . . 0.0 113.766 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.47 59.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.765 1.626 . . . . 0.0 110.324 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 m -66.22 -6.91 15.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.682 1.593 . . . . 0.0 113.9 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.33 168.85 38.21 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 127.415 2.436 . . . . 0.0 109.855 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.56 162.53 26.83 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.973 1.309 . . . . 0.0 113.399 -170.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.26 143.98 68.89 Favored 'Cis proline' 0 C--N 1.358 1.072 0 CA-C-N 119.481 0.85 . . . . 0.0 113.199 1.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.3 m -137.32 111.41 8.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.0 1.32 . . . . 0.0 109.638 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.03 130.21 46.17 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.483 0.713 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -129.95 153.5 48.3 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.618 1.967 . . . . 0.0 111.412 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -121.47 133.73 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.474 1.51 . . . . 0.0 109.649 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.01 97.64 4.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.459 1.104 . . . . 0.0 111.665 -170.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -68.28 125.29 25.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.62 1.168 . . . . 0.0 110.444 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 49.79 25.91 1.71 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.418 1.487 . . . . 0.0 114.665 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.45 45.05 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.151 1.357 . . . . 0.0 116.069 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -140.51 143.77 35.63 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.082 1.753 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.87 131.37 49.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.486 0.715 . . . . 0.0 111.375 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.99 -15.62 2.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 0.0 111.908 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.34 -145.11 6.73 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 123.109 1.394 . . . . 0.0 111.092 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.84 157.87 41.36 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.577 1.951 . . . . 0.0 111.988 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -65.57 152.29 44.42 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.621 1.168 . . . . 0.0 112.702 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.65 53.4 0.94 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.279 1.032 . . . . 0.0 111.88 -172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.29 -176.58 26.76 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 124.65 1.119 . . . . 0.0 114.416 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.65 144.98 50.66 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.489 3.46 . . . . 0.0 114.379 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -82.34 59.74 4.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.789 1.236 . . . . 0.0 111.731 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.6 p -149.48 160.04 43.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.78 2.032 . . . . 0.0 110.719 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.99 67.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 112.978 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.93 -36.37 79.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.661 1.184 . . . . 0.0 112.162 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.66 -48.16 83.46 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.11 0.862 . . . . 0.0 112.066 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.62 -48.63 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.635 0.718 . . . . 0.0 111.175 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.13 -45.76 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.424 1.09 . . . . 0.0 111.784 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 p -63.34 -44.85 93.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -57.14 -38.06 72.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.166 0.987 . . . . 0.0 112.154 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.37 -52.6 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.15 0.98 . . . . 0.0 112.291 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -65.38 -22.76 66.83 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.863 -1.148 . . . . 0.0 113.565 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.99 -21.17 66.8 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.549 1.94 . . . . 0.0 114.29 172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -124.33 -32.6 3.16 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.824 1.25 . . . . 0.0 114.103 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.74 -32.45 73.58 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.01 -41.68 1.32 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -52.34 -33.14 54.67 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.967 3.111 . . . . 0.0 116.203 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.68 -12.12 61.36 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.6 m -138.12 -14.83 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 124.437 1.095 . . . . 0.0 113.588 172.1 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.014 0.435 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.27 7.36 4.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.94 1.296 . . . . 0.0 113.31 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.4 t -110.36 135.58 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.791 1.636 . . . . 0.0 110.178 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.98 144.81 40.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.592 1.157 . . . . 0.0 111.276 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.32 98.44 5.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.423 1.489 . . . . 0.0 108.999 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -110.08 166.14 11.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.638 1.175 . . . . 0.0 113.577 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 t -153.42 156.33 38.02 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.416 1.886 . . . . 0.0 109.746 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.4 -26.32 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.772 1.629 . . . . 0.0 114.695 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.84 -27.25 64.95 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 114.311 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.03 -14.51 0.8 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -47.16 -41.45 17.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.154 1.382 . . . . 0.0 113.941 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.52 -25.46 25.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.342 1.857 . . . . 0.0 115.507 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.6 p -86.89 -17.06 34.18 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.97 -28.51 13.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -23.45 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -78.04 -10.84 59.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.604 1.562 . . . . 0.0 113.956 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -79.94 32.32 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.613 1.565 . . . . 0.0 113.219 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -52.27 144.78 12.05 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.672 1.989 . . . . 0.0 112.932 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.88 -175.25 50.27 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.362 -0.836 . . . . 0.0 113.347 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.4 m -55.34 -25.66 36.25 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.84 -14.84 62.08 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.69 15.97 57.36 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.198 0.904 . . . . 0.0 113.944 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -146.35 174.55 11.27 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.07 1.435 . . . . 0.0 114.255 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 61.9 ttp -126.54 148.69 49.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.147 2.179 . . . . 0.0 109.182 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -122.75 128.75 50.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.427 1.491 . . . . 0.0 108.275 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.19 152.02 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.57 1.148 . . . . 0.0 110.896 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.32 117.38 23.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.919 1.287 . . . . 0.0 110.926 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -85.11 126.08 33.31 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -153.48 -156.38 0.68 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.991 1.316 . . . . 0.0 111.481 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.14 156.95 50.51 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.653 1.981 . . . . 0.0 110.074 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.69 13.42 2.3 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.349 3.366 . . . . 0.0 114.695 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -57.44 108.6 0.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.963 1.705 . . . . 0.0 112.874 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -58.07 -30.49 66.25 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.73 -16.79 59.56 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.462 1.506 . . . . 0.0 114.709 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -121.82 -28.97 4.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.809 1.244 . . . . 0.0 112.756 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.8 m -62.88 -35.8 81.19 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.325 -0.859 . . . . 0.0 112.611 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -50.94 -34.55 29.17 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 tpm_? -94.85 -16.78 22.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.675 2.39 . . . . 0.0 113.239 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 tp -117.98 -25.54 6.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.37 97.15 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.011 -1.056 . . . . 0.0 112.779 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.54 -11.41 28.18 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.875 1.716 . . . . 0.0 113.372 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.83 -46.9 16.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.898 0.772 . . . . 0.0 111.275 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 58' ' ' LYS . 11.1 t80 -82.06 -33.66 29.81 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -169.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.72 -40.96 98.04 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.998 -1.064 . . . . 0.0 112.657 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.19 95.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.903 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.5 93.34 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.254 0.621 . . . . 0.0 112.058 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.51 -36.19 83.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.311 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.4 m -66.54 -43.79 84.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.549 1.14 . . . . 0.0 111.424 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -72.79 -25.87 61.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.632 1.173 . . . . 0.0 113.627 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.39 7.87 29.31 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.272 1.829 . . . . 0.0 113.393 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -49.49 114.75 1.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.456 1.502 . . . . 0.0 112.987 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.91 -22.35 18.63 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.306 1.431 . . . . 0.0 114.823 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -85.17 -45.0 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.826 1.313 . . . . 0.0 109.594 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.8 t -144.44 114.75 5.26 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.86 1.664 . . . . 0.0 108.839 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.94 150.51 55.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.716 2.277 . . . . 0.0 110.887 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.92 138.97 54.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.084 1.354 . . . . 0.0 110.906 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.93 164.49 31.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.83 0.852 . . . . 0.0 112.852 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HE2' ' CD2' ' A' ' 43' ' ' TYR . 63.6 mttt -130.97 158.84 39.17 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.021 1.328 . . . . 0.0 113.301 169.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.9 t -140.24 126.05 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.763 2.025 . . . . 0.0 108.632 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -85.36 107.3 17.3 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.54 -0.725 . . . . 0.0 111.14 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.66 -37.34 58.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.199 1.4 . . . . 0.0 113.814 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -66.55 -19.06 65.69 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.72 -4.18 13.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.523 1.529 . . . . 0.0 113.868 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -142.69 45.69 1.59 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 124.216 1.96 . . . . 0.0 112.071 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -64.4 -33.28 75.5 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 125.746 1.618 . . . . 0.0 111.999 -169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -66.06 -37.71 86.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.115 1.366 . . . . 0.0 112.381 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -69.97 -46.76 64.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.01 0.924 . . . . 0.0 110.265 170.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 53.8 t -60.06 -50.64 72.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.737 1.615 . . . . 0.0 112.44 -170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -71.97 -36.97 69.99 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.03 -28.52 69.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.393 1.077 . . . . 0.0 112.566 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -92.19 -6.89 49.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.896 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.37 11.14 57.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.96 1.267 . . . . 0.0 113.927 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.97 61.15 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 126.128 1.771 . . . . 0.0 109.779 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.7 p -62.26 -10.96 12.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.523 1.529 . . . . 0.0 114.556 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.66 166.75 36.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 128.564 2.983 . . . . 0.0 109.413 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -155.43 162.06 28.12 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.255 1.422 . . . . 0.0 112.789 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.91 139.67 35.93 Favored 'Cis proline' 0 C--N 1.355 0.921 0 CA-C-N 120.234 1.119 . . . . 0.0 113.621 3.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.4 m -137.25 112.29 9.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.202 1.401 . . . . 0.0 109.714 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.88 140.05 30.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.458 0.703 . . . . 0.0 111.475 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -136.13 156.4 48.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.176 1.39 . . . . 0.0 112.105 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.2 mt -120.57 137.64 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.177 1.791 . . . . 0.0 109.283 -174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.37 90.58 2.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.418 1.087 . . . . 0.0 110.463 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -69.59 124.17 23.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.764 1.226 . . . . 0.0 110.27 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t0 49.42 33.57 5.67 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.041 1.736 . . . . 0.0 113.418 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.88 30.29 63.78 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.207 0.908 . . . . 0.0 115.337 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.01 141.7 34.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.91 1.684 . . . . 0.0 109.865 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.21 112.28 0.94 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.795 0.838 . . . . 0.0 112.688 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.13 48.44 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.45 -84.04 0.13 Allowed Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.185 0.898 . . . . 0.0 112.403 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.49 158.03 34.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.784 1.633 . . . . 0.0 111.87 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -69.78 159.65 33.19 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.161 0.984 . . . . 0.0 112.011 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.18 46.31 1.32 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.746 1.218 . . . . 0.0 112.807 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -159.95 -173.85 28.98 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.978 1.275 . . . . 0.0 113.631 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.46 146.93 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.936 2.424 . . . . 0.0 111.445 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -80.28 6.68 11.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.617 1.567 . . . . 0.0 114.983 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.3 p -74.56 152.72 39.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.872 1.669 . . . . 0.0 110.663 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.34 -50.59 12.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.576 1.15 . . . . 0.0 113.784 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -25.24 61.01 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.26 1.024 . . . . 0.0 112.626 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.51 -51.39 54.7 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.361 0.982 . . . . 0.0 111.455 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.0 mm -58.29 -44.95 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.567 0.747 . . . . 0.0 110.636 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.08 -49.66 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.19 0.996 . . . . 0.0 111.352 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -58.86 -42.35 89.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.598 0.759 . . . . 0.0 112.693 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -59.38 -35.51 74.05 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.883 0.873 . . . . 0.0 112.908 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -79.26 -46.8 17.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.089 0.955 . . . . 0.0 112.157 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -60.14 -30.07 69.06 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.217 -1.552 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -65.11 -12.39 50.32 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.63 1.572 . . . . 0.0 114.848 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -129.0 -33.15 2.01 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.191 1.396 . . . . 0.0 114.201 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.92 69.04 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.45 -179.25 21.43 Favored Glycine 0 CA--C 1.547 2.075 0 C-N-CA 124.875 1.226 . . . . 0.0 114.468 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.17 -21.59 23.44 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.72 2.947 . . . . 0.0 114.485 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.59 43.07 3.08 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.777 2.031 . . . . 0.0 115.674 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.1 m -124.36 11.16 8.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.844 1.258 . . . . 0.0 114.287 -170.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.575 1.95 . . . . 0.0 112.55 177.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.863 0.363 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -130.89 -26.94 2.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.578 1.551 . . . . 0.0 112.402 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.2 t -77.14 139.15 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.899 1.68 . . . . 0.0 110.002 169.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 mt -69.2 115.92 9.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.019 0.528 . . . . 0.0 111.33 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.3 109.07 17.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.085 -1.009 . . . . 0.0 110.243 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -115.39 160.63 19.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 112.895 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -157.89 163.05 38.3 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 109.283 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -52.4 -26.38 12.39 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.804 1.641 . . . . 0.0 114.714 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.67 -25.51 67.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.021 1.328 . . . . 0.0 114.55 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -141.85 -14.45 0.82 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -48.2 -41.19 26.54 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.347 1.859 . . . . 0.0 113.997 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -60.59 -16.22 35.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.814 1.646 . . . . 0.0 114.564 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.7 m -118.35 22.91 11.87 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.443 1.497 . . . . 0.0 112.682 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -133.8 -37.46 0.92 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.847 1.659 . . . . 0.0 113.176 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tp -58.88 -35.68 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 126.182 1.793 . . . . 0.0 113.267 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 p -76.79 -5.8 49.7 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.087 2.555 . . . . 0.0 114.752 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -79.5 39.21 0.4 Allowed 'General case' 0 CA--C 1.551 0.981 0 CA-C-O 122.368 1.08 . . . . 0.0 112.78 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -62.76 -32.26 73.37 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.137 1.775 . . . . 0.0 114.339 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.29 -162.52 28.23 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.366 0.984 . . . . 0.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.7 m -58.67 -19.69 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.025 1.73 . . . . 0.0 114.748 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.25 -22.18 64.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.709 1.203 . . . . 0.0 113.993 171.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.7 -5.29 57.77 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.876 1.227 . . . . 0.0 115.616 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 pp -152.54 170.97 18.86 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.828 1.314 . . . . 0.0 112.666 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.0 tpp -123.12 145.15 48.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.017 1.727 . . . . 0.0 108.58 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.87 122.18 40.71 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.032 1.733 . . . . 0.0 107.073 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 57' ' ' ALA . 32.6 t -136.24 135.23 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.574 -0.704 . . . . 0.0 111.787 -169.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.53 139.12 31.59 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.255 1.422 . . . . 0.0 111.945 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -122.19 121.33 36.6 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.861 1.264 . . . . 0.0 109.619 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.49 176.94 12.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.384 1.474 . . . . 0.0 111.17 -170.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.7 124.79 21.09 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.355 1.062 . . . . 0.0 109.812 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.68 -22.78 18.15 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.425 3.417 . . . . 0.0 116.546 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -61.91 -23.65 66.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.209 1.404 . . . . 0.0 113.731 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.19 145.83 55.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.225 1.01 . . . . 0.0 112.832 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.61 72.48 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.191 0.9 . . . . 0.0 115.02 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -107.2 0.86 23.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.1 t -58.34 -35.5 72.02 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.73 -1.231 . . . . 0.0 111.243 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -64.83 -24.65 67.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.589 1.556 . . . . 0.0 113.169 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -97.2 -29.3 13.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.775 1.63 . . . . 0.0 113.122 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.7 tp -81.24 -32.36 33.4 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.67 -50.8 70.85 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.52 -20.64 30.99 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.282 1.988 . . . . 0.0 113.23 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -73.8 -42.18 61.32 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.556 1.071 . . . . 0.0 110.864 172.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -73.18 -31.93 64.51 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.206 -0.934 . . . . 0.0 112.085 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -63.45 -42.94 98.65 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.726 1.21 . . . . 0.0 112.143 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.58 -45.54 93.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 110.974 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.78 92.11 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 -32.35 73.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.702 0.801 . . . . 0.0 112.338 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -70.63 -45.47 65.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.787 1.235 . . . . 0.0 111.647 172.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.25 -25.46 63.37 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.6 11.11 19.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.821 1.648 . . . . 0.0 113.223 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -54.33 -33.22 58.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.56 22.14 22.57 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.289 1.423 . . . . 0.0 113.275 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.84 -47.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.811 1.244 . . . . 0.0 112.093 -169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.33 125.56 2.44 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.734 1.614 . . . . 0.0 110.914 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.46 151.22 42.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.81 2.34 . . . . 0.0 112.435 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.13 142.54 51.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.993 1.717 . . . . 0.0 111.812 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -143.23 169.46 17.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.644 0.656 . . . . 0.0 112.185 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -138.39 153.24 48.92 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.177 0.991 . . . . 0.0 112.438 170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.92 131.45 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.554 1.941 . . . . 0.0 109.263 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -84.69 113.48 21.33 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.447 0.699 . . . . 0.0 111.169 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.4 t -59.88 -42.59 94.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.899 1.28 . . . . 0.0 112.533 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -64.42 -25.2 67.91 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.64 -23.61 29.43 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.209 1.004 . . . . 0.0 112.921 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -140.57 77.2 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.104 1.361 . . . . 0.0 113.177 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -66.24 -35.86 81.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.189 0.996 . . . . 0.0 112.191 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -66.1 -42.39 89.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.011 1.325 . . . . 0.0 112.137 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -67.16 -45.2 77.72 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.449 0.7 . . . . 0.0 110.869 170.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 51.9 t -61.08 -49.13 78.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.09 0.956 . . . . 0.0 112.572 -172.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -71.75 -37.39 70.55 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.72 -0.612 . . . . 0.0 112.516 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.51 -28.24 69.71 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.265 1.026 . . . . 0.0 112.597 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -90.07 -8.35 51.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.736 1.214 . . . . 0.0 112.657 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.7 20.28 54.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.539 1.066 . . . . 0.0 113.797 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.55 53.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.625 1.97 . . . . 0.0 109.739 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -73.11 -3.82 28.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.991 1.716 . . . . 0.0 114.654 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.74 61.34 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.888 1.233 . . . . 0.0 112.949 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.97 157.26 5.91 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.27 143.21 69.44 Favored 'Cis proline' 0 C--N 1.357 1.017 0 CA-C-N 119.349 0.803 . . . . 0.0 113.224 2.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.7 m -134.83 108.74 8.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.591 1.156 . . . . 0.0 108.503 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.4 136.42 33.69 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -133.28 154.13 50.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.776 1.63 . . . . 0.0 111.923 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 93.5 mt -119.39 136.55 56.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -133.84 86.34 2.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.785 1.234 . . . . 0.0 111.066 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -60.31 123.5 17.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.682 1.193 . . . . 0.0 110.564 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 47.4 25.75 0.65 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.349 1.46 . . . . 0.0 114.605 -170.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.4 17.86 58.09 Favored Glycine 0 CA--C 1.535 1.344 0 N-CA-C 115.955 1.142 . . . . 0.0 115.955 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.6 140.09 46.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.551 1.54 . . . . 0.0 109.969 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -50.52 121.9 6.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.677 1.191 . . . . 0.0 113.938 -169.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.01 -33.22 10.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.474 1.11 . . . . 0.0 110.417 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.96 -92.62 0.12 Allowed Glycine 0 N--CA 1.468 0.829 0 C-N-CA 123.96 0.79 . . . . 0.0 113.334 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.15 153.92 24.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.681 1.193 . . . . 0.0 113.69 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.21 163.39 17.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.858 1.663 . . . . 0.0 112.069 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -139.65 15.39 2.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.54 -176.72 14.55 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.59 150.42 52.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.445 3.43 . . . . 0.0 113.894 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.87 65.51 8.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 109.884 171.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 75.6 p -148.58 158.84 44.4 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.69 1.996 . . . . 0.0 110.669 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.99 68.29 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.036 0.935 . . . . 0.0 112.91 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -64.02 -31.92 73.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.607 1.163 . . . . 0.0 112.535 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.5 -48.24 87.16 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.998 0.808 . . . . 0.0 112.022 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.21 -48.34 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.33 0.565 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.9 t -62.11 -50.59 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 111.284 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.8 p -61.12 -42.64 98.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.878 0.763 . . . . 0.0 112.947 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -52.09 -34.3 43.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.865 1.266 . . . . 0.0 113.12 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.4 -50.66 11.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.879 0.871 . . . . 0.0 111.668 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.27 -31.04 68.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.512 -1.367 . . . . 0.0 113.374 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -66.27 -13.17 60.01 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 114.931 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -122.68 -34.84 3.16 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.225 1.41 . . . . 0.0 113.64 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.79 60.7 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.124 0.97 . . . . 0.0 113.503 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.62 152.21 22.9 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 126.535 2.017 . . . . 0.0 111.826 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.37 -29.22 11.49 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.992 2.461 . . . . 0.0 113.49 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 46.79 24.86 0.38 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.335 2.254 . . . . 0.0 116.214 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m -140.21 -15.31 0.99 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 127.116 2.166 . . . . 0.0 112.513 -172.627 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.051 0.453 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -76.77 -18.23 58.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.05 127.22 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.224 1.01 . . . . 0.0 111.016 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.71 120.05 17.79 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.247 1.419 . . . . 0.0 110.909 171.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.14 67.68 6.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.279 1.038 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.61 149.06 50.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.277 1.031 . . . . 0.0 113.34 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -146.34 168.35 21.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.382 1.473 . . . . 0.0 111.447 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -51.23 -25.76 6.08 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 171.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -76.63 -24.82 53.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.357 . . . . 0.0 114.562 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -133.47 -16.77 2.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.2 -40.69 77.95 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.294 1.037 . . . . 0.0 112.714 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.99 1.31 2.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.5 m -137.19 -8.59 1.76 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.599 -1.313 . . . . 0.0 114.19 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -72.62 -22.91 60.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.235 1.014 . . . . 0.0 112.654 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -23.54 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 t -67.56 -21.42 65.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.509 1.523 . . . . 0.0 112.41 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.53 -15.53 62.78 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.1 p -56.95 -23.84 48.45 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.914 1.285 . . . . 0.0 114.418 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.71 -22.89 41.99 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 118.766 0.712 . . . . 0.0 114.436 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -78.18 -36.9 46.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.13 -4.31 7.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.04 1.336 . . . . 0.0 113.452 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.11 -24.97 15.86 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.944 1.735 . . . . 0.0 114.161 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.79 172.7 15.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.368 1.467 . . . . 0.0 111.982 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.9 ttm -136.19 146.98 47.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.146 1.378 . . . . 0.0 109.727 169.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.1 138.07 42.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.561 1.144 . . . . 0.0 108.263 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.28 147.94 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.617 0.767 . . . . 0.0 111.887 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.17 108.51 12.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.136 1.774 . . . . 0.0 109.728 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -79.82 130.53 35.39 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.631 -0.668 . . . . 0.0 109.324 170.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -151.61 -171.15 3.85 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.29 159.04 32.37 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.753 1.621 . . . . 0.0 110.541 169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.39 2.73 0.8 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 124.884 3.722 . . . . 0.0 117.348 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 136.16 57.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.239 1.416 . . . . 0.0 114.585 -169.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.73 -18.67 60.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.755 1.622 . . . . 0.0 115.352 -172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.32 -30.81 71.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.401 1.0 . . . . 0.0 114.148 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -136.41 -20.64 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.2 p -63.16 -21.14 66.01 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.785 2.084 . . . . 0.0 114.319 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -93.1 -14.42 27.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.967 1.707 . . . . 0.0 113.831 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -107.3 -23.86 12.08 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.199 1.8 . . . . 0.0 113.466 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 tp -110.05 -28.26 8.79 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.976 1.31 . . . . 0.0 113.49 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.53 97.29 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.39 -12.3 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 121.664 1.63 . . . . 0.0 113.326 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -83.19 -49.68 9.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.191 0.905 . . . . 0.0 111.946 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -77.95 -31.84 51.13 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.69 -45.02 94.69 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.095 -1.003 . . . . 0.0 111.599 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.36 99.03 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.225 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.18 81.54 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.594 -0.692 . . . . 0.0 112.626 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.18 82.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.595 0.758 . . . . 0.0 112.664 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.5 m -71.58 -40.4 69.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.384 0.674 . . . . 0.0 112.152 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -69.19 -18.92 63.97 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.381 1.072 . . . . 0.0 113.749 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.85 19.65 13.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.374 1.87 . . . . 0.0 112.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -57.33 122.98 13.83 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.787 -1.196 . . . . 0.0 111.624 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.07 8.78 83.6 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.144 0.878 . . . . 0.0 114.939 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.1 mt -124.99 -43.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.684 1.594 . . . . 0.0 110.765 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.84 111.22 4.83 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.678 1.591 . . . . 0.0 109.207 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.27 138.34 36.0 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 121.934 1.756 . . . . 0.0 110.138 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 mp -119.64 149.34 42.12 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.518 1.527 . . . . 0.0 110.096 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.8 162.93 36.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 112.24 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -136.21 153.49 51.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.77 0.828 . . . . 0.0 112.578 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.74 116.39 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.644 1.578 . . . . 0.0 109.423 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.47 108.75 8.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.385 -0.822 . . . . 0.0 111.153 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.6 t -53.76 -39.64 65.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 114.09 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t -64.88 -28.7 69.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.349 -0.844 . . . . 0.0 113.033 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.98 -16.76 20.46 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.548 1.139 . . . . 0.0 113.96 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -139.31 56.89 1.66 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 124.193 1.949 . . . . 0.0 111.628 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -69.96 -33.68 72.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.48 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -62.49 -44.04 97.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.831 0.452 . . . . 0.0 111.519 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 m -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.957 0.903 . . . . 0.0 111.179 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 38.0 t -57.99 -37.14 73.7 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.744 0.818 . . . . 0.0 112.532 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -86.07 -34.37 20.71 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.903 0.881 . . . . 0.0 112.868 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.27 -25.49 67.87 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.089 . . . . 0.0 112.545 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -108.89 3.48 22.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.641 1.177 . . . . 0.0 112.546 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.14 27.84 71.18 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.755 1.645 . . . . 0.0 115.284 169.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.53 -41.6 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 126.081 1.752 . . . . 0.0 112.051 -174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m 62.58 -18.26 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.784 2.434 . . . . 0.0 116.917 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.77 165.75 30.96 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.677 3.036 . . . . 0.0 108.159 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -152.63 160.09 31.63 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 121.42 -1.047 . . . . 0.0 113.245 -170.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.1 141.0 38.46 Favored 'Cis proline' 0 C--N 1.356 0.93 0 N-CA-C 114.374 0.875 . . . . 0.0 114.374 2.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 m -136.67 113.01 9.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.842 1.657 . . . . 0.0 109.277 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.23 138.7 41.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.86 0.864 . . . . 0.0 111.172 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -143.31 152.54 41.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.439 1.496 . . . . 0.0 111.936 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 136.99 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.409 1.883 . . . . 0.0 108.903 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.68 103.43 7.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.353 1.461 . . . . 0.0 110.669 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -74.96 125.75 29.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.215 1.006 . . . . 0.0 110.653 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.32 27.1 2.53 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.611 1.564 . . . . 0.0 115.097 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.57 18.63 47.79 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.624 1.107 . . . . 0.0 115.162 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.63 141.24 37.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.957 1.703 . . . . 0.0 110.35 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.38 129.15 39.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.809 0.844 . . . . 0.0 112.009 -171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.82 -12.17 2.0 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.28 118.77 0.53 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 118.662 0.665 . . . . 0.0 114.371 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.48 133.1 48.87 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.71 -0.876 . . . . 0.0 109.089 167.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -63.35 148.18 49.09 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.619 0.768 . . . . 0.0 112.446 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -144.52 41.12 1.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.874 1.269 . . . . 0.0 112.025 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -173.74 13.79 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.687 1.613 . . . . 0.0 112.619 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.44 136.94 35.15 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.782 2.321 . . . . 0.0 110.768 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -79.01 59.35 2.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.905 1.282 . . . . 0.0 111.832 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 p -134.45 150.58 50.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.681 1.992 . . . . 0.0 109.937 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.94 -43.38 49.88 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.346 1.058 . . . . 0.0 113.221 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.53 -32.17 73.35 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.956 0.902 . . . . 0.0 112.565 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.78 -45.8 86.58 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.243 0.925 . . . . 0.0 112.601 171.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.24 -47.24 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 117.531 0.666 . . . . 0.0 111.127 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.98 -47.15 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.568 1.147 . . . . 0.0 111.386 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -59.3 -41.83 89.91 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.662 -0.649 . . . . 0.0 112.751 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -59.52 -32.3 70.18 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.354 1.062 . . . . 0.0 112.672 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -76.03 -51.93 11.27 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.079 0.854 . . . . 0.0 111.964 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -59.0 -32.87 70.1 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -68.12 -12.08 60.25 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -124.08 -31.54 3.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.19 -1.18 23.91 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.83 -179.03 52.75 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.674 1.131 . . . . 0.0 114.775 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.75 4.47 5.61 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.722 3.615 . . . . 0.0 114.732 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.89 -6.17 3.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.241 1.816 . . . . 0.0 115.857 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -62.62 -16.34 56.11 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.709 1.604 . . . . 0.0 114.924 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.216 1.806 . . . . 0.0 114.394 177.62 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -79.44 -23.29 43.25 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.542 -0.724 . . . . 0.0 112.7 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.78 131.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.98 0.912 . . . . 0.0 109.882 171.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.65 120.01 22.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.391 1.076 . . . . 0.0 110.947 172.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -89.86 64.5 6.4 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.95 -1.094 . . . . 0.0 111.519 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.53 160.15 17.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -148.34 158.54 44.16 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.591 1.556 . . . . 0.0 109.653 173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -52.38 -29.61 24.92 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.66 -12.58 60.23 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.139 1.376 . . . . 0.0 114.365 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -131.18 -34.08 1.46 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.113 1.765 . . . . 0.0 113.92 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -46.05 -47.79 17.0 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.629 1.972 . . . . 0.0 112.768 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.25 -8.66 2.68 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.387 1.875 . . . . 0.0 115.193 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -106.48 -13.98 15.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.154 1.382 . . . . 0.0 114.671 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -103.98 -26.99 12.42 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -17.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.795 1.238 . . . . 0.0 113.389 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.1 m -70.62 -20.01 62.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.456 1.502 . . . . 0.0 112.209 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.25 -4.99 50.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.181 0.992 . . . . 0.0 113.661 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.1 p -59.54 -22.11 61.21 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.09 -31.71 6.07 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.061 1.315 . . . . 0.0 115.615 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.88 -18.54 64.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.29 -6.9 3.38 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.407 1.483 . . . . 0.0 114.05 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.0 -22.65 17.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.819 1.676 . . . . 0.0 115.591 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -156.02 169.93 23.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.396 1.598 . . . . 0.0 113.635 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.4 tpp -117.57 137.35 52.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.845 1.658 . . . . 0.0 109.645 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.6 tp -104.87 129.71 53.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 168.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.3 150.19 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.173 0.589 . . . . 0.0 111.276 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -124.11 108.83 12.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 0.0 110.693 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.09 126.28 34.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.797 0.839 . . . . 0.0 110.016 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.21 174.82 11.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.837 1.255 . . . . 0.0 112.149 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 105.22 5.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.396 1.079 . . . . 0.0 111.924 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.18 -35.62 74.12 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.701 2.934 . . . . 0.0 116.348 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -83.82 -8.65 59.17 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.17 21.64 3.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.122 1.769 . . . . 0.0 112.289 -173.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.85 -156.73 8.16 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.389 0.995 . . . . 0.0 114.521 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.39 31.71 4.02 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.093 1.757 . . . . 0.0 112.055 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.5 m -52.48 -39.61 61.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.741 1.216 . . . . 0.0 112.54 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -59.8 -22.23 61.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.245 2.218 . . . . 0.0 116.084 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -103.7 -23.71 13.42 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.873 2.069 . . . . 0.0 113.831 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.0 tp -100.19 -27.31 13.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.06 -46.08 88.4 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -23.37 31.58 Favored 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 121.801 1.679 . . . . 0.0 113.301 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -73.32 -44.11 59.6 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.016 0.825 . . . . 0.0 110.696 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -72.55 -34.87 67.83 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.822 -0.548 . . . . 0.0 111.953 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.97 -44.91 91.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.82 1.248 . . . . 0.0 111.976 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.23 81.43 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.097 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.96 -45.08 83.06 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.173 0.589 . . . . 0.0 112.158 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.07 -36.82 80.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.0 112.522 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -64.86 -38.24 90.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.94 0.896 . . . . 0.0 112.926 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -26.92 63.67 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.36 6.87 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.627 1.571 . . . . 0.0 113.631 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.72 -30.53 63.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.67 18.02 35.39 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.365 1.46 . . . . 0.0 112.847 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.73 -51.47 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.795 1.238 . . . . 0.0 111.845 -169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -157.28 125.15 2.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.915 1.686 . . . . 0.0 110.161 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.76 151.59 46.31 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.887 2.392 . . . . 0.0 112.279 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.47 146.01 49.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.757 1.623 . . . . 0.0 110.28 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.54 161.99 38.49 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -132.68 151.23 52.02 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.568 1.147 . . . . 0.0 112.096 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.07 143.02 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.028 1.731 . . . . 0.0 109.751 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -110.22 106.97 16.6 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.006 1.323 . . . . 0.0 111.339 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.4 m -70.02 -12.51 61.66 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -78.66 -26.27 45.05 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.375 1.443 . . . . 0.0 111.096 168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.02 -31.28 16.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.672 1.589 . . . . 0.0 112.811 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -136.12 67.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 123.597 1.665 . . . . 0.0 112.656 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -68.94 -35.36 76.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.789 1.236 . . . . 0.0 111.834 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -65.14 -36.02 82.94 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.958 1.303 . . . . 0.0 112.952 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -69.66 -48.95 58.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.085 0.954 . . . . 0.0 110.357 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 13.0 m -68.16 -43.47 78.16 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -170.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -69.25 -35.79 76.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.708 0.685 . . . . 0.0 112.674 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -64.51 -28.51 69.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.856 1.262 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -88.68 -9.08 53.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.762 1.225 . . . . 0.0 112.611 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.79 19.02 45.38 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.521 1.534 . . . . 0.0 114.46 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 t -79.46 56.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.395 1.478 . . . . 0.0 110.348 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 m -78.34 -1.93 35.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.509 1.524 . . . . 0.0 113.532 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.56 52.62 0.33 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.615 1.103 . . . . 0.0 113.021 -171.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.84 154.91 4.52 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.785 1.234 . . . . 0.0 113.614 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.27 145.0 79.38 Favored 'Cis proline' 0 C--N 1.353 0.79 0 CA-C-N 119.375 0.813 . . . . 0.0 112.562 1.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.8 m -136.49 108.89 7.34 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.106 0.962 . . . . 0.0 109.352 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.12 134.71 37.53 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.361 0.664 . . . . 0.0 110.93 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -135.55 156.41 48.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.017 1.727 . . . . 0.0 111.666 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 85.2 mt -124.28 132.27 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.296 1.438 . . . . 0.0 110.044 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -129.62 94.57 3.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.324 1.45 . . . . 0.0 111.115 -174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -67.86 129.11 38.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.278 0.631 . . . . 0.0 109.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 52.0 21.61 1.57 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.868 1.267 . . . . 0.0 114.126 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.95 17.44 59.53 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 115.486 0.954 . . . . 0.0 115.486 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -133.1 136.01 45.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.688 1.595 . . . . 0.0 109.981 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -53.58 128.71 30.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.41 -13.98 2.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.296 0.638 . . . . 0.0 111.987 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.61 -142.99 6.16 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.677 1.132 . . . . 0.0 111.545 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 155.11 31.28 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 126.166 1.786 . . . . 0.0 112.253 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -64.81 159.25 22.91 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.102 1.761 . . . . 0.0 113.097 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.73 -38.14 79.96 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.07 -35.03 2.24 Favored Glycine 0 CA--C 1.548 2.143 0 CA-C-O 116.29 -2.394 . . . . 0.0 119.024 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.8 -31.1 49.94 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 124.336 3.358 . . . . 0.0 117.611 -170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.289 34.5 ptt-85 45.28 57.24 4.95 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.839 2.456 . . . . 0.0 114.559 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.8 p -144.0 156.71 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.032 2.533 . . . . 0.0 109.041 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.74 -46.9 50.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.38 -35.0 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.776 1.231 . . . . 0.0 112.297 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.54 -36.26 83.1 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.534 1.54 . . . . 0.0 113.139 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.9 mm -68.01 -48.89 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.909 1.354 . . . . 0.0 110.761 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.5 t -57.8 -46.52 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.335 0.654 . . . . 0.0 111.221 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.1 m -59.37 -44.76 92.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.132 0.573 . . . . 0.0 112.461 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -59.24 -34.05 71.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.228 1.011 . . . . 0.0 113.017 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.01 -52.3 17.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.488 0.715 . . . . 0.0 111.664 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -59.08 -35.7 73.84 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.833 -1.167 . . . . 0.0 112.978 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -62.45 -7.68 4.92 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.62 1.968 . . . . 0.0 115.542 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -126.63 -35.68 2.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.523 1.529 . . . . 0.0 113.157 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.35 -25.98 59.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.89 66.55 0.18 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.281 -1.288 . . . . 0.0 113.576 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.21 -30.39 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 125.046 3.83 . . . . 0.0 115.586 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.06 -7.78 50.86 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 m -134.92 13.27 3.64 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.257 1.45 0 C-N-CA 126.676 1.99 . . . . 0.0 112.511 176.045 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -130.3 7.91 5.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.191 1.397 . . . . 0.0 113.172 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.03 139.6 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.569 1.548 . . . . 0.0 111.275 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.59 153.63 42.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 112.846 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -128.04 102.71 6.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.299 1.84 . . . . 0.0 107.667 172.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.54 163.32 16.59 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -168.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.0 t -159.91 175.74 12.71 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.97 1.708 . . . . 0.0 110.386 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -47.59 -26.44 1.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.316 2.247 . . . . 0.0 115.163 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.92 -34.55 55.65 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.587 1.555 . . . . 0.0 114.392 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -147.63 -12.81 0.39 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -47.29 -44.39 23.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.777 1.231 . . . . 0.0 113.321 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.79 2.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.019 2.128 . . . . 0.0 115.286 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.5 p -113.58 -21.66 10.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.831 1.653 . . . . 0.0 113.837 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -75.51 -33.26 60.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.006 0.922 . . . . 0.0 112.642 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -19.11 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.402 1.881 . . . . 0.0 114.18 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -67.27 -19.73 65.55 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.171 1.389 . . . . 0.0 112.469 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.46 -12.18 61.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 p -60.4 -21.35 62.09 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.53 -20.81 12.28 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.816 1.198 . . . . 0.0 115.865 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -107.89 -1.89 20.33 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.099 1.36 . . . . 0.0 114.332 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.1 -15.57 4.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.028 1.731 . . . . 0.0 114.626 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.3 -33.05 2.75 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.838 1.685 . . . . 0.0 114.05 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.74 171.65 19.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 112.468 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.53 150.03 47.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.221 1.808 . . . . 0.0 109.44 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.9 tp -124.93 132.39 53.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 109.056 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 57' ' ' ALA . 40.6 t -138.89 140.1 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.446 -0.784 . . . . 0.0 111.142 -175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -107.17 134.13 50.73 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.867 1.667 . . . . 0.0 110.225 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -118.77 129.53 55.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.156 1.382 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 -172.97 4.3 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -168.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.92 29.96 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 127.122 2.169 . . . . 0.0 110.295 169.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.64 -1.62 11.0 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.702 2.935 . . . . 0.0 114.167 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -143.9 172.73 12.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.048 2.139 . . . . 0.0 112.153 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.7 m 51.81 31.74 8.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.868 1.667 . . . . 0.0 114.067 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.98 -176.14 43.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.664 1.602 . . . . 0.0 113.097 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -106.01 26.33 9.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.471 1.109 . . . . 0.0 113.434 -170.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 t -54.15 -39.77 66.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.927 0.891 . . . . 0.0 113.064 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -64.41 -17.31 63.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.425 1.49 . . . . 0.0 114.083 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.73 -29.49 8.31 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.491 1.517 . . . . 0.0 113.262 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 tp -91.33 -29.44 17.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -44.44 95.72 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.74 -15.66 30.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.439 2.092 . . . . 0.0 113.596 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.27 -39.51 17.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.502 -0.749 . . . . 0.0 111.815 170.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -67.45 -39.12 85.35 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.891 -1.131 . . . . 0.0 112.989 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.8 -31.65 72.74 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.879 -1.138 . . . . 0.0 113.193 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.09 75.0 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.856 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.34 89.41 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.175 1.352 . . . . 0.0 110.9 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.74 92.27 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.853 0.461 . . . . 0.0 111.849 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -62.76 -43.2 99.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.158 0.983 . . . . 0.0 112.047 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -75.56 -19.79 59.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.954 1.301 . . . . 0.0 114.27 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.91 14.99 14.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.186 1.794 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.76 -30.28 56.19 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.321 1.849 . . . . 0.0 115.881 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.2 12.12 60.28 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.278 1.418 . . . . 0.0 114.589 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.36 -40.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.593 1.197 . . . . 0.0 112.931 -170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.18 124.83 9.25 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.175 0.99 . . . . 0.0 111.314 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.41 131.18 17.21 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.386 2.058 . . . . 0.0 110.758 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mp -120.59 148.46 43.85 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.142 1.377 . . . . 0.0 111.71 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -148.05 169.06 20.76 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -130.71 152.72 49.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.022 1.729 . . . . 0.0 111.77 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -145.17 155.96 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 128.403 2.681 . . . . 0.0 109.043 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -131.17 121.87 25.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 112.033 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.8 m -81.04 -5.8 58.04 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -103.5 -28.54 11.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.169 1.35 . . . . 0.0 111.639 169.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.88 -35.26 62.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.977 0.511 . . . . 0.0 111.943 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -143.3 72.38 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.189 1.796 . . . . 0.0 112.31 -175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -67.03 -33.64 75.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.892 1.277 . . . . 0.0 111.167 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.05 -41.47 97.37 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.072 1.349 . . . . 0.0 112.565 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 m -65.43 -38.16 89.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.909 0.884 . . . . 0.0 111.23 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 42.8 m -72.09 -36.8 69.59 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -70.37 -21.11 62.91 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.23 -0.919 . . . . 0.0 113.153 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.27 -25.53 61.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.291 1.036 . . . . 0.0 112.81 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -124.38 -16.52 6.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -173.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.54 25.81 8.48 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 124.104 0.859 . . . . 0.0 113.786 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 t -76.1 63.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.969 1.308 . . . . 0.0 111.225 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -67.97 -6.01 20.09 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.89 1.676 . . . . 0.0 114.13 170.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.09 162.31 35.11 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 127.174 2.321 . . . . 0.0 110.411 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -149.95 161.18 32.0 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.219 1.408 . . . . 0.0 113.427 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.98 143.69 52.36 Favored 'Cis proline' 0 C--N 1.357 0.99 0 CA-C-N 119.344 0.801 . . . . 0.0 113.505 -1.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 16.2 m -140.38 122.5 15.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.166 1.386 . . . . 0.0 107.897 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.14 142.44 41.65 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.819 0.848 . . . . 0.0 110.133 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -128.96 140.79 51.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.053 1.341 . . . . 0.0 111.489 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.69 139.74 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.907 1.283 . . . . 0.0 109.246 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -130.03 86.38 2.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.417 1.087 . . . . 0.0 110.76 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -64.31 123.54 19.41 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.481 1.113 . . . . 0.0 109.909 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.8 t70 48.3 27.62 1.39 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.322 1.449 . . . . 0.0 114.285 -172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.18 14.93 53.43 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.894 1.235 . . . . 0.0 116.034 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.63 147.43 41.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.577 1.689 . . . . 0.0 111.344 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.88 110.8 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.355 1.062 . . . . 0.0 113.522 -169.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.8 56.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.576 0.75 . . . . 0.0 110.349 169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.9 -84.03 0.1 Allowed Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.893 0.758 . . . . 0.0 113.679 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.92 167.12 18.92 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.835 1.654 . . . . 0.0 111.883 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -122.81 139.83 53.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.966 1.307 . . . . 0.0 110.8 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -150.76 149.41 29.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.615 1.566 . . . . 0.0 110.373 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.97 -148.98 10.85 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.589 -170.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.66 -21.88 26.61 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.218 3.279 . . . . 0.0 116.135 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 51.65 57.75 6.22 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.995 1.718 . . . . 0.0 111.978 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.6 p -152.85 159.46 43.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.048 2.539 . . . . 0.0 110.049 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.27 -43.71 61.64 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.29 -31.48 72.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.024 0.93 . . . . 0.0 112.705 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.78 98.52 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.55 0.595 . . . . 0.0 112.606 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.4 mm -64.33 -47.38 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 117.815 0.808 . . . . 0.0 111.19 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.8 -40.53 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.052 0.941 . . . . 0.0 111.812 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -62.2 -41.25 98.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.789 0.836 . . . . 0.0 113.164 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -63.65 -38.03 89.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.184 0.994 . . . . 0.0 112.154 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.88 -50.76 26.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.524 0.73 . . . . 0.0 112.3 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -60.58 -29.1 68.98 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.548 -1.345 . . . . 0.0 113.614 -174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -72.9 -8.7 56.81 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.128 1.771 . . . . 0.0 115.023 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.59 -32.88 3.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.056 1.342 . . . . 0.0 113.401 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.96 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.878 169.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.16 -177.79 40.1 Favored Glycine 0 CA--C 1.542 1.727 0 C-N-CA 124.947 1.26 . . . . 0.0 113.795 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.49 -23.28 76.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.637 3.558 . . . . 0.0 115.097 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 59.04 14.65 3.53 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.473 2.309 . . . . 0.0 115.593 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -137.99 14.9 2.86 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.245 1.818 . . . . 0.0 112.946 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 126.207 1.803 . . . . 0.0 114.408 178.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -130.99 13.61 5.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.401 1.48 . . . . 0.0 112.558 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.02 133.76 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.405 1.882 . . . . 0.0 109.022 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.95 114.36 8.04 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.675 0.79 . . . . 0.0 111.214 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -81.85 55.62 2.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.484 1.514 . . . . 0.0 113.053 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -63.12 161.07 14.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.298 1.439 . . . . 0.0 114.232 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -153.42 158.08 40.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.289 1.836 . . . . 0.0 109.526 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -54.24 -24.47 18.76 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.793 1.637 . . . . 0.0 114.374 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.29 -23.63 64.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.949 1.3 . . . . 0.0 114.319 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -139.0 -18.67 1.02 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -51.43 -36.94 46.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.072 1.349 . . . . 0.0 113.419 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.17 0.42 0.62 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 64.0 m -134.87 3.12 3.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.34 -1.475 . . . . 0.0 114.12 169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -76.93 -31.0 56.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.276 1.03 . . . . 0.0 111.576 169.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -23.13 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.486 1.114 . . . . 0.0 113.5 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -71.04 -21.22 62.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.699 1.6 . . . . 0.0 113.08 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -74.48 -9.66 58.8 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -63.96 -20.66 66.04 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -48.96 -37.66 22.7 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.285 1.421 . . . . 0.0 116.233 -172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 p -83.95 -39.41 19.78 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.321 1.061 . . . . 0.0 113.51 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.13 57.51 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.669 1.588 . . . . 0.0 114.041 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.89 -25.3 12.07 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.197 1.856 . . . . 0.0 113.97 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.47 178.55 10.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.278 1.431 . . . . 0.0 112.737 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.5 ttm -133.6 146.93 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.661 1.984 . . . . 0.0 107.651 168.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.58 122.32 28.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.087 1.355 . . . . 0.0 107.93 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 57' ' ' ALA . 48.4 t -132.2 142.65 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.93 0.492 . . . . 0.0 110.922 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.8 134.54 46.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.982 1.313 . . . . 0.0 111.849 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -117.43 126.66 53.01 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.985 1.314 . . . . 0.0 109.435 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -152.67 -174.47 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.101 1.36 . . . . 0.0 112.343 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.02 157.04 58.2 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.515 1.126 . . . . 0.0 110.179 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.17 29.73 0.42 Allowed 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 124.137 3.225 . . . . 0.0 114.468 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -78.13 5.39 10.2 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.644 1.578 . . . . 0.0 115.074 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.9 m 60.29 18.16 7.72 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.459 1.904 . . . . 0.0 114.884 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.34 -52.08 18.97 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.566 -0.709 . . . . 0.0 112.665 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -138.85 -9.58 1.36 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.6 p -69.37 -12.51 61.72 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -105.65 3.82 29.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.496 1.518 . . . . 0.0 113.314 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -123.14 -35.9 2.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.013 1.725 . . . . 0.0 112.425 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.81 -24.64 13.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.3 1.44 . . . . 0.0 113.489 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.32 -40.98 72.96 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.23 -16.8 31.52 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.108 1.872 . . . . 0.0 113.711 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -90.56 -37.62 13.72 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.707 -0.62 . . . . 0.0 112.181 171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -69.84 -33.75 72.72 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.24 -0.913 . . . . 0.0 112.713 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.89 -34.47 77.87 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.036 -1.04 . . . . 0.0 113.162 169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.3 93.41 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.711 . . . . 0.0 111.191 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.11 93.58 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.335 -0.853 . . . . 0.0 112.603 172.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.46 -35.02 79.67 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.483 0.713 . . . . 0.0 112.611 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.3 m -67.5 -44.01 79.51 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.229 1.011 . . . . 0.0 111.515 171.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -69.09 -25.66 64.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.78 1.232 . . . . 0.0 113.698 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.01 10.32 20.47 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.741 1.617 . . . . 0.0 113.496 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -59.6 116.81 4.27 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.063 0.945 . . . . 0.0 110.71 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.74 89.62 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 123.992 0.806 . . . . 0.0 115.003 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mt -118.22 -48.73 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.673 1.589 . . . . 0.0 110.132 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -146.13 103.42 4.1 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 126.791 2.036 . . . . 0.0 107.896 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -50.89 133.63 40.33 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.311 2.674 . . . . 0.0 112.221 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.29 135.83 54.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.027 1.331 . . . . 0.0 111.381 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' HB3' HG22 ' A' ' 26' ' ' VAL . . . -138.58 165.97 25.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.766 0.827 . . . . 0.0 112.302 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -139.49 142.61 37.31 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.341 1.056 . . . . 0.0 111.423 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.71 131.02 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.803 1.241 . . . . 0.0 110.938 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.12 117.7 24.23 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.52 1.128 . . . . 0.0 112.329 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.8 t -58.13 -39.21 78.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 114.022 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -70.61 -25.77 63.19 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.351 -0.843 . . . . 0.0 112.468 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.49 -31.32 26.56 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -137.96 77.24 1.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.226 1.488 . . . . 0.0 111.597 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 -28.04 61.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.572 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -58.3 -46.1 86.75 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.317 1.847 . . . . 0.0 113.303 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 m -65.9 -45.92 80.19 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.793 0.837 . . . . 0.0 110.581 170.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.75 -49.88 76.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.635 1.174 . . . . 0.0 112.901 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -73.8 -36.69 65.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.84 -30.25 70.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.837 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -92.4 -10.02 39.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.986 1.314 . . . . 0.0 113.111 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 21.77 56.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.746 1.165 . . . . 0.0 113.321 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 t -82.01 58.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.385 1.474 . . . . 0.0 110.599 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -63.72 -7.62 8.11 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.38 -179.98 40.57 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.429 2.443 . . . . 0.0 110.231 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.3 163.23 33.4 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 124.814 1.246 . . . . 0.0 113.064 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.87 139.01 52.43 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 118.962 0.665 . . . . 0.0 111.3 -10.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 m -127.97 112.06 14.25 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.273 1.029 . . . . 0.0 109.616 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.52 138.36 35.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 110.864 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -135.2 149.22 49.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.854 1.261 . . . . 0.0 112.231 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.1 mt -107.47 141.51 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.281 1.832 . . . . 0.0 110.082 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -131.42 78.34 1.82 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.077 1.351 . . . . 0.0 110.572 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -65.16 128.11 34.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.585 1.154 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t70 47.49 28.85 1.23 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.662 1.585 . . . . 0.0 114.15 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.84 49.51 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 120.884 -1.135 . . . . 0.0 114.949 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.98 143.59 31.99 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.5 1.52 . . . . 0.0 110.583 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -52.45 110.87 0.55 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.223 1.009 . . . . 0.0 113.331 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.42 -41.66 32.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.75 -74.85 0.22 Allowed Glycine 0 C--N 1.343 0.956 0 C-N-CA 123.709 0.671 . . . . 0.0 114.093 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.57 154.7 34.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.455 1.502 . . . . 0.0 111.567 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -61.46 153.58 26.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.695 1.198 . . . . 0.0 112.516 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -143.25 62.91 1.38 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.463 1.105 . . . . 0.0 111.89 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.56 -178.57 40.29 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.107 1.337 . . . . 0.0 113.004 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.19 136.18 63.04 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.88 2.387 . . . . 0.0 110.683 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -86.21 63.53 8.06 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.049 0.94 . . . . 0.0 111.755 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.8 p -146.98 153.35 39.96 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.411 2.284 . . . . 0.0 109.619 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.12 -41.99 37.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -72.31 -30.9 65.22 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.56 -41.83 64.83 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.19 1.376 . . . . 0.0 112.847 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.7 mm -60.79 -47.54 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 118.363 1.082 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.42 -46.72 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.305 0.642 . . . . 0.0 111.533 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -57.36 -43.41 83.47 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.497 -0.752 . . . . 0.0 113.016 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -57.59 -37.1 72.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.449 1.1 . . . . 0.0 112.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.18 -49.78 32.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.844 0.857 . . . . 0.0 111.843 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -59.74 -34.65 73.23 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.871 -1.143 . . . . 0.0 112.802 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.08 -17.29 57.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.672 1.989 . . . . 0.0 115.027 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -119.92 -33.6 3.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.194 1.398 . . . . 0.0 113.436 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.16 -27.64 65.71 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.85 52.13 40.87 Favored Glycine 0 CA--C 1.546 1.983 0 C-N-CA 125.32 1.438 . . . . 0.0 115.868 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.49 -6.71 18.68 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.917 3.078 . . . . 0.0 115.105 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.83 158.62 10.23 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.906 1.283 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.1 m 58.17 27.56 15.24 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.17 1.788 . . . . 0.0 114.734 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.476 1.911 . . . . 0.0 110.429 177.35 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 119.847 -0.12 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.2 -30.29 63.42 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.604 -0.685 . . . . 0.0 111.901 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.02 127.31 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.383 1.073 . . . . 0.0 109.252 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.38 116.84 12.18 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.269 1.027 . . . . 0.0 110.617 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.66 61.67 6.95 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.612 -1.305 . . . . 0.0 110.958 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.7 162.89 12.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.714 1.606 . . . . 0.0 114.484 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.53 173.14 17.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.037 1.735 . . . . 0.0 109.807 170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -53.83 -25.28 18.74 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.38 -22.84 64.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.042 1.337 . . . . 0.0 114.578 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -136.1 -21.7 1.4 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.73 -35.28 70.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.625 1.102 . . . . 0.0 111.224 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.87 7.7 0.35 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.356 2.662 . . . . 0.0 115.59 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -135.37 -2.3 2.5 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.15 -24.25 54.83 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 121.241 -0.912 . . . . 0.0 112.62 169.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -16.64 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.368 1.467 . . . . 0.0 113.747 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m -96.65 0.9 50.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.21 1.804 . . . . 0.0 113.826 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -128.19 -2.03 5.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.16 1.384 . . . . 0.0 113.22 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -61.28 -24.36 66.35 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.16 -21.74 19.28 Favored Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.611 1.1 . . . . 0.0 114.609 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -59.8 -33.68 72.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.33 -7.01 4.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 0.0 113.498 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 -17.95 33.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.4 1.476 . . . . 0.0 114.615 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.67 173.49 16.65 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.588 1.555 . . . . 0.0 112.225 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 ttp -128.24 142.76 51.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.063 1.345 . . . . 0.0 109.459 168.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -109.27 134.22 52.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.137 1.375 . . . . 0.0 108.267 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.22 144.0 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.656 0.782 . . . . 0.0 110.983 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.44 113.73 26.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.062 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -78.67 136.11 37.37 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.442 -0.786 . . . . 0.0 110.64 169.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -152.25 -175.66 5.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.426 1.491 . . . . 0.0 112.509 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.14 160.09 38.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.335 1.454 . . . . 0.0 110.149 170.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.74 -12.6 22.1 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.28 2.653 . . . . 0.0 113.528 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -67.88 168.96 10.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.032 1.733 . . . . 0.0 113.188 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 18.6 p -57.55 129.1 40.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.116 0.967 . . . . 0.0 112.959 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 164.34 179.04 38.26 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.088 0.852 . . . . 0.0 113.897 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -70.01 -4.4 20.67 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 79.6 m -61.58 -40.75 95.9 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.129 -0.982 . . . . 0.0 111.295 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -68.67 -26.01 65.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.891 1.676 . . . . 0.0 113.582 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -79.78 -25.47 40.94 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.917 1.287 . . . . 0.0 113.144 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.1 tp -96.78 -31.63 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.29 -42.57 64.92 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.55 -12.95 29.84 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.198 2.599 . . . . 0.0 113.887 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -96.52 -40.83 8.86 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 111.728 170.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -63.19 -36.73 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.082 -1.011 . . . . 0.0 112.531 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -32.81 73.65 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.086 -1.009 . . . . 0.0 113.416 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.5 85.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.3 0.64 . . . . 0.0 111.916 172.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.75 95.7 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.043 0.838 . . . . 0.0 111.761 171.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.6 76.19 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.616 -0.677 . . . . 0.0 112.608 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -70.4 -42.64 71.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.78 0.718 . . . . 0.0 112.256 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -72.84 -20.61 61.09 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.592 1.157 . . . . 0.0 113.825 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.1 mt -115.44 15.98 16.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.761 2.025 . . . . 0.0 112.324 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.4 119.62 7.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.959 1.304 . . . . 0.0 111.415 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.82 89.45 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.807 1.194 . . . . 0.0 114.912 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.1 mm -113.7 -38.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.84 1.656 . . . . 0.0 110.683 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.3 t -145.2 127.57 8.07 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 125.643 1.577 . . . . 0.0 109.763 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 120.16 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.652 2.234 . . . . 0.0 109.928 169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.67 146.08 31.19 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.618 1.167 . . . . 0.0 109.79 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.76 167.02 25.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.938 0.895 . . . . 0.0 112.832 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -142.78 150.25 39.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.597 0.759 . . . . 0.0 112.42 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.04 128.09 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.593 1.157 . . . . 0.0 111.291 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.07 106.18 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.344 1.057 . . . . 0.0 111.715 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.7 t -57.39 -40.73 78.84 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.304 -0.873 . . . . 0.0 112.547 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 t -66.27 -27.05 67.64 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 121.359 -0.838 . . . . 0.0 112.651 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.53 -18.59 26.36 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -136.34 64.96 1.54 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.574 1.55 . . . . 0.0 111.488 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -68.93 -39.71 79.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.99 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.43 -45.51 92.78 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.052 0.541 . . . . 0.0 111.56 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -60.34 -45.48 93.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 0.0 110.729 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.05 -42.83 99.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.839 1.255 . . . . 0.0 112.212 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -78.85 -34.82 44.76 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.255 -0.903 . . . . 0.0 111.895 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.16 -30.65 70.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.872 . . . . 0.0 112.116 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -89.97 -12.94 37.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.41 20.66 56.34 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.497 1.046 . . . . 0.0 113.227 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.0 62.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.073 1.749 . . . . 0.0 109.12 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 m -62.0 -9.2 6.55 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.215 1.406 . . . . 0.0 114.731 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.99 176.24 41.4 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.07 2.748 . . . . 0.0 109.701 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.0 161.41 29.52 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.45 1.5 . . . . 0.0 112.636 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 138.55 47.2 Favored 'Cis proline' 0 C--N 1.358 1.036 0 CA-C-N 119.873 0.99 . . . . 0.0 113.358 1.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.9 m -135.58 108.63 7.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.372 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.24 136.31 33.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.23 0.612 . . . . 0.0 111.495 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -137.42 151.98 49.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.829 1.652 . . . . 0.0 112.299 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.02 138.64 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.0 1.72 . . . . 0.0 109.219 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -129.3 87.07 2.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.647 1.179 . . . . 0.0 110.71 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -66.87 122.54 17.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.902 1.281 . . . . 0.0 110.388 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 43.35 37.37 1.33 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.933 1.693 . . . . 0.0 113.992 -169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.76 20.78 57.48 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.956 0.788 . . . . 0.0 114.993 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.34 137.57 34.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.242 1.417 . . . . 0.0 109.139 -176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.67 108.9 0.54 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.825 0.85 . . . . 0.0 112.17 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.41 73.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.4 -76.82 0.18 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 114.51 0.564 . . . . 0.0 114.51 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 156.02 28.24 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.38 1.872 . . . . 0.0 110.332 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.86 -31.95 72.13 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.5 t0 34.49 58.33 0.67 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 128.743 2.817 . . . . 0.0 114.314 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.94 -158.15 9.34 Favored Glycine 0 CA--C 1.542 1.738 0 C-N-CA 124.484 1.04 . . . . 0.0 114.165 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.55 164.39 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 125.127 3.884 . . . . 0.0 116.412 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -129.65 61.05 1.57 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.565 1.546 . . . . 0.0 109.932 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.3 p -147.14 152.04 37.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.812 2.045 . . . . 0.0 111.03 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.82 -44.44 70.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.864 0.866 . . . . 0.0 113.01 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -63.92 -31.89 73.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.064 0.946 . . . . 0.0 112.248 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.9 -44.85 97.6 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.276 0.941 . . . . 0.0 112.489 172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.4 mm -64.5 -48.01 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 121.841 -0.799 . . . . 0.0 110.854 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.8 -41.72 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.824 0.85 . . . . 0.0 111.897 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 t -61.04 -44.2 97.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.719 1.207 . . . . 0.0 112.973 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -61.95 -39.55 92.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.309 1.043 . . . . 0.0 112.157 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.81 -49.85 48.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.818 0.847 . . . . 0.0 112.419 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -63.85 -22.01 66.71 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.773 -1.204 . . . . 0.0 113.893 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.0 -15.24 62.56 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.363 1.865 . . . . 0.0 115.432 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -128.79 -27.73 2.53 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -19.93 42.97 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.6 176.61 46.87 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.492 1.044 . . . . 0.0 113.689 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.46 -17.49 23.71 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.555 2.836 . . . . 0.0 113.377 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.87 164.45 35.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.915 1.686 . . . . 0.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.6 p -142.41 6.5 1.69 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 127.11 2.164 . . . . 0.0 112.76 -176.79 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.721 0.296 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.03 -23.66 2.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.318 1.447 . . . . 0.0 112.536 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.57 135.99 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.103 1.361 . . . . 0.0 109.918 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.96 114.25 6.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.803 0.841 . . . . 0.0 111.836 175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -83.66 96.45 8.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.917 -1.114 . . . . 0.0 110.144 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -109.37 163.42 13.42 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.56 1.144 . . . . 0.0 112.621 -171.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 p -146.82 161.67 40.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.839 1.256 . . . . 0.0 111.612 -173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.72 -24.83 9.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.35 1.46 . . . . 0.0 113.76 171.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -72.94 -26.91 61.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.108 1.363 . . . . 0.0 113.429 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.4 -13.79 1.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -171.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -50.41 -39.57 47.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 120.494 1.497 . . . . 0.0 113.603 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.66 -25.13 25.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.429 1.892 . . . . 0.0 115.644 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 p -83.04 -11.26 58.22 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -104.98 -26.41 12.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -169.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -22.52 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.075 0.95 . . . . 0.0 113.503 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -75.05 -16.29 60.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.134 1.774 . . . . 0.0 114.035 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.68 -15.44 63.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.021 0.928 . . . . 0.0 113.42 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.2 p -58.14 -23.34 54.76 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.372 1.869 . . . . 0.0 114.862 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.93 -22.97 13.67 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.824 1.202 . . . . 0.0 115.972 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -94.91 -9.93 32.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.47 -4.65 3.34 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.54 3.27 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.949 1.738 . . . . 0.0 114.677 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -155.38 174.2 15.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.435 1.494 . . . . 0.0 112.191 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 59.7 ttm -128.92 143.44 50.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.356 1.462 . . . . 0.0 109.361 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.96 138.92 42.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.686 1.194 . . . . 0.0 108.999 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.4 t -140.43 135.01 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.295 -0.878 . . . . 0.0 111.082 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -102.78 136.88 41.78 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.2 1.4 . . . . 0.0 111.078 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -117.5 126.92 53.42 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.202 1.401 . . . . 0.0 110.099 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.84 -179.84 7.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.676 1.19 . . . . 0.0 112.818 -169.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.81 60.08 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.298 1.439 . . . . 0.0 112.083 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.88 -7.23 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.664 2.91 . . . . 0.0 115.772 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -69.11 -27.88 65.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.6 m -80.06 173.82 12.21 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.316 1.046 . . . . 0.0 113.42 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.23 19.58 5.48 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.608 1.575 . . . . 0.0 114.714 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -57.55 -24.32 55.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.261 1.824 . . . . 0.0 115.261 -170.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 99.6 m -60.92 -21.8 63.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.394 1.078 . . . . 0.0 112.851 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -118.21 -7.14 10.81 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.189 1.396 . . . . 0.0 114.355 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -121.13 -16.3 8.02 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.205 1.402 . . . . 0.0 114.5 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -138.23 -21.47 1.06 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.708 1.603 . . . . 0.0 113.12 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.41 90.52 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.7 -22.28 6.58 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.814 1.676 . . . . 0.0 114.057 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.48 -51.32 52.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.46 1.027 . . . . 0.0 112.549 -169.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -79.23 -29.21 42.6 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.05 -41.4 82.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.517 1.127 . . . . 0.0 112.038 170.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.91 91.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.527 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.02 -46.88 78.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -42.7 97.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.287 0.635 . . . . 0.0 111.436 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.4 m -62.35 -42.1 99.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.576 1.151 . . . . 0.0 112.81 174.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.77 -27.03 63.62 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.166 0.986 . . . . 0.0 113.485 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.99 15.64 24.17 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.664 1.585 . . . . 0.0 112.72 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.39 112.13 1.64 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.397 1.479 . . . . 0.0 110.675 177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.2 84.38 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.545 1.069 . . . . 0.0 114.356 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.7 mm -114.36 -45.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.785 1.634 . . . . 0.0 110.6 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 t -148.46 118.44 4.17 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.172 1.789 . . . . 0.0 109.771 175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.13 139.49 35.63 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.368 2.045 . . . . 0.0 111.094 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.44 141.41 51.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.921 1.689 . . . . 0.0 111.036 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.81 163.76 29.09 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -137.65 142.62 41.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.93 127.04 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.461 1.504 . . . . 0.0 110.31 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -84.44 112.6 20.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.54 1.136 . . . . 0.0 110.665 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.7 t -55.97 -35.5 66.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.144 1.777 . . . . 0.0 114.8 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.2 p -74.48 -26.84 60.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.719 -1.238 . . . . 0.0 111.969 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.06 27.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.312 1.045 . . . . 0.0 113.412 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -141.16 56.73 1.54 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.958 1.837 . . . . 0.0 112.465 -173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.8 m -70.44 -30.96 67.95 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.823 1.249 . . . . 0.0 111.78 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -63.62 -37.68 88.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.621 1.569 . . . . 0.0 113.679 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.7 m -74.35 -44.36 52.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.299 1.04 . . . . 0.0 109.943 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 43.0 t -59.21 -50.14 75.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.571 1.149 . . . . 0.0 112.462 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -73.61 -37.72 65.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.03 -30.81 70.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.136 1.374 . . . . 0.0 112.622 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.34 -11.5 40.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.116 0.966 . . . . 0.0 112.79 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.96 52.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.772 1.177 . . . . 0.0 113.414 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.98 58.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.719 1.608 . . . . 0.0 109.385 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 m -62.82 -11.23 16.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.334 1.454 . . . . 0.0 114.031 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.28 -179.72 37.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.814 2.626 . . . . 0.0 109.717 170.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.69 152.23 52.06 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.878 1.271 . . . . 0.0 112.425 -175.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.46 145.97 80.24 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 119.173 0.74 . . . . 0.0 113.663 2.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.9 m -136.31 128.28 29.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.826 1.65 . . . . 0.0 108.522 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.82 135.01 54.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.766 0.827 . . . . 0.0 110.209 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.76 157.18 44.49 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.668 1.187 . . . . 0.0 113.184 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.22 138.91 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.683 1.993 . . . . 0.0 109.507 -172.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -132.88 86.05 2.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.155 0.982 . . . . 0.0 111.482 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.43 120.41 9.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.083 1.753 . . . . 0.0 109.748 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.7 t70 50.32 28.63 3.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.346 1.458 . . . . 0.0 113.921 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.83 21.82 54.75 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.143 -0.973 . . . . 0.0 114.56 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -136.3 138.08 41.34 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.867 1.667 . . . . 0.0 109.853 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -50.59 113.39 0.88 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.308 1.043 . . . . 0.0 112.951 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.84 -38.79 20.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.185 0.594 . . . . 0.0 109.703 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.05 -86.3 0.12 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.455 1.026 . . . . 0.0 112.471 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.39 155.27 28.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.012 1.325 . . . . 0.0 112.518 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -67.49 161.42 25.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 112.051 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -138.62 14.88 2.73 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -169.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.8 -172.34 13.21 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 125.216 1.389 . . . . 0.0 113.652 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.71 150.14 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.115 2.543 . . . . 0.0 111.212 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.29 45.86 0.18 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.515 1.926 . . . . 0.0 113.795 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.6 p -131.49 152.21 50.91 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.431 1.492 . . . . 0.0 111.056 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.59 -47.06 40.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -66.24 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.416 1.086 . . . . 0.0 112.389 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.29 94.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.933 0.778 . . . . 0.0 112.514 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mm -63.32 -46.02 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 117.911 0.856 . . . . 0.0 110.6 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.61 -46.52 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.85 0.86 . . . . 0.0 111.005 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.0 m -58.46 -43.07 88.74 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -57.0 -35.64 69.46 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.143 0.977 . . . . 0.0 112.995 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.79 -49.59 24.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.634 0.774 . . . . 0.0 111.571 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -59.37 -34.23 72.14 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.962 -1.086 . . . . 0.0 113.173 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -62.65 -17.52 60.61 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.498 1.919 . . . . 0.0 114.958 177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.38 -33.88 4.22 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.069 1.347 . . . . 0.0 113.484 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.5 73.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.779 0.832 . . . . 0.0 113.211 170.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.81 -58.19 15.27 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.767 1.651 . . . . 0.0 114.849 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.21 -27.43 41.27 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.668 2.246 . . . . 0.0 113.242 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -14.57 61.93 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.1 m 57.49 23.47 9.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.696 1.998 . . . . 0.0 115.007 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.483 1.175 0 C-N-CA 126.041 1.736 . . . . 0.0 113.471 176.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.84 -33.06 74.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.625 0.77 . . . . 0.0 112.225 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.15 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.156 1.382 . . . . 0.0 109.452 169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.74 116.23 18.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.923 0.889 . . . . 0.0 109.842 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -103.29 64.08 0.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.714 -1.241 . . . . 0.0 110.942 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 169.38 13.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 123.208 1.48 . . . . 0.0 113.78 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -145.42 159.0 43.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.637 1.975 . . . . 0.0 108.495 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.08 -22.75 6.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.5 -27.95 41.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.045 1.338 . . . . 0.0 114.292 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.23 -18.42 0.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -45.06 -44.31 10.13 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.657 1.583 . . . . 0.0 113.816 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.35 -20.97 21.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -95.29 -17.09 21.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.796 1.639 . . . . 0.0 114.812 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -95.67 -33.42 12.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.748 0.819 . . . . 0.0 113.055 -170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -23.23 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.631 0.772 . . . . 0.0 112.239 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.2 p -101.05 -1.21 34.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.544 1.938 . . . . 0.0 113.646 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -85.45 11.74 9.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.488 1.515 . . . . 0.0 112.811 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -62.72 154.2 30.23 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.341 2.256 . . . . 0.0 113.419 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.2 -36.88 0.18 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.716 1.151 . . . . 0.0 114.54 174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -66.98 -22.75 65.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.71 -2.35 4.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.812 1.645 . . . . 0.0 114.02 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.1 -10.03 36.35 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.399 1.476 . . . . 0.0 115.595 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.71 169.86 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.995 1.318 . . . . 0.0 112.846 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.2 tpt -118.14 147.58 43.18 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.648 1.579 . . . . 0.0 109.197 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -117.2 133.48 55.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 0.0 107.67 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.7 141.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.673 0.669 . . . . 0.0 110.631 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.24 124.04 51.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.322 1.849 . . . . 0.0 110.568 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -103.84 126.28 50.86 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.203 1.001 . . . . 0.0 109.618 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -152.15 -176.26 5.6 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.162 0.985 . . . . 0.0 112.863 -168.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 144.4 18.2 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.051 0.94 . . . . 0.0 109.998 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -10.7 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.777 2.985 . . . . 0.0 115.07 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -87.6 -2.12 58.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.381 . . . . 0.0 114.352 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -68.2 -14.46 63.0 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.62 -39.05 1.71 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 126.089 1.804 . . . . 0.0 114.692 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.1 0.63 11.01 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.873 1.669 . . . . 0.0 114.02 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.8 m -54.1 -39.49 66.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.954 1.701 . . . . 0.0 112.778 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -53.51 -31.96 48.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.77 2.028 . . . . 0.0 114.997 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -87.78 -21.23 25.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.494 1.518 . . . . 0.0 113.564 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.52 -33.88 6.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.585 1.154 . . . . 0.0 113.154 -172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.39 -45.67 98.37 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 117.311 -1.328 . . . . 0.0 114.448 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.74 -14.06 17.65 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.949 1.766 . . . . 0.0 113.283 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -82.09 -43.98 17.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.076 -1.015 . . . . 0.0 112.435 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -72.68 -32.0 65.47 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.166 -0.959 . . . . 0.0 112.622 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.24 -33.08 73.74 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.821 -1.174 . . . . 0.0 113.276 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.92 -42.28 85.63 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.816 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.49 -44.15 84.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.666 1.121 . . . . 0.0 112.482 172.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.49 69.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.559 0.743 . . . . 0.0 112.689 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.7 m -73.24 -44.02 60.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.867 1.267 . . . . 0.0 111.046 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -72.71 -26.18 61.5 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.39 16.48 23.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.57 1.548 . . . . 0.0 112.727 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -56.9 117.28 3.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.134 1.374 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.43 9.71 86.68 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.324 0.964 . . . . 0.0 114.773 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.7 mt -121.31 -46.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.494 1.518 . . . . 0.0 110.337 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 t -146.28 123.92 6.12 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 125.209 1.404 . . . . 0.0 109.742 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.48 138.75 19.9 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.1 2.533 . . . . 0.0 111.764 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.27 140.39 52.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.928 1.691 . . . . 0.0 110.875 -172.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.5 168.48 19.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -147.36 156.55 43.0 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -141.49 133.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.631 1.973 . . . . 0.0 108.792 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.37 113.62 24.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.427 0.691 . . . . 0.0 111.618 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.86 -21.55 66.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 t -70.79 -31.57 68.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.531 1.06 . . . . 0.0 111.891 169.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.8 -36.54 25.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.23 1.012 . . . . 0.0 112.379 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -135.56 80.42 1.83 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 123.201 1.477 . . . . 0.0 112.232 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -77.16 -40.43 45.47 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.206 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.36 -39.66 92.59 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.144 0.578 . . . . 0.0 110.927 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -60.78 -44.83 96.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.838 1.255 . . . . 0.0 111.099 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 18.0 m -69.1 -36.32 77.43 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.14 -34.53 71.1 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.834 0.743 . . . . 0.0 111.973 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -63.3 -26.67 68.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 112.604 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -94.84 -11.53 28.67 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.456 1.103 . . . . 0.0 113.544 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.29 25.17 34.39 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 125.044 1.306 . . . . 0.0 113.824 173.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 53.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.965 1.706 . . . . 0.0 110.773 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.6 p -65.21 -7.09 11.33 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.28 63.83 0.23 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.329 0.966 . . . . 0.0 113.479 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -57.59 156.71 16.12 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.63 145.79 75.26 Favored 'Cis proline' 0 C--N 1.358 1.067 0 CA-C-N 119.066 0.702 . . . . 0.0 113.172 -0.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.8 m -140.1 118.72 12.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.661 1.184 . . . . 0.0 109.407 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.66 139.65 36.04 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.652 0.781 . . . . 0.0 109.661 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -139.01 146.04 40.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.973 0.909 . . . . 0.0 112.436 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.55 138.72 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.915 2.086 . . . . 0.0 108.318 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -133.72 89.5 2.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.204 1.402 . . . . 0.0 111.027 -174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.3 124.52 21.94 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.538 0.735 . . . . 0.0 110.01 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 48.31 26.27 1.06 Allowed 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.83 1.652 . . . . 0.0 114.378 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.52 21.58 56.01 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.154 -0.966 . . . . 0.0 115.428 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.86 137.89 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.655 1.582 . . . . 0.0 110.66 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -52.23 123.23 10.19 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.06 . . . . 0.0 112.853 -171.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.08 -11.46 2.23 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.43 105.88 0.2 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 119.222 0.919 . . . . 0.0 114.604 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 127.06 31.42 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.643 -0.916 . . . . 0.0 109.637 168.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -107.85 148.78 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.902 1.281 . . . . 0.0 112.137 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -143.51 36.82 1.33 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.236 1.814 . . . . 0.0 110.963 -171.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.13 -164.69 17.68 Favored Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.302 1.43 . . . . 0.0 114.865 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -54.52 -12.52 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.052 1 C-N-CA 125.518 4.145 . . . . 0.0 118.26 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 55.24 40.42 31.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.247 1.419 . . . . 0.0 112.86 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 p -143.39 161.06 39.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.249 2.22 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.37 -44.91 54.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.341 1.056 . . . . 0.0 113.498 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.33 -34.43 75.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.575 1.15 . . . . 0.0 112.306 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.69 -26.93 72.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.415 1.007 . . . . 0.0 114.318 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.9 -45.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 118.276 1.038 . . . . 0.0 111.076 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.02 -45.96 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.395 1.078 . . . . 0.0 111.065 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.2 t -57.79 -45.16 86.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.855 0.862 . . . . 0.0 112.356 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -57.22 -33.97 68.07 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.41 -53.61 9.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.641 0.655 . . . . 0.0 112.169 170.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -61.09 -33.5 73.44 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.87 -1.144 . . . . 0.0 113.309 -173.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -64.13 -15.22 59.26 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -115.63 -34.31 4.9 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.789 1.236 . . . . 0.0 113.394 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.6 66.76 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.82 51.23 50.58 Favored Glycine 0 CA--C 1.544 1.874 0 C-N-CA 125.606 1.575 . . . . 0.0 116.066 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 -19.91 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.349 2.699 . . . . 0.0 114.558 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.76 13.09 1.7 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.173 1.389 . . . . 0.0 113.929 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -106.89 1.22 24.47 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.04 1.336 . . . . 0.0 114.389 -172.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.178 0 C-N-CA 126.686 1.995 . . . . 0.0 110.595 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -139.8 9.28 2.38 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.49 130.36 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.326 1.05 . . . . 0.0 111.332 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.04 143.84 35.23 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.948 1.299 . . . . 0.0 110.919 169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.21 73.46 0.82 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.935 -1.103 . . . . 0.0 110.042 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.97 152.11 35.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.0 p -146.78 173.35 12.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.696 1.998 . . . . 0.0 110.687 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -56.25 -22.42 29.64 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.52 -24.32 56.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.833 1.253 . . . . 0.0 113.899 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -136.36 -20.13 1.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.89 -36.24 69.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.265 1.393 . . . . 0.0 111.398 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -63.01 -0.33 0.68 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 128.428 2.691 . . . . 0.0 115.26 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -114.36 -18.54 11.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 114.212 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -79.31 -25.38 42.39 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -14.71 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 126.968 2.107 . . . . 0.0 114.372 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -125.29 3.31 7.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.71 2.004 . . . . 0.0 114.335 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.46 -7.14 58.0 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.718 1.207 . . . . 0.0 114.173 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.6 p -67.64 154.59 41.12 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.812 1.645 . . . . 0.0 113.02 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.97 -44.2 0.43 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.192 . . . . 0.0 113.632 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -71.56 -22.48 61.74 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.35 -4.99 9.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.178 1.391 . . . . 0.0 114.395 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 -20.73 3.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.414 1.483 . . . . 0.0 115.473 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.63 173.71 15.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.032 1.416 . . . . 0.0 112.83 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -129.49 145.82 51.4 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.737 1.615 . . . . 0.0 109.029 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.7 tp -121.54 133.61 55.02 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.685 1.594 . . . . 0.0 108.968 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.76 149.68 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.27 1.028 . . . . 0.0 111.599 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -120.24 123.12 42.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.001 2.12 . . . . 0.0 110.716 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.01 134.92 48.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.366 1.066 . . . . 0.0 110.979 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.17 -160.34 0.99 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.377 1.471 . . . . 0.0 110.587 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.3 148.11 18.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.136 1.374 . . . . 0.0 110.066 169.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.43 -33.65 97.36 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.832 2.355 . . . . 0.0 113.432 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -67.11 -14.28 62.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 p -126.26 3.51 7.08 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.24 -19.4 1.91 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 168.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -53.24 -39.04 63.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.016 1.908 . . . . 0.0 115.493 -168.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.9 p -66.28 -7.89 21.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -148.31 -34.64 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -82.56 -30.59 29.55 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.44 -16.76 1.81 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -169.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.53 -49.0 74.49 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.16 -22.27 19.4 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.911 1.741 . . . . 0.0 113.536 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -75.35 -48.98 20.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.61 0.764 . . . . 0.0 111.85 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.85 -32.54 65.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.117 -0.99 . . . . 0.0 113.254 -170.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -60.98 -41.75 97.03 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.648 1.179 . . . . 0.0 111.541 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.21 86.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.9 0.88 . . . . 0.0 112.691 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.4 98.92 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.828 0.74 . . . . 0.0 111.909 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.98 -38.25 85.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.66 0.784 . . . . 0.0 111.991 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -62.65 -41.54 99.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.438 0.695 . . . . 0.0 111.412 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -67.61 -38.86 84.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.106 0.962 . . . . 0.0 113.321 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.45 5.56 48.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.655 1.582 . . . . 0.0 113.1 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.43 124.7 19.86 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.835 -1.166 . . . . 0.0 111.302 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.37 5.69 89.65 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.547 1.07 . . . . 0.0 114.631 -172.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mt -125.78 -44.4 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.551 1.541 . . . . 0.0 111.211 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -146.87 127.37 6.95 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.054 1.341 . . . . 0.0 110.851 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 134.65 15.12 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.353 2.702 . . . . 0.0 110.483 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mp -118.55 148.13 42.97 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.284 1.434 . . . . 0.0 110.728 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.35 44.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.342 1.057 . . . . 0.0 113.328 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -129.97 145.23 51.63 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 112.431 175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 t -144.75 151.39 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.824 2.05 . . . . 0.0 108.978 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -119.7 121.99 40.45 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.468 -0.77 . . . . 0.0 110.659 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 15.4 t -58.83 -31.81 68.82 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.6 t -71.65 -30.3 65.59 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.03 25.86 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.163 0.985 . . . . 0.0 113.324 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -138.04 78.7 1.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.282 1.515 . . . . 0.0 111.761 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.7 m -69.08 -31.0 69.44 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.052 1.341 . . . . 0.0 111.892 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -60.19 -50.54 73.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.273 1.029 . . . . 0.0 111.368 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 m -63.64 -39.88 95.46 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.709 0.804 . . . . 0.0 111.893 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.86 -51.8 62.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.544 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.0 -34.79 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.312 -0.867 . . . . 0.0 112.992 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -57.74 -28.03 63.55 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.846 1.258 . . . . 0.0 113.147 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -105.71 3.79 29.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.742 1.217 . . . . 0.0 113.291 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.71 59.32 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.847 1.213 . . . . 0.0 114.516 169.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.14 56.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.448 1.499 . . . . 0.0 109.98 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.1 m -60.71 -10.41 5.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.781 1.632 . . . . 0.0 114.692 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.03 165.93 35.46 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 127.211 2.339 . . . . 0.0 109.795 171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -155.89 161.63 29.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.546 1.538 . . . . 0.0 113.121 -171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.57 139.01 39.18 Favored 'Cis proline' 0 C--N 1.359 1.083 0 CA-C-N 120.554 1.233 . . . . 0.0 113.551 5.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 m -142.13 110.74 6.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.997 1.319 . . . . 0.0 109.328 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.76 145.74 28.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.354 0.661 . . . . 0.0 109.73 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -139.62 140.62 37.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.089 0.956 . . . . 0.0 112.384 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.12 136.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.441 1.896 . . . . 0.0 109.457 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.91 91.96 3.31 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.113 1.765 . . . . 0.0 110.086 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 51.5 ttm-85 -68.3 119.05 12.21 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.072 0.949 . . . . 0.0 109.502 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.33 40.37 1.79 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.651 1.98 . . . . 0.0 114.062 -168.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.87 61.61 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 116.101 1.201 . . . . 0.0 116.101 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -135.19 138.08 43.29 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.704 1.601 . . . . 0.0 109.622 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.26 124.36 15.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 0.0 111.994 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.31 -11.65 1.89 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.19 112.75 0.37 Allowed Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.891 0.769 . . . . 0.0 114.871 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.64 124.77 25.94 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.695 -0.885 . . . . 0.0 109.133 167.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -64.12 149.44 47.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.095 1.358 . . . . 0.0 112.718 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.56 14.27 1.96 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 113.179 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.62 -177.06 38.49 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.831 1.205 . . . . 0.0 113.737 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.33 137.58 64.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.024 3.149 . . . . 0.0 113.593 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.81 66.19 8.3 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 169.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.2 p -147.23 155.22 41.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.12 2.168 . . . . 0.0 109.673 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.42 -40.52 62.26 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.135 0.974 . . . . 0.0 113.033 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.31 -36.82 81.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.554 1.142 . . . . 0.0 112.686 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.47 -45.73 95.78 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.578 1.085 . . . . 0.0 112.37 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.9 mm -65.07 -46.4 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.719 0.808 . . . . 0.0 111.941 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.71 -47.73 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.949 0.9 . . . . 0.0 110.095 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.9 m -58.26 -43.94 88.13 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -60.17 -35.11 74.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.629 1.171 . . . . 0.0 112.876 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -71.53 -52.83 16.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.734 0.814 . . . . 0.0 111.056 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -58.07 -36.77 73.3 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.24 0.927 . . . . 0.0 112.543 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -63.44 -13.2 37.73 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.181 1.792 . . . . 0.0 115.662 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -117.74 -32.44 4.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.815 1.246 . . . . 0.0 113.145 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.97 -19.44 65.72 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.96 -169.48 33.21 Favored Glycine 0 CA--C 1.544 1.852 0 C-N-CA 125.842 1.687 . . . . 0.0 113.348 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.1 -27.46 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.75 2.967 . . . . 0.0 113.894 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 42.97 46.57 4.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.383 1.873 . . . . 0.0 115.044 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.9 m -65.38 -16.53 63.71 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.304 2.241 . . . . 0.0 110.471 -179.803 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.537 0.208 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.5 -20.27 54.58 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -170.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.1 t -56.62 128.18 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.008 1.323 . . . . 0.0 111.459 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.2 120.96 18.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.301 1.04 . . . . 0.0 111.438 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -87.94 99.31 12.04 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.859 -1.151 . . . . 0.0 110.677 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -106.61 165.14 11.51 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.44 1.496 . . . . 0.0 112.848 -171.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -166.63 169.49 13.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.193 2.197 . . . . 0.0 108.416 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.14 -24.09 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 114.555 -175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.48 -29.22 67.67 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.964 1.306 . . . . 0.0 114.267 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -140.49 -12.49 1.02 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.5 -37.56 57.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.045 1.293 . . . . 0.0 111.115 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.88 -3.39 0.53 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.272 2.629 . . . . 0.0 115.75 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.0 p -111.86 -15.04 13.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.405 1.482 . . . . 0.0 114.137 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -84.24 -32.15 24.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.035 1.334 . . . . 0.0 113.134 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.61 -32.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 113.947 -169.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 p -98.78 -12.64 20.71 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.886 1.674 . . . . 0.0 113.836 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.72 -3.86 58.14 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.918 1.287 . . . . 0.0 112.886 171.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -57.23 -24.22 53.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.631 1.572 . . . . 0.0 114.776 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.41 -19.24 4.13 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.271 1.891 . . . . 0.0 116.868 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.3 p -64.07 -32.73 74.39 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.89 -10.39 7.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.147 1.779 . . . . 0.0 113.177 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 -8.54 70.45 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.118 1.818 . . . . 0.0 114.22 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -158.38 174.54 14.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.406 1.483 . . . . 0.0 112.756 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 54.7 ttp -132.31 146.29 51.88 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.958 1.303 . . . . 0.0 109.564 168.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.32 139.62 42.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.839 1.656 . . . . 0.0 107.902 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -140.82 146.57 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.026 -1.046 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -119.99 103.01 8.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.279 1.832 . . . . 0.0 109.716 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -86.71 123.79 32.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.739 0.816 . . . . 0.0 109.122 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.45 163.96 37.82 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.92 118.21 25.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.782 1.233 . . . . 0.0 109.309 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.85 -24.82 67.89 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.809 2.34 . . . . 0.0 114.422 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -17.74 64.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.7 m -75.54 -8.71 57.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.25 -50.2 4.36 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.278 1.418 . . . . 0.0 114.831 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -60.06 -32.03 70.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.167 0.987 . . . . 0.0 112.093 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.69 -37.43 87.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.613 1.165 . . . . 0.0 112.214 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -69.65 -28.68 66.1 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.368 1.467 . . . . 0.0 113.081 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.6 -31.59 59.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.043 1.337 . . . . 0.0 112.478 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -89.26 -34.49 16.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.26 -42.44 81.34 Favored Pre-proline 0 CA--C 1.556 1.207 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 -11.12 23.92 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.864 2.376 . . . . 0.0 113.605 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.6 -38.43 10.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.979 0.809 . . . . 0.0 111.88 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -63.69 -36.01 82.46 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.046 -1.034 . . . . 0.0 112.838 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -69.79 -30.69 68.3 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.483 -1.386 . . . . 0.0 113.792 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.45 82.54 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.836 -0.54 . . . . 0.0 111.164 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.16 90.2 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.524 -0.735 . . . . 0.0 111.942 171.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.35 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.192 -0.942 . . . . 0.0 112.411 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.5 m -65.04 -43.94 90.72 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.113 0.965 . . . . 0.0 111.653 170.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -69.19 -31.81 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.015 1.326 . . . . 0.0 113.792 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.63 13.54 26.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.685 1.994 . . . . 0.0 112.7 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -54.01 117.79 3.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.486 1.914 . . . . 0.0 111.672 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.98 -1.62 78.68 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.796 1.188 . . . . 0.0 115.034 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.16 -41.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.29 1.436 . . . . 0.0 110.492 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.24 123.47 4.0 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.524 1.13 . . . . 0.0 110.947 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.08 132.2 49.99 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.893 3.062 . . . . 0.0 112.855 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.56 141.34 49.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.632 1.573 . . . . 0.0 110.203 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.33 169.94 16.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.619 0.768 . . . . 0.0 112.839 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -138.14 161.58 36.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.44 1.496 . . . . 0.0 112.736 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.68 128.1 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.666 1.586 . . . . 0.0 109.002 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.25 92.74 9.17 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.925 1.29 . . . . 0.0 111.538 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -64.66 -23.64 67.32 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -66.41 -23.09 66.25 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.383 0.992 . . . . 0.0 112.63 170.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.22 -12.01 11.91 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.227 1.811 . . . . 0.0 112.968 -174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -143.32 52.56 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.49 2.316 . . . . 0.0 111.327 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -66.54 -38.32 86.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.957 -169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.88 -39.76 94.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.54 0.736 . . . . 0.0 111.7 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 m -62.63 -42.4 99.57 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.722 0.809 . . . . 0.0 110.947 172.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 68.0 m -72.87 -29.31 63.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.481 -1.387 . . . . 0.0 113.908 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -73.29 -33.37 65.18 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 120.777 -1.202 . . . . 0.0 112.253 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.98 -25.96 67.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.331 1.452 . . . . 0.0 112.726 169.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -107.41 -15.76 14.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.303 1.041 . . . . 0.0 113.711 -175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.74 32.07 8.87 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.417 1.008 . . . . 0.0 114.054 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.94 49.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.718 1.607 . . . . 0.0 110.927 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.8 p -65.33 -4.8 5.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.7 49.29 0.51 Allowed Glycine 0 N--CA 1.473 1.128 0 C-N-CA 124.607 1.099 . . . . 0.0 114.083 -172.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.07 153.55 6.24 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.18 140.08 62.4 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 118.697 0.571 . . . . 0.0 111.686 -5.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -130.38 109.65 10.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.694 1.198 . . . . 0.0 109.365 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.15 142.64 27.47 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.23 0.612 . . . . 0.0 110.857 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.54 148.78 34.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.121 1.368 . . . . 0.0 112.056 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.13 138.41 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.466 1.906 . . . . 0.0 108.85 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -132.14 85.85 2.28 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.252 1.421 . . . . 0.0 111.101 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -67.66 128.43 36.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.724 0.81 . . . . 0.0 109.86 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.38 29.53 3.92 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.044 1.337 . . . . 0.0 112.962 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.78 22.04 75.5 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.495 1.045 . . . . 0.0 115.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -133.69 141.13 47.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.346 1.858 . . . . 0.0 110.03 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.31 122.15 9.01 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.965 0.906 . . . . 0.0 112.687 -170.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.77 -11.37 3.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 180.0 111.71 0.32 Allowed Glycine 0 C--N 1.338 0.674 0 O-C-N 121.774 -0.579 . . . . 0.0 114.008 171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.53 130.02 41.65 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.9 150.39 47.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.006 0.922 . . . . 0.0 113.28 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.56 13.74 1.95 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.546 1.138 . . . . 0.0 113.099 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.28 -177.85 34.4 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.702 1.144 . . . . 0.0 113.595 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.06 136.71 76.38 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.835 3.023 . . . . 0.0 113.568 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -76.13 63.63 1.86 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.519 1.128 . . . . 0.0 110.963 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.6 p -146.76 157.3 43.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.674 1.99 . . . . 0.0 110.453 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.15 -42.76 66.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 112.652 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.72 -34.17 76.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.723 1.209 . . . . 0.0 112.553 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -39.87 98.06 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.932 0.777 . . . . 0.0 112.602 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.5 mm -69.37 -49.3 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.218 1.009 . . . . 0.0 111.155 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.76 -42.48 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.252 1.021 . . . . 0.0 111.387 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -60.51 -48.57 81.2 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.677 1.191 . . . . 0.0 112.516 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -60.19 -37.56 80.6 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.947 -1.096 . . . . 0.0 112.616 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.14 -51.62 23.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.347 1.059 . . . . 0.0 112.499 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.87 -26.55 68.83 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.869 -1.145 . . . . 0.0 113.551 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -70.74 -5.52 30.53 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.241 1.816 . . . . 0.0 114.784 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -132.62 -36.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.765 1.226 . . . . 0.0 113.436 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.07 -26.44 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 66.93 0.11 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.158 -1.357 . . . . 0.0 114.52 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.69 -28.96 59.25 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 115.196 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.81 169.77 20.33 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.341 1.856 . . . . 0.0 111.236 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.735 1.614 . . . . 0.0 113.739 177.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.464 0.173 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.97 -23.42 52.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.23 134.58 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.587 1.155 . . . . 0.0 109.797 172.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.84 149.14 48.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.242 0.617 . . . . 0.0 112.232 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -120.07 95.15 4.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.491 1.117 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -102.41 165.42 11.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 113.577 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.5 p -145.68 165.25 29.31 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.216 1.807 . . . . 0.0 110.321 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.35 -27.04 54.76 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 113.082 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.76 -25.96 54.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.561 1.544 . . . . 0.0 114.018 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -14.37 3.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -170.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -50.94 -37.79 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.686 1.13 . . . . 0.0 112.315 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.58 -10.98 21.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.306 1.842 . . . . 0.0 114.99 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -92.34 -25.36 18.58 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.439 1.096 . . . . 0.0 113.932 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -78.3 -37.48 44.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.136 0.975 . . . . 0.0 112.922 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -23.63 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 113.998 -169.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -77.92 -17.83 56.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.539 1.536 . . . . 0.0 113.031 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.19 -3.89 58.45 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.246 1.019 . . . . 0.0 113.399 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 p -59.74 -23.68 63.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.34 -30.2 24.83 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.803 1.192 . . . . 0.0 114.947 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -74.99 -16.65 60.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.07 -6.61 3.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.745 1.218 . . . . 0.0 114.244 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -29.7 3.23 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.295 1.902 . . . . 0.0 114.883 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.16 174.3 13.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.591 1.556 . . . . 0.0 112.263 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.4 ttt -132.85 148.28 52.3 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.828 1.651 . . . . 0.0 110.648 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -118.49 137.31 53.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.502 1.521 . . . . 0.0 108.091 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.59 147.45 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.965 0.906 . . . . 0.0 111.776 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -118.26 127.17 53.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.275 1.43 . . . . 0.0 111.391 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -103.53 126.92 50.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.846 1.258 . . . . 0.0 109.416 171.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -147.34 172.5 13.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.518 1.127 . . . . 0.0 112.139 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.44 104.89 17.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.868 1.267 . . . . 0.0 110.341 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.66 -8.03 22.12 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.142 2.562 . . . . 0.0 114.72 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -68.47 -23.39 64.58 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.4 m -72.66 143.07 48.25 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.138 0.975 . . . . 0.0 111.888 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -23.47 60.69 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.448 1.023 . . . . 0.0 114.825 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.87 -16.09 60.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.99 1.316 . . . . 0.0 114.145 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.38 -38.24 65.92 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -69.51 -19.52 63.73 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -103.15 -35.45 8.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.284 1.433 . . . . 0.0 112.627 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -81.13 -40.47 23.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.855 1.262 . . . . 0.0 113.568 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.99 -44.96 98.25 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.03 -15.06 26.17 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.607 2.205 . . . . 0.0 113.274 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -87.97 -38.25 15.7 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.183 -0.948 . . . . 0.0 112.562 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -70.31 -32.97 70.96 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.096 -1.003 . . . . 0.0 112.453 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.83 -32.68 71.23 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.327 -1.483 . . . . 0.0 112.972 170.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.7 98.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.553 -0.717 . . . . 0.0 111.282 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.33 -44.49 95.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.521 1.055 . . . . 0.0 112.415 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.51 70.94 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 m -73.35 -42.63 62.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 0.0 111.805 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -76.18 -19.47 58.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.789 1.235 . . . . 0.0 113.763 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -114.37 14.77 18.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.132 1.773 . . . . 0.0 112.432 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -56.54 118.37 4.76 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.739 1.215 . . . . 0.0 111.809 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.86 -0.72 86.2 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.598 1.094 . . . . 0.0 115.144 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.6 mm -108.64 -41.96 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.316 1.846 . . . . 0.0 110.342 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.45 120.05 5.6 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 125.959 1.703 . . . . 0.0 109.215 173.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.81 132.94 17.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.591 2.194 . . . . 0.0 110.77 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.05 143.21 48.22 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.374 1.469 . . . . 0.0 110.859 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.74 161.13 39.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.255 1.422 . . . . 0.0 112.129 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 161.75 37.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.6 t -148.54 141.49 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.435 2.294 . . . . 0.0 109.299 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -99.79 115.35 29.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.507 0.723 . . . . 0.0 111.145 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.79 -40.29 83.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.823 1.249 . . . . 0.0 112.822 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -68.14 -24.25 64.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.735 0.814 . . . . 0.0 113.112 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.17 -12.8 25.73 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 114.003 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -140.61 66.66 1.37 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.875 1.67 . . . . 0.0 111.901 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 -43.04 80.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.741 1.216 . . . . 0.0 111.754 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -63.25 -44.16 95.99 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.105 0.562 . . . . 0.0 111.314 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 m -61.7 -45.59 93.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.985 0.914 . . . . 0.0 110.941 173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 46.9 t -59.74 -42.95 94.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.419 1.088 . . . . 0.0 112.208 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.82 -39.15 64.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.349 0.659 . . . . 0.0 112.225 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.68 -30.24 71.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.758 1.223 . . . . 0.0 112.968 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.54 -10.06 33.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.32 0.648 . . . . 0.0 112.644 -176.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 23.91 41.4 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.66 1.124 . . . . 0.0 113.263 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.98 58.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 126.089 1.756 . . . . 0.0 109.491 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -60.97 -9.98 5.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.72 172.24 38.73 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.805 2.622 . . . . 0.0 109.416 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.18 158.15 38.9 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.603 1.161 . . . . 0.0 113.779 -170.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.23 143.84 71.19 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 118.752 0.59 . . . . 0.0 112.918 -4.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 m -125.7 119.61 28.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.485 1.514 . . . . 0.0 108.421 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.16 130.35 55.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.041 0.937 . . . . 0.0 110.706 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -129.33 149.07 51.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.2 1.4 . . . . 0.0 113.444 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.74 133.7 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.875 2.07 . . . . 0.0 108.544 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -127.8 102.65 6.89 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.04 1.336 . . . . 0.0 109.857 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -79.2 128.21 33.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.243 1.017 . . . . 0.0 110.223 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.262 4.3 p30 43.99 28.11 0.23 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.563 1.945 . . . . 0.0 115.583 -173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.86 14.62 28.73 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.858 1.218 . . . . 0.0 115.985 172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -143.06 142.67 31.61 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.17 1.388 . . . . 0.0 110.542 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -52.46 129.7 29.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.075 0.95 . . . . 0.0 111.289 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.14 -14.06 1.17 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.065 0.546 . . . . 0.0 111.765 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.06 -170.4 38.03 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-O 124.388 2.104 . . . . 0.0 111.14 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.37 140.72 30.62 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 128.08 2.552 . . . . 0.0 111.016 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -77.42 145.07 37.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.796 0.838 . . . . 0.0 110.739 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -149.12 126.94 11.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.977 1.311 . . . . 0.0 109.767 169.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.82 -159.71 31.19 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.667 0.651 . . . . 0.0 112.909 -170.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.32 -23.72 10.58 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.836 3.691 . . . . 0.0 117.525 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 55.18 46.88 22.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.369 1.468 . . . . 0.0 112.316 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 p -142.0 161.2 38.57 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.775 2.43 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.46 -46.94 38.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -66.36 -31.63 72.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.056 0.942 . . . . 0.0 112.508 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.84 -39.38 93.45 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.62 1.105 . . . . 0.0 113.258 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.15 -47.62 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 118.482 1.141 . . . . 0.0 110.611 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -41.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.024 0.93 . . . . 0.0 111.603 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -61.97 -41.15 97.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.72 -36.21 83.12 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.466 -0.772 . . . . 0.0 112.234 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.78 -50.74 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.49 0.716 . . . . 0.0 112.306 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -65.4 -24.38 67.2 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.68 -1.262 . . . . 0.0 113.476 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -71.47 -9.27 57.92 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -129.3 -33.66 1.9 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.25 -5.5 25.43 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.3 -162.31 30.54 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.835 1.683 . . . . 0.0 113.061 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -21.37 27.69 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.079 2.519 . . . . 0.0 113.722 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.46 167.02 19.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.771 1.228 . . . . 0.0 112.509 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -152.68 160.47 43.16 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.496 1.518 . . . . 0.0 111.369 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.168 2.187 . . . . 0.0 111.909 -177.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.393 0.616 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.48 -13.81 4.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.613 1.565 . . . . 0.0 112.417 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.16 132.77 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.11 1.364 . . . . 0.0 110.338 170.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.09 124.47 23.51 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.845 1.258 . . . . 0.0 111.976 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.51 105.61 17.74 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.969 -1.082 . . . . 0.0 110.582 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.6 mt -116.51 167.27 11.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.794 1.238 . . . . 0.0 113.397 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -147.67 168.98 20.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.462 1.905 . . . . 0.0 110.574 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.87 -24.66 53.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.0 -23.06 60.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.957 1.303 . . . . 0.0 114.118 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -128.83 -25.2 2.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -56.87 -35.27 68.72 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.762 1.165 . . . . 0.0 111.524 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.73 1.68 0.58 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.399 2.28 . . . . 0.0 115.507 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -131.89 -16.48 2.9 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -63.98 -23.96 67.54 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.969 -1.082 . . . . 0.0 113.105 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -21.31 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -80.76 -10.74 59.7 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.61 -6.41 49.51 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -71.41 161.47 30.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 112.767 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.71 -56.4 0.25 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.322 0.963 . . . . 0.0 113.568 169.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 p -72.87 -38.38 67.03 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.629 1.172 . . . . 0.0 113.232 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.88 -22.36 58.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.585 1.154 . . . . 0.0 114.074 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.61 -23.54 2.92 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.284 1.421 . . . . 0.0 114.492 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.28 173.52 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.738 1.615 . . . . 0.0 112.049 176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ttt -127.57 147.53 50.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.648 1.579 . . . . 0.0 109.083 169.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -121.4 134.58 55.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.51 1.124 . . . . 0.0 109.237 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.45 148.01 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.926 0.89 . . . . 0.0 110.85 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.68 132.05 54.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.175 1.39 . . . . 0.0 111.261 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.51 138.03 44.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.266 1.026 . . . . 0.0 111.326 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -151.69 -177.42 6.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.484 1.913 . . . . 0.0 110.619 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.98 144.23 17.89 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 120.793 -1.192 . . . . 0.0 109.797 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.01 4.45 3.71 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.005 3.136 . . . . 0.0 115.146 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -66.01 -14.63 61.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.405 1.482 . . . . 0.0 114.264 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.5 p -141.83 167.68 21.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.672 1.589 . . . . 0.0 112.319 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.62 4.36 69.16 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 115.759 1.064 . . . . 0.0 115.759 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.94 -16.81 53.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.356 1.578 . . . . 0.0 114.25 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.2 p -54.75 -32.17 59.52 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.222 1.009 . . . . 0.0 113.601 170.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -58.52 -21.62 52.73 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -108.83 -12.7 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.405 2.282 . . . . 0.0 112.966 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -120.18 -30.54 4.62 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.847 1.259 . . . . 0.0 113.422 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.95 99.9 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 117.874 -1.06 . . . . 0.0 113.494 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.45 -11.0 24.37 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.919 1.746 . . . . 0.0 113.273 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -87.16 -44.48 11.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.209 0.913 . . . . 0.0 111.82 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -78.04 -32.99 51.22 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.364 -0.835 . . . . 0.0 113.012 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.14 -39.72 93.41 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.812 -1.18 . . . . 0.0 111.546 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.24 99.66 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.023 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.29 91.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.594 1.088 . . . . 0.0 112.392 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.04 70.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.638 0.775 . . . . 0.0 112.471 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 38.4 m -72.67 -44.1 62.26 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.621 1.169 . . . . 0.0 111.642 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -73.42 -21.81 60.38 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.622 1.169 . . . . 0.0 113.444 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.26 16.27 20.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.367 1.867 . . . . 0.0 112.386 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.11 118.39 6.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.435 1.094 . . . . 0.0 111.162 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.05 8.26 87.96 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.7 mt -121.81 -42.49 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.892 1.677 . . . . 0.0 110.958 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.39 126.84 7.66 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 125.177 1.391 . . . . 0.0 110.215 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 125.75 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.63 2.22 . . . . 0.0 110.327 171.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.77 138.54 51.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.303 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.63 163.41 34.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -134.84 150.25 50.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.515 1.526 . . . . 0.0 112.596 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.2 t -143.81 150.63 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.273 2.229 . . . . 0.0 108.761 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -111.5 122.45 47.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.622 0.769 . . . . 0.0 111.475 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 38.9 t -62.9 -33.9 76.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 113.924 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 t -63.43 -26.72 68.86 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.965 -1.084 . . . . 0.0 112.476 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.42 -15.29 16.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.831 1.252 . . . . 0.0 113.57 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.07 57.02 1.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.905 1.812 . . . . 0.0 111.002 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.7 m -69.23 -39.55 78.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.123 -167.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.04 -42.21 97.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.162 0.585 . . . . 0.0 111.733 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -61.47 -48.72 79.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.163 0.985 . . . . 0.0 110.319 173.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.5 t -57.4 -45.13 84.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.649 1.58 . . . . 0.0 112.006 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -75.98 -34.89 59.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.345 -0.847 . . . . 0.0 112.73 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.42 -28.62 69.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.913 0.885 . . . . 0.0 111.91 170.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -89.5 -10.28 46.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.031 0.932 . . . . 0.0 113.131 -173.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.87 20.42 57.88 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.359 0.981 . . . . 0.0 113.82 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.36 57.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.477 1.911 . . . . 0.0 109.832 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.0 p -66.65 -9.75 39.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.589 1.556 . . . . 0.0 114.918 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.58 68.99 0.17 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.688 1.137 . . . . 0.0 112.526 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -55.23 157.64 6.14 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 113.9 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.17 142.41 57.41 Favored 'Cis proline' 0 C--N 1.355 0.871 0 CA-C-N 119.348 0.803 . . . . 0.0 113.43 0.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 m -139.32 118.52 12.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.917 0.887 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.5 137.12 36.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.982 0.513 . . . . 0.0 109.981 172.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -129.82 148.39 51.69 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.174 1.39 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.6 mt -112.72 139.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.826 1.65 . . . . 0.0 109.367 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -129.83 90.38 2.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.024 1.329 . . . . 0.0 109.79 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -61.51 117.73 6.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.183 1.393 . . . . 0.0 109.441 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.8 t0 37.14 43.69 0.35 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.734 2.014 . . . . 0.0 114.379 -168.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.59 21.11 58.74 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.21 136.02 37.77 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.273 1.536 . . . . 0.0 109.507 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -53.31 112.08 0.82 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.288 1.035 . . . . 0.0 113.008 -172.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 -41.94 29.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.082 0.553 . . . . 0.0 109.709 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.07 -77.58 0.2 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.12 0.866 . . . . 0.0 113.926 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.89 155.78 33.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.052 1.741 . . . . 0.0 111.517 -174.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.6 159.67 26.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.527 1.131 . . . . 0.0 113.095 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.33 -39.38 94.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.008 1.323 . . . . 0.0 114.478 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 149.82 -52.89 0.51 Allowed Glycine 0 CA--C 1.543 1.837 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.3 92.13 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.153 2.569 . . . . 0.0 112.365 -172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -75.87 56.03 0.93 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.338 1.855 . . . . 0.0 113.358 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.2 p -130.61 150.63 51.72 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.438 1.895 . . . . 0.0 109.754 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.28 20.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.22 1.408 . . . . 0.0 113.622 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.57 -31.52 71.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.141 0.977 . . . . 0.0 112.867 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.97 -47.49 85.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.628 1.109 . . . . 0.0 112.082 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mm -61.97 -46.01 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 117.805 0.803 . . . . 0.0 110.618 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -61.96 -46.31 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.48 1.112 . . . . 0.0 111.667 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.9 m -59.23 -40.92 87.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.29 0.636 . . . . 0.0 112.534 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.64 -34.11 75.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.641 1.176 . . . . 0.0 112.446 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.73 -49.89 28.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.004 0.922 . . . . 0.0 111.866 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -57.74 -33.78 68.81 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.991 -1.068 . . . . 0.0 113.301 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -67.62 -11.78 58.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.285 1.834 . . . . 0.0 115.53 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -124.95 -28.68 3.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.232 1.413 . . . . 0.0 114.408 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.85 -12.57 11.36 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.217 1.807 . . . . 0.0 114.992 172.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.84 166.53 27.87 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.311 1.434 . . . . 0.0 113.368 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.16 -20.93 12.42 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.613 2.875 . . . . 0.0 114.395 -171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.27 18.72 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.559 1.543 . . . . 0.0 112.41 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m -109.36 12.13 24.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.516 1.526 . . . . 0.0 112.911 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.393 2.277 . . . . 0.0 113.28 -176.21 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -81.57 -17.65 47.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.842 0.857 . . . . 0.0 113.27 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.18 131.07 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.532 1.133 . . . . 0.0 110.482 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.38 133.49 44.95 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.958 1.303 . . . . 0.0 111.576 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.47 67.77 1.03 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.765 1.269 . . . . 0.0 111.812 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.71 152.36 31.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.297 1.039 . . . . 0.0 112.384 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 p -145.89 169.0 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.392 1.477 . . . . 0.0 111.139 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.08 -19.87 21.86 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.405 1.482 . . . . 0.0 113.609 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.62 -23.28 34.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.623 1.569 . . . . 0.0 114.407 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -133.92 -20.87 1.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.53 -43.5 68.43 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.328 1.422 . . . . 0.0 111.631 -172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.2 0.23 3.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.917 2.087 . . . . 0.0 114.9 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 m -132.13 13.46 4.7 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.426 1.49 . . . . 0.0 113.78 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -117.72 -8.36 10.88 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.37 1.468 . . . . 0.0 114.529 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -24.5 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.581 1.152 . . . . 0.0 113.29 171.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 p -81.2 -13.79 58.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.709 2.003 . . . . 0.0 113.725 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -75.05 -3.15 30.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.421 1.488 . . . . 0.0 112.768 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 p -62.62 -23.72 67.21 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.177 1.791 . . . . 0.0 115.136 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.41 -29.28 16.52 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 124.964 1.268 . . . . 0.0 115.854 -174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -72.16 -18.78 61.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.89 -7.89 2.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.519 1.128 . . . . 0.0 113.832 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.45 -9.89 60.5 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.377 1.465 . . . . 0.0 114.541 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.19 171.18 20.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.09 1.445 . . . . 0.0 112.671 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.7 tpp -124.27 141.04 52.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.353 1.861 . . . . 0.0 109.088 170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.25 127.5 53.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 168.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.66 148.01 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.14 0.576 . . . . 0.0 111.77 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -119.05 102.0 8.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.332 1.853 . . . . 0.0 109.616 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.04 124.94 30.25 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -151.61 168.45 24.91 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.715 0.806 . . . . 0.0 112.607 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.85 44.12 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.988 1.715 . . . . 0.0 108.639 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.73 -11.9 31.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.597 2.865 . . . . 0.0 115.215 -170.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.33 -20.57 62.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.46 1.104 . . . . 0.0 113.636 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.2 m -72.88 150.1 42.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.538 1.135 . . . . 0.0 112.708 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.83 -24.3 64.4 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.467 1.032 . . . . 0.0 115.172 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -61.49 -19.07 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.916 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.8 t -57.18 -44.06 83.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.301 1.04 . . . . 0.0 111.74 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -63.08 -28.96 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.227 1.411 . . . . 0.0 113.344 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -91.02 -37.08 13.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.431 1.492 . . . . 0.0 112.303 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 tp -93.88 -32.6 13.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.5 -45.16 90.66 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 -19.36 18.58 Favored 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.016 1.811 . . . . 0.0 113.862 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.2 -41.3 61.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.892 0.769 . . . . 0.0 111.77 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -76.12 -30.64 58.3 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.367 -0.833 . . . . 0.0 112.676 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.23 -40.5 94.14 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.684 -1.26 . . . . 0.0 112.203 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.44 99.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.281 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.58 96.62 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.032 0.833 . . . . 0.0 112.588 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.37 75.66 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.364 -0.835 . . . . 0.0 112.297 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.3 m -67.31 -45.43 76.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.403 1.481 . . . . 0.0 111.522 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -76.15 -20.05 57.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.806 1.243 . . . . 0.0 114.252 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.08 14.89 17.16 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.916 1.686 . . . . 0.0 112.693 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.9 120.08 7.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.732 1.213 . . . . 0.0 112.222 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.51 -2.48 85.31 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.379 0.99 . . . . 0.0 115.074 -174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -112.35 -39.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.797 1.639 . . . . 0.0 110.792 -177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.36 121.77 6.57 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.856 1.662 . . . . 0.0 108.879 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.91 135.06 22.7 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.924 1.749 . . . . 0.0 109.783 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -114.87 142.18 46.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.701 1.2 . . . . 0.0 109.876 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.58 162.23 35.86 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.224 1.009 . . . . 0.0 112.202 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -135.17 155.94 49.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.932 1.293 . . . . 0.0 111.892 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.22 130.48 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.853 1.661 . . . . 0.0 109.344 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -98.58 97.66 8.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.684 -175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -61.34 -21.47 64.04 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.6 p -68.85 -20.09 64.28 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.765 0.826 . . . . 0.0 112.694 171.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.56 -9.92 9.32 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.145 1.778 . . . . 0.0 114.557 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -140.62 46.4 1.79 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 124.19 1.948 . . . . 0.0 112.035 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -37.18 84.47 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 126.653 1.981 . . . . 0.0 111.899 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.9 -39.06 87.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.544 0.738 . . . . 0.0 112.505 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 m -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.109 0.413 . . . . 0.0 110.682 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.82 -33.34 73.68 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.62 -22.84 61.65 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.945 -1.097 . . . . 0.0 113.268 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -60.09 -22.96 63.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.958 0.903 . . . . 0.0 112.652 169.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -122.79 -20.56 5.85 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -170.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 35.4 5.66 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.414 0.531 . . . . 0.0 112.939 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.88 50.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.589 1.955 . . . . 0.0 111.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.9 p -69.86 -3.37 15.48 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.623 1.569 . . . . 0.0 114.697 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.83 49.65 0.53 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.038 1.304 . . . . 0.0 113.82 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.51 155.43 5.33 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 140.38 56.39 Favored 'Cis proline' 0 C--N 1.352 0.734 0 CA-C-N 119.241 0.765 . . . . 0.0 113.235 -5.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.7 m -134.86 112.8 10.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.212 1.405 . . . . 0.0 109.903 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.94 141.88 28.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.101 0.56 . . . . 0.0 110.947 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -144.59 147.99 33.81 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.524 1.129 . . . . 0.0 111.965 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.29 135.82 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.057 1.743 . . . . 0.0 108.988 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -126.05 99.89 6.11 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.895 1.678 . . . . 0.0 110.519 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -70.81 125.83 27.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.127 0.971 . . . . 0.0 110.279 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 49.63 25.86 1.59 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.484 1.514 . . . . 0.0 114.453 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.37 49.99 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.742 1.163 . . . . 0.0 115.595 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -136.41 139.48 42.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.008 1.723 . . . . 0.0 110.512 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.12 126.97 22.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.607 1.163 . . . . 0.0 112.508 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.07 -14.97 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -170.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.92 118.02 0.54 Allowed Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.057 0.844 . . . . 0.0 114.043 171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 129.4 39.81 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.039 -0.683 . . . . 0.0 110.052 168.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -67.57 148.59 51.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.536 1.134 . . . . 0.0 112.195 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -142.63 14.31 1.95 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.508 1.123 . . . . 0.0 113.239 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.46 -174.37 40.2 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.89 1.234 . . . . 0.0 113.527 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -55.84 133.83 60.42 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.621 2.881 . . . . 0.0 112.236 173.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -81.07 54.88 2.33 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.596 1.158 . . . . 0.0 111.183 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.1 p -144.22 155.46 43.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.813 2.045 . . . . 0.0 110.494 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.68 43.06 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -65.52 -33.9 77.01 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.37 1.068 . . . . 0.0 112.285 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.92 87.77 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.84 0.733 . . . . 0.0 112.024 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.2 mm -62.03 -47.96 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 117.783 0.792 . . . . 0.0 111.276 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.77 -48.99 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 111.149 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 t -57.12 -45.5 83.4 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.291 0.636 . . . . 0.0 112.198 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.338 1.055 . . . . 0.0 113.001 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.44 -51.13 21.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.734 0.814 . . . . 0.0 112.193 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -57.92 -36.6 72.7 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.755 -1.216 . . . . 0.0 112.593 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -67.08 -14.46 62.93 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.938 1.695 . . . . 0.0 115.217 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -118.21 -33.96 4.24 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.861 1.265 . . . . 0.0 113.178 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.55 78.61 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.397 1.079 . . . . 0.0 113.522 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.8 -57.49 12.21 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-O 118.693 -1.06 . . . . 0.0 114.204 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.0 2.85 7.16 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.959 3.106 . . . . 0.0 115.154 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.6 17.63 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -128.29 9.42 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.698 1.599 . . . . 0.0 113.781 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.642 1.577 . . . . 0.0 111.175 178.768 . . . . . . . . 0 0 . 1 stop_ save_